<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003811.pub2" GROUP_ID="ORAL" ID="534801082312095943" MERGED_FROM="" MODIFIED="2013-04-24 14:18:23 +0100" MODIFIED_BY="Luisa Fernandez Mauleffinch" REVIEW_NO="0062" REVMAN_SUB_VERSION="5.2.3 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2013-04-24 14:12:37 +0100" MODIFIED_BY="Luisa Fernandez Mauleffinch">
<TITLE>Antibiotics to prevent complications following tooth extractions</TITLE>
<CONTACT>
<PERSON ID="18367" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Giovanni</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lodi</LAST_NAME>
<SUFFIX/>
<POSITION>Researcher</POSITION>
<EMAIL_1>giovanni.lodi@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche</DEPARTMENT>
<ORGANISATION>Università degli Studi di Milano</ORGANISATION>
<ADDRESS_1>Via Beldiletto 1/3</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20142</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+39 02 50319021</PHONE_1>
<PHONE_2/>
<FAX_1>+39 02 50319041</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2013-04-24 12:02:45 +0100" MODIFIED_BY="Luisa Fernandez Mauleffinch">
<PERSON ID="18367" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Giovanni</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lodi</LAST_NAME>
<SUFFIX/>
<POSITION>Researcher</POSITION>
<EMAIL_1>giovanni.lodi@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche</DEPARTMENT>
<ORGANISATION>Università degli Studi di Milano</ORGANISATION>
<ADDRESS_1>Via Beldiletto 1/3</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20142</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+39 02 50319021</PHONE_1>
<PHONE_2/>
<FAX_1>+39 02 50319041</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5522B85282E26AA2000F11BC1BED4E92" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Lara</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Figini</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>lara.figini@libero.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>Piazzale Aquileia 6</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20144</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+39 02 48018847</PHONE_1>
<PHONE_2>+39 02 3471079271</PHONE_2>
<FAX_1>+39 02 48018847</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="11539" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Andrea</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Sardella</LAST_NAME>
<SUFFIX/>
<POSITION>Associate Professor</POSITION>
<EMAIL_1>andrea.sardella@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche</DEPARTMENT>
<ORGANISATION>Università degli Studi di Milano</ORGANISATION>
<ADDRESS_1>Via Beldiletto 1/3</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20142</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>0039 02 50319022</PHONE_1>
<PHONE_2>0039 02 50319019</PHONE_2>
<FAX_1>0039 02 50319041</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="6188" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Antonio</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Carrassi</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>antonio.carrassi@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche</DEPARTMENT>
<ORGANISATION>Università degli Studi di Milano</ORGANISATION>
<ADDRESS_1>Via Beldiletto 1/3</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20142</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+ 39 02 503 19020</PHONE_1>
<PHONE_2>+ 39 02 503 19019</PHONE_2>
<FAX_1>+ 39 02 503 19041</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="72D5CC1082E26AA2014A55948B988ADF" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Massimo</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Del Fabbro</LAST_NAME>
<SUFFIX/>
<POSITION>Head of Section of Oral Physiology</POSITION>
<EMAIL_1>massimo.delfabbro@unimi.it</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche</DEPARTMENT>
<ORGANISATION>Università degli Studi di Milano, IRCCS Istituto Ortopedico Galeazzi</ORGANISATION>
<ADDRESS_1>Via Riccardo Galeazzi 4</ADDRESS_1>
<ADDRESS_2/>
<CITY>Milan</CITY>
<ZIP>20161</ZIP>
<REGION/>
<COUNTRY CODE="IT">Italy</COUNTRY>
<PHONE_1>+39 02 50319950</PHONE_1>
<PHONE_2/>
<FAX_1>+39 02 50319960</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="50BB1C5582E26AA20094E4F45CBA083C" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Susan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Furness</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>Susan.Furness@manchester.ac.uk</EMAIL_1>
<EMAIL_2>suefurness@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Oral Health Group</DEPARTMENT>
<ORGANISATION>School of Dentistry, The University of Manchester</ORGANISATION>
<ADDRESS_1>Coupland III Building, Oxford Rd</ADDRESS_1>
<ADDRESS_2/>
<CITY>Manchester</CITY>
<ZIP>M13 9PL</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 161 275 6877</PHONE_1>
<PHONE_2/>
<FAX_1>+44 161 275 7815</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2013-03-20 09:43:46 +0000" MODIFIED_BY="Giovanni Lodi">
<UP_TO_DATE>
<DATE DAY="25" MONTH="1" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="25" MONTH="1" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="11" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="11" YEAR="2012"/>
<LAST_CITATION_ISSUE ISSUE="11" YEAR="2012"/>
</DATES>
<WHATS_NEW MODIFIED="2013-04-24 14:12:37 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<WHATS_NEW_ENTRY EVENT="FEEDBACK" MODIFIED="2013-04-24 14:12:37 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<DATE DAY="24" MONTH="4" YEAR="2013"/>
<DESCRIPTION>
<P>Comment from Dr John Curran.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY/>
<SOURCES_OF_SUPPORT MODIFIED="2013-04-24 14:11:28 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-10-05 16:00:53 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-10-05 16:00:36 +0100" MODIFIED_BY="[Empty name]">
<NAME>MAHSC</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The Cochrane Oral Health Group is supported by the Manchester Academic Health Sciences Centre (MAHSC) and the NIHR Manchester Biomedical Research Centre.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2012-10-05 16:00:53 +0100" MODIFIED_BY="[Empty name]">
<NAME>The University of Manchester</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2013-04-24 14:11:28 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-10-05 15:58:38 +0100" MODIFIED_BY="[Empty name]">
<NAME>Cochrane Oral Health Group Global Alliance</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>All reviews in the Cochrane Oral Health Group are supported by Global Alliance member organisations (British Orthodontic Society, UK; British Society of Paediatric Dentistry, UK; National Center for Dental Hygiene Research &amp; Practice, USA and New York University College of Dentistry, USA) providing funding for the editorial process (<A HREF="http://ohg.cochrane.org/">http://ohg.cochrane.org/</A>).</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2013-04-24 14:11:28 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>
<U>CRG funding acknowledgement</U>:<BR/>The NIHR is the largest single funder of the Cochrane Oral Health Group.</P>
<P>
<U>Disclaimer</U>:<BR/>The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-10-15 11:38:02 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-09-20 16:33:29 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-06-13 16:10:02 +0100" MODIFIED_BY="[Empty name]">Antibiotics to prevent complications following tooth extractions</TITLE>
<SUMMARY_BODY MODIFIED="2012-09-20 16:33:29 +0100" MODIFIED_BY="Jo Leese">
<P>Tooth extraction is a surgical treatment to remove teeth that are affected by decay or gum disease (performed by general dentists). The other common reason for tooth extraction, performed by oral surgeons, is to remove wisdom teeth that are poorly aligned/developed (also known as impacted wisdom teeth) or those causing pain or inflammation.</P>
<P>The risk of infection after extracting wisdom teeth from healthy young people is about 10%; however, it may be up to 25% in patients who are already sick or have low immunity. Infectious complications include swelling, pain, pus drainage, fever, and also dry socket (this is where the tooth socket is not filled by a blood clot, and there is severe pain and bad odour). Treatment of these infections is generally simple and involves patients receiving antibiotics and drainage of infection from the wound.</P>
<P>This review looks at whether antibiotics, given to dental patients as part of their treatment, prevent infection after tooth extraction. There were 18 studies considered, with a total of 2456 participants who received either antibiotics (of different kinds and dosages) or placebo, immediately before and/or just after tooth extraction. There were concerns about aspects of the design and reporting of all the studies. In all of the studies healthy people had extractions of impacted wisdom teeth done by oral surgeons.</P>
<P>This review provides evidence that antibiotics administered just before and/or just after surgery reduce the risk of infection, pain and dry socket after wisdom teeth are removed by oral surgeons, but that using antibiotics also causes more (generally brief and minor) side effects for these patients. Additionally, there was no evidence that antibiotics prevent fever, swelling or problems with restricted mouth opening in patients who have had wisdom teeth removed.</P>
<P>There was no evidence to judge the effects of preventative antibiotics for extractions of severely decayed teeth, teeth in diseased gums, or extractions in patients who are sick or have low immunity to infection. Undertaking research in these groups of people may not be possible or ethical. However, it is likely that in situations where patients are at a higher risk of infection that preventative antibiotics may be beneficial, because infections in this group are likely to be more frequent and more difficult to treat.</P>
<P>Another concern, which cannot be assessed by clinical trials, is that widespread use of antibiotics by people who do not have an infection is likely to contribute to the development of bacterial resistance.</P>
<P>The conclusion of this review is that antibiotics given to healthy people to prevent infections, may cause more harm than benefit to both the individual patients and the population as a whole.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-10-04 16:24:13 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-07-30 15:06:27 +0100" MODIFIED_BY="[Empty name]">
<P>The most frequent indications for tooth extractions are dental caries and periodontal infections, and these extractions are generally done by general dental practitioners. Antibiotics may be prescribed to patients undergoing extractions to prevent complications due to infection.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-04-12 16:46:16 +0100" MODIFIED_BY="[Empty name]">
<P>To determine the effect of antibiotic prophylaxis on the development of infectious complications following tooth extractions.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-10-04 16:19:47 +0100" MODIFIED_BY="[Empty name]">
<P>The following electronic databases were searched: the Cochrane Oral Health Group's Trials Register (to 25 January 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2012, Issue 1), MEDLINE via OVID (1948 to 25 January 2012), EMBASE via OVID (1980 to 25 January 2012) and LILACS via BIREME (1982 to 25 January 2012). There were no restrictions regarding language or date of publication.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-10-04 16:20:03 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomised double-blind placebo-controlled trials of antibiotic prophylaxis in patients undergoing tooth extraction(s) for any indication.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-10-04 16:20:45 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed risk of bias for the included studies and extracted data. We contacted trial authors for further details where these were unclear. For dichotomous outcomes we calculated risk ratios (RR) and 95% confidence intervals (CI) using random-effects models. For continuous outcomes we used mean differences (MD) with 95% CI using random-effects models. We examined potential sources of heterogeneity. The quality of the body of evidence has been assessed using the GRADE tool.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-10-04 16:23:56 +0100" MODIFIED_BY="[Empty name]">
<P>This review included 18 double-blind placebo-controlled trials with a total of 2456 participants. Five trials were assessed at unclear risk of bias, thirteen at high risk, and none at low risk of bias. Compared to placebo, antibiotics probably reduce the risk of infection in patients undergoing third molar extraction(s) by approximately 70% (RR 0.29 (95% CI 0.16 to 0.50) P &lt; 0.0001, 1523 participants, moderate quality evidence) which means that 12 people (range 10-17) need to be treated with antibiotics to prevent one infection following extraction of impacted wisdom teeth.<B> </B>There is evidence that antibiotics may reduce the risk of dry socket by 38% (RR 0.62 (95% CI 0.41 to 0.95) P = 0.03, 1429 participants, moderate quality evidence) which means that 38 people (range 24-250) need to take antibiotics to prevent one case of dry socket following extraction of impacted wisdom teeth. There is also some evidence that patients who have prophylactic antibiotics may have less pain (MD -8.17<B> </B>(95% CI -11.90 to -4.45) P &lt; 0.0001, 372 participants, moderate quality evidence ) overall 7 days after the extraction compared to those receiving placebo, which may be a direct result of the lower risk of infection. There is no evidence of a difference between antibiotics and placebo in the outcomes of fever (RR 0.34, 95% CI 0.06 to 1.99), swelling (RR 0.92, 95% CI 0.65 to 1.30) or trismus (RR 0.84, 95% CI 0.42 to 1.71) 7 days after tooth extraction.</P>
<P>Antibiotics are associated with an increase in generally mild and transient adverse effects compared to placebo (RR 1.98 (95% CI 1.10 to 3.59) P = 0.02) which means that for every 21 people (range 8-200) who receive antibiotics, an adverse effect is likely.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-10-04 16:24:13 +0100" MODIFIED_BY="[Empty name]">
<P>Although general dentists perform dental extractions because of severe dental caries or periodontal infection, there were no trials identified which evaluated the role of antibiotic prophylaxis in this group of patients in this setting. All of the trials included in this review included healthy patients undergoing extraction of impacted third molars, often performed by oral surgeons. There is evidence that prophylactic antibiotics reduce the risk of infection, dry socket and pain following third molar extraction and result in an increase in mild and transient adverse effects. It is unclear whether the evidence in this review is generalisable to those with concomitant illnesses or immunodeficiency, or those undergoing the extraction of teeth due to severe caries or periodontitis. However, patients at a higher risk of infection are more likely to benefit from prophylactic antibiotics, because infections in this group are likely to be more frequent, associated with complications and be more difficult to treat. Due to the increasing prevalence of bacteria which are resistant to treatment by currently available antibiotics, clinicians should consider carefully whether treating 12 healthy patients with antibiotics to prevent one infection is likely to do more harm than good.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-10-15 11:38:02 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-10-15 11:38:02 +0100" MODIFIED_BY="[Empty name]">
<P> </P>
<CONDITION MODIFIED="2012-10-04 16:25:39 +0100" MODIFIED_BY="[Empty name]">
<P>Tooth extraction is a very common surgical procedure, and is most frequently done by general dental practitioners. In spite of the steady decrease in routine extraction of permanent teeth registered in the last decades (<LINK REF="REF-Thomas-1994" TYPE="REFERENCE">Thomas 1994</LINK>; <LINK REF="REF-Sleeman-1995" TYPE="REFERENCE">Sleeman 1995</LINK>; <LINK REF="REF-McCaul-2001" TYPE="REFERENCE">McCaul 2001</LINK>), general dental practitioners from European countries may extract up to seven teeth per week (<LINK REF="REF-McCaul-2001" TYPE="REFERENCE">McCaul 2001</LINK>). An estimated 17% of patients undergo extractions over a 5-year period (<LINK REF="REF-Worthington-1999" TYPE="REFERENCE">Worthington 1999</LINK>), with the highest tooth extraction rate per patient being among patients in the sixth and seventh decade of life (<LINK REF="REF-Chrysanthakopoulos-2011" TYPE="REFERENCE">Chrysanthakopoulos 2011</LINK>). The main reasons for extraction of permanent teeth are still caries and periodontal disease, in variable proportions according to age of patients, country and year of publication (Additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). Wisdom teeth failing to erupt or erupting only partially represent a distinct category of dental elements named impacted (third molar) teeth. In fact, impacted wisdom teeth are extracted either because of local inflammatory problems, or in order to avoid possible future complications (although a recent Cochrane review did not find sufficient evidence to support or refute routine prophylactic removal of asymptomatic impacted wisdom teeth in adults (<LINK REF="REF-Mettes-2012" TYPE="REFERENCE">Mettes 2012</LINK>)).</P>
<P>The main objective for a successful surgery is to minimise, as much as possible, patient discomfort in the post-operative period after tooth extraction. Symptoms such as pain, swelling, trismus, fever and dry socket are complications which are unpleasant for patients and could generate difficulty in chewing, in speaking, in performing oral hygiene, and alteration of other activities of daily living, resulting in days off from work or study. All these complications depend on inflammatory response, but they can be due to subsequent infection, for example if surgical trauma is in a contaminated area (where severe caries or periodontitis is present) or where more complex and aggressive procedures are performed (e.g. ostectomy).</P>
<P>Signs of post-extraction infectious complications include abscess, pain, fever, swelling, trismus. Another complication of putative bacterial origin is alveolar osteitis (dry socket), a painful condition which follows the dissolution of the blood clot which occurs as a result of bacterial invasion. The overall incidence of post-operative infections is relatively low (<LINK REF="REF-Jaafar-2000" TYPE="REFERENCE">Jaafar 2000</LINK>; <LINK REF="REF-Bouloux-2007" TYPE="REFERENCE">Bouloux 2007</LINK>; <LINK REF="REF-Bortoluzzi-2010" TYPE="REFERENCE">Bortoluzzi 2010</LINK>), however antibiotics are frequently prescribed in a prophylactic way, particularly in case of complicated surgeries and patients with systemic conditions potentially causing immunodeficiency, such as HIV infection, diabetes and cancer (<LINK REF="REF-Epstein-2000" TYPE="REFERENCE">Epstein 2000</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-06-11 09:55:50 +0100" MODIFIED_BY="[Empty name]">
<P>There are a range of antibiotics which are effective in treating dental infections. These include penicillin, amoxicillin, erythromycin, clindamycin, doxycycline and metronidazole which are usually administered orally, between one and four times daily. Alternatively antibiotics can also be administered by parenteral or local routes.</P>
</INTERVENTION>
<THEORY MODIFIED="2012-10-04 16:25:48 +0100" MODIFIED_BY="[Empty name]">
<P>The oral environment contains a range of bacteria which have the potential to cause painful infections in wounds. Antibiotics are effective in treating such infections and are also likely to act to prevent the development of painful wound infections. The optimal timing of the dose or doses is unclear. Antibiotics could be administered as a large single dose prior to the extraction, or a course of antibiotics taken over the post-operative period, or some combination of these. Adverse effects, such as diarrhoea or allergy due to antibiotics are also possible.</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-10-15 11:38:02 +0100" MODIFIED_BY="[Empty name]">
<P>In 2010, a systematic review showed that both long duration and multiple courses of antibiotics prescribed in general medical practice were consistently associated with the development of bacterial resistance to those antibiotics in that individual and that the greater the number of antibiotic courses prescribed, the higher the chance of resistant bacteria development (<LINK REF="REF-Costelloe-2010" TYPE="REFERENCE">Costelloe 2010</LINK>). Dental prescribing accounts for a significant proportion of total antibacterial prescribing in primary care (7% to 9%) (<LINK REF="REF-Dar_x002d_Odeh-2010" TYPE="REFERENCE">Dar-Odeh 2010</LINK>; <LINK REF="REF-Karki-2011" TYPE="REFERENCE">Karki 2011</LINK>). In addition, antibiotics used in dental practice can cause potentially serious adverse drug reactions and interactions (<LINK REF="REF-Hersh-1999" TYPE="REFERENCE">Hersh 1999</LINK>). According to the European Commission, overuse and misuse of antibiotics are the main causes of microbial resistance to drugs. For this reason in 2011 an action plan to tackle microbial resistance to drugs was presented; the first aim of such plan is to make sure that antimicrobials are used appropriately both in humans and animals. Better evidence is needed about the use of antibiotic prophylaxis in patients undergoing tooth extraction in order to determine appropriate use (<LINK REF="REF-EU-Commission-2011" TYPE="REFERENCE">EU Commission 2011</LINK>).</P>
<P>This systematic review will summarise the evidence of the effects of systemic antibiotics prescribed to prevent infectious complications following tooth extraction. A separate Cochrane systematic review evaluating interventions to manage dry socket following tooth extraction will be published in 2012 (<LINK REF="REF-Daly-2008" TYPE="REFERENCE">Daly 2008</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-10-04 16:26:36 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>To assess the effects of antibiotic prophylaxis on the incidence of infectious complications following tooth extraction.</LI>
<LI>To assess the effects of antibiotic prophylaxis following tooth extraction in immunosuppressed patients (e.g. HIV infection, AIDS, diabetes, transplants) or patients with other conditions (e.g. bone diseases).</LI>
<LI>To assess the effects of antibiotic prophylaxis in particular procedures, such as extraction of impacted teeth or wisdom teeth.</LI>
</UL>
</OBJECTIVES>
<METHODS MODIFIED="2012-10-04 16:38:43 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-10-04 16:27:23 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-10-04 16:26:41 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trials with a double-blind design (participants and assessors) were included. Cross-over studies were included providing the interval (or washout period) between interventions was at least 6 weeks.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Anyone undergoing a tooth extraction, including extraction of impacted teeth.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-10-04 16:27:23 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Active</HEADING>
<P>1) Any regimen of systemic antibiotic prophylaxis (i.e. prescribed in absence of infection) administered before or after tooth extraction. Topical antibiotic therapy was not included.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control</HEADING>
<P>1) Placebo.<BR/>
</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-07-30 15:39:52 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-05-04 15:54:24 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Post-surgical complications of putative infectious nature, including: alveolar osteitis (dry socket), pain, fever, swelling, trismus.</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-07-30 15:39:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Other post-surgical complications.</LI>
<LI>Any adverse effect related to antibiotics.</LI>
</UL>
<P>Trials which reported the outcomes of endocarditis incidence, bacteriaemia or serum markers of infection only, were not considered for inclusion in this review.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-10-04 16:29:40 +0100" MODIFIED_BY="[Empty name]">
<P>For the identification of studies included or considered for this review, we developed detailed search strategies for each database searched. These were based on the search strategy developed for MEDLINE (OVID) but revised appropriately for each database. The search strategy used a combination of controlled vocabulary and free text terms and was linked with the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials (RCTs) in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the <I>Cochrane Handbook for</I> <I>Systematic Reviews of Interventions</I> version 5.1.0 (updated March 2011) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>)<I>.</I>
</P>
<P>We searched the following electronic databases:</P>
<UL>
<LI>The Cochrane Oral Health Group's Trials Register (to 25 January 2012) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>)</LI>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2012, Issue 1) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>)</LI>
<LI>MEDLINE via OVID (1948 to 25 January 2012) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>)</LI>
<LI>EMBASE via OVID (1980 to 25 January 2012) (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>)</LI>
<LI>LILACS via BIREME (1982 to 25 January 2012) (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>).</LI>
</UL>
<P>Details of the MEDLINE search are provided in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>. We linked the search of EMBASE to the Cochrane Oral Health Group filter for identifying RCTs (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>), and the search of LILACS to the Brazilian Cochrane Center filter (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Handsearching</HEADING>
<P>The following journals were identified as being important to handsearch for this review:</P>
<UL>
<LI>
<I>British Journal of Oral and Maxillofacial Surgery</I>
</LI>
<LI>
<I>British Dental Journal</I>
</LI>
<LI>
<I>International Journal of Oral and Maxillofacial Surgery</I>
</LI>
<LI>
<I>Journal of the American Dental Association</I>
</LI>
<LI>
<I>Journal of Dental Research</I>
</LI>
<LI>
<I>Journal of Dentistry</I>
</LI>
<LI>
<I>Oral Surgery, Oral Pathology, Oral Medicine, Oral Radiology and Endodontics.</I>
</LI>
</UL>
<P>The handsearching was done as part of the Cochrane Worldwide Handsearching Programme. <I>See</I> the <A HREF="http://us.cochrane.org/master-list">Cochrane Masterlist of Journals</A> for details of the volumes and issues that have been searched to date.</P>
<P>Reference lists of all eligible trials and of existing reviews were checked for additional studies. The first named authors of all included trials were contacted in an attempt to identify unpublished studies and to obtain further information about the trials.</P>
<P>There were no restrictions on language or date of publication.</P>
</SUBSECTION>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-10-04 16:38:43 +0100" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<STUDY_SELECTION MODIFIED="2012-10-04 16:30:21 +0100" MODIFIED_BY="[Empty name]">
<P>The title and abstract of each article resulting from the different search strategies were examined independently by two review authors (Giovanni Lodi (GL) and Susan Furness (SF)). Where studies appeared to meet the inclusion criteria for this review or where there were insufficient data in the title and abstract to make a clear decision, the full report was obtained. The full report was then assessed by at least two review authors to determine whether studies met the inclusion criteria. Any disagreements were resolved by discussion. Studies rejected at this or subsequent stages were recorded in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table where the reason(s) for exclusion were recorded. A flow chart to summarise the results of the search was prepared (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-10-04 16:30:51 +0100" MODIFIED_BY="[Empty name]">
<P>All studies which met the inclusion criteria for this review underwent risk of bias assessment and data extraction using a specially designed data extraction form. Data were extracted by at least two review authors independently and were also entered into a spreadsheet. Any disagreement was discussed and agreement reached. When necessary authors were contacted for clarification or missing information.</P>
<P>For each trial the following data were recorded.</P>
<UL>
<LI>Year of publication, country of origin, number of centres, source of study funding, recruitment period.</LI>
<LI>Details of the participants including demographic characteristics and criteria for inclusion and exclusion, type of teeth being extracted and reasons, numbers randomised to each treatment group.</LI>
<LI>Details of the type of antibiotic, dose, mode of administration, time of administration relative to the extraction procedure and duration of antibiotic treatment.</LI>
<LI>Details of other concomitant treatments - type of anaesthetic, mouthrinses, pain management.</LI>
<LI>Details of the outcomes reported, including method of assessment, and time(s) assessed.</LI>
<LI>Description of operators.</LI>
<LI>Sample size calculation.</LI>
</UL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-10-04 16:34:03 +0100" MODIFIED_BY="[Empty name]">
<P>Each of the trials included in this review was assessed for risk of bias using The Cochrane Collaboration's risk of bias assessment tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The following six domains were assessed for each trial: random sequence generation, allocation concealment, blinding, completeness of outcome data, risk of selective outcome reporting and risk of other bias.</P>
<P>A description of what was reported to have occurred was included for each domain in each trial, together with a judgement of low, unclear or high risk of bias. For example criteria, used for risk of bias judgements for allocation concealment as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) are described below.</P>
<P>1) Method of allocation concealment. Criteria for the judgement of low risk of bias: when the randomisation schedule is concealed from the researcher recruiting participants to the trial by means of either:</P>
<UL>
<LI>central allocation (including telephone, web-based and pharmacy-controlled randomisations); or</LI>
<LI>sequentially numbered drug containers of identical appearance;or</LI>
<LI>sequentially numbered, opaque, sealed envelopes.</LI>
</UL>
<P>When this information is not reported, the domain was judged as unclear.</P>
<P>2) Protection against performance and detection bias (blindness of the study). One of the inclusion criteria for this review is that trials be double blind. This is interpreted as meaning that neither the participants nor the researchers assessing the outcomes of the trial were aware of the allocated treatment, unless further information is given.</P>
<P>3) Incomplete outcome data. Criteria for the judgement of low risk of bias for this domain are:</P>
<UL>
<LI>no missing outcome data; or</LI>
<LI>less than 20% of randomised participants excluded from the analysis and numbers of trial participants excluded balanced in numbers across intervention groups, with similar reasons for missing data across groups;</LI>
</UL>
<P>and</P>
<UL>
<LI>for dichotomous outcome data, the proportion of missing outcomes compared with observed event rate not great enough to have a clinically relevant impact on the effect estimate.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Overall risk of bias</HEADING>
<P>A summary assessment of the risk of bias was undertaken (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) as follows:</P>
<P>1) low risk of bias: all of the domains judged to be at low risk of bias<BR/>2) unclear risk of bias: one or more domains judged to be at unclear risk of bias<BR/>3) high risk of bias: one or more domains judged to be at high risk of bias.</P>
<P>Risk of bias assessment of the studies was carried out without blinding the name of authors, institutions and journal. Data about the study, its eligibility, validity, design and outcome information, were recorded by each review author on an extraction form. In case of disagreement, consensus was achieved by discussion.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-10-04 16:35:07 +0100" MODIFIED_BY="[Empty name]">
<P>The primary measure of intervention effect was reduction in incidence of infectious complications, such as alveolar osteitis (dry socket), pain, fever, swelling or trismus between the control and intervention group. Dichotomous data are expected for these. Other dichotomous data may include the incidence of adverse effects.</P>
<P>For each intervention, data on the number of patients of intervention and control group who experienced the event (outcome) and the total number of patients, were sought and summarised. Dichotomous data were analysed by calculating risk ratios and 95% confidence intervals.</P>
<P>Where pooling of data from both parallel and cross-over studies was appropriate we used the generic inverse variance method to enter the data into Review Manager (RevMan) software (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2012-10-04 16:35:18 +0100" MODIFIED_BY="[Empty name]">
<P>Missing data were obtained from tables and graphs if possible. Where data were missing or unclear we attempted to contact the authors of the studies to request clarification or additional data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-10-04 16:36:55 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed heterogeneity by inspection of the point estimates and confidence intervals on the forest plots. We assessed the variation in treatment effects by means of Cochran's test for heterogeneity and quantified by the I<SUP>2</SUP> statistic. We considered heterogeneity statistically significant if the P value was &lt; 0.1. A rough guide to the interpretation of the I<SUP>2</SUP> statistic given in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> is: 0% to 40% might not be important, 30% to 60% may represent moderate heterogeneity, 50% to 90% may represent substantial heterogeneity, 75% to 100% considerable heterogeneity (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-10-04 16:37:26 +0100" MODIFIED_BY="[Empty name]">
<P>Only a proportion of research projects conducted are ultimately published in an indexed journal and become easily identifiable for inclusion in systematic reviews. Reporting biases arise when the reporting of research findings is influenced by the nature and direction of the findings of the research. We attempted to minimise potential reporting biases including publication bias, time lag bias, multiple (duplicate) publication bias and language bias in this review.</P>
<P>If there had been more than ten studies in one outcome we planned to construct a funnel plot. If there were asymmetry in the funnel plot indicating possible publication bias we planned to undertake statistical analysis using the methods introduced by <LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK> (continuous outcome) and <LINK REF="REF-R_x00fc_cker-2008" TYPE="REFERENCE">Rücker 2008</LINK> (dichotomous outcome).</P>
<P>We attempted to avoid time lag bias, multiple (duplicate) publication bias and language bias by conducting a detailed sensitive search, including searching for ongoing studies. There were no restrictions on language, and we found translators for potentially relevant trials published in other languages.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-10-04 16:37:52 +0100" MODIFIED_BY="[Empty name]">
<P>We only conducted a meta-analysis if there were studies of similar comparisons reporting the same outcome measures. We combined risk ratios for dichotomous data, and mean differences for continuous data, using random-effects models provided there were more than three studies in the meta-analysis.</P>
<P>We combined the treatment effects from cross-over trials with those from parallel group trials where appropriate, using the data from both periods of the cross-over studies (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). We used the generic inverse variance method incorporated in RevMan for all analyses that included cross-over trials using appropriate methods as outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>; <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-10-04 16:38:18 +0100" MODIFIED_BY="[Empty name]">
<P>Whenever possible, subgroup analyses were undertaken based on time of administration (pre- or post-procedure) and the presence or absence of patients with systemic conditions (HIV, diabetes, etc).</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-10-04 16:38:43 +0100" MODIFIED_BY="[Empty name]">
<P>A sensitivity analysis was undertaken, excluding studies at high risk of bias.</P>
<SUBSECTION>
<HEADING LEVEL="3">Presentation of main results</HEADING>
<P>A summary of findings table was developed for the main outcomes of this review using GRADEPro software. We used the mean risk in the placebo groups of the included studies as the assumed risk for each outcome and calculated the corresponding risk using the risk ratio (or mean difference) estimate obtained from the meta-analysis. The quality of the body of evidence was assessed with reference to the overall risk of bias of the included studies, the directness of the evidence, the inconsistency of the results, the precision of the estimates, the risk of publication bias and the magnitude of the effect. The quality of the body of evidence for each of the main outcomes was categorised as high, moderate, low or very low.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-10-05 15:40:44 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-10-05 15:40:44 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-10-04 16:40:15 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 1053 references were identified by the electronic searches. The titles and abstracts were scanned by two review authors (Susan Furness (SF) and Giovanni Lodi (GL)) and 997 references were excluded as not relevant to this review. Full text copies of 56 potentially eligible papers were retrieved and after close reading, 37 studies were excluded (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). Two further studies were identified from searches of reference lists of included studies. Finally 21 references to 18 studies met the inclusion criteria for this review (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-10-04 17:10:37 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of trial design and setting</HEADING>
<P>For a summary of the characteristics of each of the included studies <I>see</I>
<B> </B>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.</P>
<P>Of the 18 included studies, three were conducted in Spain (<LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>), three in Sweden (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>), three in the UK (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>), two in India (<LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>) and one study was conducted in each of Brazil (<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>), Colombia (<LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>), Denmark (<LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>), Finland (<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>), Poland (<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>), New Zealand (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>), and United States of America (<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>).</P>
<P>Seventeen studies used parallel group designs and one was a split-mouth cross-over trial (<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>) where participants each had two extraction procedures, which were separated by a period of at least 45 days. Nine studies had two treatment arms (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>), eight studies had three treatment arms (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) and one study (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>) had three subtrials, each with two or three arms. The data from these separately randomised subtrials were then combined and were unsuitable for inclusion in meta-analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of participants</HEADING>
<P>The 18 included studies randomised more than 2456 participants to either an antibiotic or placebo. (One of the included trials (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>) used an unusual design and did not state exactly how many participants were randomised and analysed.) All of the included studies compared at least one antibiotic regimen with placebo in patients undergoing dental extraction. Fifteen trials described extraction procedures done using local anaesthesia, two trials used general anaesthesia (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>), and in one trial the method of anaesthesia was not stated (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>).</P>
<P>In all of the included studies the participants underwent extraction of third molars only, and in the majority of the studies only mandibular third molars were included (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>). Fourteen studies included participants with impacted teeth only (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>), two studies included participants with either impacted or partially impacted teeth (<LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>), one study included participants with only partially impacted teeth (<LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>), and one study included participants with "teeth needing surgical extraction" (<LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>).</P>
<P>In one trial (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>) the participants had a history of non-acute pericoronitis, and in another (<LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>) 41% of participants had pericoronitis at some stage and were entered into the trial "after objective and subjective symptoms of pericoronitis had ceased", thus participants of both these studies were likely to be at higher risk of infectious complications. Recent episodes of local infection were reason for exclusion in two other studies (<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>). In the remaining trials, participants were considered healthy at baseline and systemic conditions, including those causing immunosuppression, were often reason for exclusion from the trial (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>).</P>
<P>None of the trials assessed the effect of antibiotic prophylaxis in patients who required extraction of one or more teeth due to caries or periodontal disease, even though these indications are the most common reasons for tooth extraction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of interventions</HEADING>
<P>In 16 trials the antibiotics were administered orally, one study (<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>) used intravenous penicillin or clindamycin and one study (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>) administered penicillin intramuscularly.</P>
<P>The antibiotic interventions were classified into three groups, based on the time of administration relative to the extraction (studies with three or more arms may be included in more than one group).</P>
<UL>
<LI>Antibiotics given pre-operatively only (30 minutes to 2 hours prior to procedure): <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>.</LI>
<LI>Antibiotics given post-operatively only: <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>.</LI>
<LI>Antibiotics given both pre- and post-operatively: <LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>.</LI>
</UL>
<P>The antibiotics selected for use in the studies were amoxicillin (<LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>), a combination of amoxicillin/clavulanate (<LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>), azidocillin (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>), clindamycin (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>), doxycycline (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>), erythromycin (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>), metronidazole (<LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>), penicillin (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>), phenoxymethylpenicillin (<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>) and tinidazole (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>).</P>
<P>Details of specific dosage regimens are recorded in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for each study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of outcomes</HEADING>
<P>Four studies (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>) reported the development of dry socket. <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK> with a follow-up at 7 days, <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK> with a follow-up at 7 days and 8 weeks, <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK> with a follow-up between 2 and 4 days after surgery, and <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK> with a follow-up at 2, 5 and 7 days.</P>
<P>Five studies (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>) investigated pain. <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK> with a follow-up at 48 hours and 6 days, <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK> with a follow-up at 2, 5 and 7 days, <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK> had a follow-up at 6 days, <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK> with a follow-up at 1, 2 and 7 days and <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK> with a follow-up at 1, 3 and 7 days.</P>
<P>Fever in the first 24 hours was evaluated by <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK> and <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>, and three studies (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>) included swelling among outcomes.</P>
<P>Four studies investigated trismus among outcomes (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>), where <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK> had a follow-up at 6 days.</P>
<P>
<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK> reported that there were no non-infectious complications following extraction, and <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK> stated that gastric complications in the antibiotic group following extraction was the reason that 3 of the 100 participants in this trial were excluded from the analysis. The other studies did not report other complications following extraction.</P>
<P>Adverse effects were reported per participant by only 5 of the 18 trials included in this review (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-10-05 15:40:44 +0100" MODIFIED_BY="[Empty name]">
<P>For the main reason for excluding each study <I>see</I>
<B> </B>
<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
<P>A total of 37 studies were listed as excluded from this review after the full text of the paper was reviewed by two or more authors. Twenty-two studies because they were not double blind (<LINK REF="STD-Curran-1974" TYPE="STUDY">Curran 1974</LINK>; <LINK REF="STD-Krekmanov-1980" TYPE="STUDY">Krekmanov 1980</LINK>; <LINK REF="STD-Krekmanov-1981" TYPE="STUDY">Krekmanov 1981</LINK>; <LINK REF="STD-Krekmanov-1986" TYPE="STUDY">Krekmanov 1986</LINK>; <LINK REF="STD-Lombardia-Garcia-1987" TYPE="STUDY">Lombardia Garcia 1987</LINK>; <LINK REF="STD-Mitchell-1987" TYPE="STUDY">Mitchell 1987</LINK>; <LINK REF="STD-Abu_x002d_Mowais-1990" TYPE="STUDY">Abu-Mowais 1990</LINK>; <LINK REF="STD-Lyall-1991" TYPE="STUDY">Lyall 1991</LINK>; <LINK REF="STD-Samsudin-1994" TYPE="STUDY">Samsudin 1994</LINK>; <LINK REF="STD-Walkow-1995" TYPE="STUDY">Walkow 1995</LINK>; <LINK REF="STD-Monaco-1999" TYPE="STUDY">Monaco 1999</LINK>; <LINK REF="STD-Yoshii-2002" TYPE="STUDY">Yoshii 2002</LINK>; <LINK REF="STD-Delilbasi-2004" TYPE="STUDY">Delilbasi 2004</LINK>; <LINK REF="STD-Foy-2004" TYPE="STUDY">Foy 2004</LINK>; <LINK REF="STD-Poeschl-2004" TYPE="STUDY">Poeschl 2004</LINK>; <LINK REF="STD-Graziani-2005" TYPE="STUDY">Graziani 2005</LINK>; <LINK REF="STD-Sulejmanagi_x0107_-2005" TYPE="STUDY">Sulejmanagi&#263; 2005</LINK>; <LINK REF="STD-Uluibau-2005" TYPE="STUDY">Uluibau 2005</LINK>; <LINK REF="STD-Grossi-2007" TYPE="STUDY">Grossi 2007</LINK>; <LINK REF="STD-Ataoglu-2008" TYPE="STUDY">Ataoglu 2008</LINK>; <LINK REF="STD-Monaco-2009" TYPE="STUDY">Monaco 2009</LINK>; <LINK REF="STD-Lopes-2011" TYPE="STUDY">Lopes 2011</LINK>). Four studies were excluded because two antibiotic regimens were compared directly with no placebo-controlled group (<LINK REF="STD-Laird-1972" TYPE="STUDY">Laird 1972</LINK>; <LINK REF="STD-Limeres-2009" TYPE="STUDY">Limeres 2009</LINK>; <LINK REF="STD-Luaces_x002d_Rey-2010" TYPE="STUDY">Luaces-Rey 2010</LINK>; <LINK REF="STD-Olusanya-2011" TYPE="STUDY">Olusanya 2011</LINK>) and three trials were excluded because interventions were not randomly allocated (<LINK REF="STD-Osborn-1979" TYPE="STUDY">Osborn 1979</LINK>; <LINK REF="STD-Rood-1979" TYPE="STUDY">Rood 1979</LINK>; <LINK REF="STD-Fridrich-1990" TYPE="STUDY">Fridrich 1990</LINK>). Two cross-over trials were excluded because the washout period between interventions was less than 6 weeks (<LINK REF="STD-Siddiqi-2010" TYPE="STUDY">Siddiqi 2010</LINK>; <LINK REF="STD-de-Moura-2011" TYPE="STUDY">de Moura 2011</LINK>) and four trials because they evaluated topical antibiotics only (<LINK REF="STD-MacGregor-1973" TYPE="STUDY">MacGregor 1973</LINK>; <LINK REF="STD-Swanson-1989" TYPE="STUDY">Swanson 1989</LINK>; <LINK REF="STD-Reekie-2006" TYPE="STUDY">Reekie 2006</LINK>; <LINK REF="STD-Stavropoulos-2006" TYPE="STUDY">Stavropoulos 2006</LINK>). One trial was excluded because it evaluated antibiotics in conjunction with a range of dental surgical procedures not just extractions (<LINK REF="STD-Bargnesi-1985" TYPE="STUDY">Bargnesi 1985</LINK>) and one because it presented data on bacteraemia outcomes only (<LINK REF="STD-Head-1984" TYPE="STUDY">Head 1984</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-10-04 17:33:56 +0100" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2012-10-04 17:26:30 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<P>Nine studies were assessed as being at low risk of bias for this domain. Four studies reported that randomisation was generated by computer (<LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>), two studies used random number tables (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>), two used predetermined random codes (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) and one used a coin toss (<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>). The remaining nine studies gave no details about the method of sequence generation and were assessed at unclear risk of bias for this domain (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>Eleven studies described adequate allocation concealment (<LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) and were assessed at low risk of bias for this domain. For the remaining seven studies allocation concealment was not reported and these studies were assessed as at unclear risk of bias for this domain.</P>
<P>Overall eight trials were considered to be at low risk of selection bias (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) and for the remaining 10 studies the risk of selection bias was unclear.</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2012-10-04 17:24:02 +0100" MODIFIED_BY="[Empty name]">
<P>The inclusion criteria for this review specified that trials be double blind. Where trials only reported 'double blind' with no further details we interpreted this as meaning that both the participant and the person who assessed the outcomes (either the surgeon or the patient) were blinded to the allocated treatment. Consequently all included trials were assessed as being at low risk of performance and detection bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-10-04 17:28:11 +0100" MODIFIED_BY="[Empty name]">
<P>Most of the included trials had relatively low rates of participants excluded from the analysis due to loss to follow-up or withdrawal from the trials. However, these trials also reported low event rates for the outcomes of interest, which meant that even small numbers of patients excluded could have introduced a bias.</P>
<P>Three trials reported that all the randomised participants were included in the analysis (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>) and in two trials attrition was less than 1% (<LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>). In the split-mouth study by <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>, two participants were lost to follow-up but this was not considered to introduce a risk of attrition bias due to the study design. These six trials were assessed as being at low risk of attrition bias.</P>
<P>Three trials (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>) did not report the number of randomised participants included in the analysis and these trials were published more than 25 years ago and we were unable to obtain this information. In the study by <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK> there were more drop-outs in the placebo group than the antibiotic group and it was unclear whether this could have introduced a bias. These four trials were assessed as being at unclear risk of attrition bias.</P>
<P>Three trials (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) reported overall exclusion of participants from outcome evaluation of 10%, 8% and 17% respectively, and noted that losses were unequally distributed between antibiotic and placebo groups. A further five trials (<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) reported between 5% and 14% of participants were excluded from the outcome evaluation and did not describe the reasons or the treatment group from which participants were excluded. These eight trials were all assessed as being at high risk of attrition bias.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-10-04 17:29:30 +0100" MODIFIED_BY="[Empty name]">
<P>Selective reporting is difficult to assess in the absence of a trial protocol. We based our assessment on three factors: whether the trial report contained in the results section, data on all the outcome measures described in the methods section of the report; whether planned outcome measures included those that would reasonably be expected in such a trial; and whether both point estimates and variances were reported.</P>
<P>Five trials (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) reported complete data on all the outcomes that were listed in their methods sections and were consequently assessed as being at low risk of reporting bias.</P>
<P>The authors in <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK> evaluated swelling and trismus but did not report these data, stating only that there was no difference between the groups. In <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK> planned outcomes were reported only in graphical form as percentages in each group. A further four trials (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>) reported the planned single outcome but did not report pain, swelling or trismus which we consider to be important outcomes following this procedure. These six trials were assessed as being at unclear risk of reporting bias.</P>
<P>The remaining seven trials (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) were assessed as being at high risk of reporting bias. The trial by <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK> planned to measure pain scores on a VAS but these were not reported. <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK> did not report data on three of the outcomes listed in the methods of the report, and <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK> listed eight planned outcomes of which one was reported fully, one (pain) was reported as a mean for each group without an estimate of variance and the remaining six outcomes were not reported at all. <LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK> reported planned outcomes as point estimates without estimates of variance, but not for each group to which participants were randomised in the three subtrials in this report, and <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK> reported pain, swelling, and trismus for all participants combined, in graphical form only, making it impossible to determine the effects of the interventions on these outcomes. <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK> did not report the pain measured by VAS at 7 days despite stating that pain was the main reason given for participants to be unable to work. <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK> did not report the outcomes of pain swelling or trismus but it would appear that these data were collected.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-10-04 17:33:56 +0100" MODIFIED_BY="[Empty name]">
<P>For nine of the included studies there were no other sources of bias identified (<LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>).</P>
<P>Two trials were assessed as at high risk of other bias (<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>).The trial by <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK> was a split-mouth study in which participants each underwent two extraction procedures a minimum of 45 days apart. The trial report states that "the mean pain scores were lower on the last assessment [day 14] compared with the first [baseline] in both groups" suggesting that there may have been a period effect. The power calculation reported in <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK> suggests that this trial is underpowered which is likely to bias results towards the null hypothesis of no difference between antibiotic and placebo.</P>
<P>In the remaining seven trials risk of other bias was unclear.</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall risk of bias</HEADING>
<P>None of the trials included in this review were assessed as at low risk of bias for all the domains (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Five trials (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>; <LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>) were assessed as at unclear risk of bias because there was insufficient information in the trial report or available from the authors to determine risk of bias in at least one domain. The remaining 13 trials (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) were assessed as at high overall risk of bias because each of these trials was at high risk of bias in one or more domains.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-10-04 17:54:40 +0100" MODIFIED_BY="[Empty name]">
<P>Three of the trials which met the inclusion criteria for this review did not report data in a form that was suitable for inclusion in meta-analysis (<LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK>; <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK>; <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK>). The trial by <LINK REF="STD-MacGregor-1980" TYPE="STUDY">MacGregor 1980</LINK> compared a single dose of intramuscular penicillin with placebo, followed up participants for 4 days and reported only that there were no significant differences between antibiotic and placebo with regard to pain, swelling and trismus but provided no data to substantiate this claim. The authors of <LINK REF="STD-Bystedt-1980" TYPE="STUDY">Bystedt 1980</LINK> conducted three independent subtrials but reported data combining all of these trials. We were unable to draw any conclusions based on the data presented in this paper. In <LINK REF="STD-Kaziro-1984" TYPE="STUDY">Kaziro 1984</LINK> the authors did not report the number of participants included in the outcome assessments but used graphs to report the percentage of participants with infections, pain and swelling. There were fewer patients in the antibiotic group who reported infections or pain but there were no estimates of variance so the statistical significance (if any) cannot be determined from this report (Additional <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>).</P>
<P>The results from the remaining 15 trials are described below in subgroups depending on the time(s) the antibiotics were administered (either pre-operatively, post-operatively or both pre- and post-operatively). Subgroup analysis based on the immune state of patients was not possible, as studies on immunosuppressed patients, or those with underlying health conditions which may have influenced their immune system, were not identified by our searches.</P>
<P>Where there were few trials reporting an outcome, the subgroups were indicated by footnotes but in these cases separate subgroup estimates were not reported (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Local sign of infection</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Pre-operative antibiotics</HEADING>
<P>Seven trials reported the outcome of surgical site infection diagnosed clinically (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>). Antibiotics were administered intravenously in one study (<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>) immediately prior to the procedure, and in the other six trials antibiotics were administered orally 1-2 hours prior to surgery. The pooled estimate showed a statistically significant reduction in infection in the antibiotic groups with risk ratio (RR) 0.29 (95% confidence interval (CI) 0.15 to 0.54) P = 0.0001.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Post-operative antibiotics</HEADING>
<P>Four trials were included in this group (<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>). There were no infections in either the antibiotic or the placebo group in the trial by Sekhar, and the pooled estimate for the other three trials showed fewer infections in the antibiotic groups (RR 0.15 (95% CI 0.07 to 0.31) P &lt; 0.00001).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pre- and post-operative antibiotics</HEADING>
<P>Two trials (<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>) administered antibiotic or placebo both before and after the tooth extraction procedure and there was no difference between the infections reported in each group (RR 1.09 (95% CI 0.40 to 2.94) P = 0.87).</P>
<P>Overall the pooled estimate from all 10 trials which reported the outcome of infection showed that the use of antibiotics reduced the risk of infection by approximately 70% (RR 0.29 (95% CI 0.16 to 0.50) P &lt; 0.0001). In individual trials the rate of infections in the placebo group varied between 0 and 56% with a mean event rate of 12.5% (Additional <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dry socket</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Pre-operative antibiotics</HEADING>
<P>Six trials in this group reported this outcome and in two of these (<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) there were no dry sockets identified in either group. The pooled estimate for the other four trials (<LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>; <LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>) showed no evidence of a difference between pre-operative antibiotics and placebo (RR 0.75 (95% CI 0.42 to 1.33) P = 0.32) with no statistical heterogeneity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Post-operative antibiotics</HEADING>
<P>Two trials administering antibiotics after the tooth extraction reported this outcome. The trial by <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK> again reported no dry sockets in either group and the remaining trial (<LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>) showed no evidence of a difference (RR 0.18 (95% CI 0.01 to 3.70) P = 0.27).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pre- and post-operative antibiotics</HEADING>
<P>In three trials (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>) antibiotics or placebo were administered prior to the tooth extraction and continued for 5 days post-operatively. The pooled estimate showed a reduction in the risk of dry socket (RR 0.52 (95% CI 0.27 to 0.99) P = 0.04) with no statistical heterogeneity.</P>
<P>The pooled estimate for all nine trials that reported the outcome of dry socket is RR 0.62 (95% CI 0.41 to 0.95) P = 0.03 with no statistical heterogeneity. This is a reduction in the risk of dry socket from a mean of 6.9% in the placebo groups to 3.8% in the antibiotic groups (Additional <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pain (present or absent) days 6-7 or mean VAS score day 7</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Pre-operative antibiotics</HEADING>
<P>One trial in this outcome group reported pain as either present or absent and found no difference between the antibiotic and placebo groups (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>, Subgroup 1.3.1).</P>
<P>Likewise the three trials which reported mean pain score (visual analogue scale (VAS)) in each group at 7 days showed no difference between antibiotic and placebo mean difference (MD) -7.41 (95% CI -16.18 to 1.36) P = 0.10 (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>, Subgroup 1.4.1). There was moderate statistical heterogeneity in this analysis which may be due to the different study designs included or different antibiotics used in these trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Post-operative antibiotics</HEADING>
<P>Two trials (<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>) in this group reported pain as a dichotomous outcome and also found no difference between antibiotic and placebo RR 0.51 (95% CI 0.14 to 1.82) P = 0.30 with substantial statistical heterogeneity (I<SUP>2</SUP> = 75%) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>, Subgroup 1.3.2). This heterogeneity might be attributed to the different antibacterial spectrum of the two drugs. <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK> used amoxicillin/clavulanic acid, which has a broad spectrum, and <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK> used metronidazole which is active only against anaerobic bacteria.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pre- and post-operative antibiotics</HEADING>
<P>Only one study reported the dichotomous pain outcome in this group and found a benefit favouring the antibiotic group (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>, Subgroup 1.3.3).</P>
<P>In the four trials which reported the mean pain score at day 7 (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>), there was a reduction in pain in the antibiotic groups MD -8.17 (95% CI -11.90 to -4.45) P &lt; 0.001 with no statistical heterogeneity (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>) (Additional <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Fever day 7</HEADING>
<P>Results from four trials (<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>; <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>; <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>) which included a combined total of 816 participants reported fever as a dichotomous outcome at day 7. The time of administration of antibiotics varied: pre-operative administration in <LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>, post-operative administration in <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK> and both pre- and post-operative administration in <LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK> and <LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>. In two of these trials there were no cases of fever in either group. The pooled estimate for the other two trials (<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>; <LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>) showed no evidence of a difference in post-operative fever between antibiotic and placebo groups RR 0.34 (95% CI 0.06 to 1.99) P = 0.23. Statisitical heterogeneity was substantial (I<SUP>2 </SUP>= 60%) and this is likely due to the different antibiotics and the varied times the antibiotics were administered.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Swelling day 7</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Pre-operative antibiotics</HEADING>
<P>Three trials (<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>; <LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) including a total of 165 participants, comparing pre-operative antibiotics with placebo, found no evidence of a difference in swelling after 7 days between the antibiotic and placebo groups RR 1.13 (95% CI 0.69 to 1.83) P = 0.63 (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, Subgroup 1.6.1).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Post-operative antibiotics</HEADING>
<P>Only one trial in this group (<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>) reported the outcome of swelling and found no difference between antibiotic and placebo groups (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, Subgroup 1.6.2).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Pre- and post-operative antibiotics</HEADING>
<P>There was no evidence of a difference in swelling after 7 days in the two trials (<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) which reported this outcome RR 1.07 (95% CI 0.53 to 2.17) P = 0.85 (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, Subgroup 1.6.3).</P>
<P>The pooled estimate for all groups in all three trials (combined total of 334 participants) showed no evidence of a difference between antibiotic and placebo groups for the outcome of swelling (RR 0.92 (95% CI 0.65 to 1.30) P = 0.63).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Trismus (dichotomous) day 7</HEADING>
<P>The presence or absence of trismus was reported in only two trials (175 participants) in this review (<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>; <LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>) and found no evidence of a difference between antibiotic and placebo groups (RR 0.84 (95% CI 0.42 to 1.71) P = 0.64).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse effects</HEADING>
<P>Adverse effects were reported per participant by only 5 of the 18 trials included in this review. In a total of 930 participants there were twice as many people experiencing adverse effects in the antibiotic groups RR 1.98 (95% CI 1.10 to 3.59) P = 0.02. Reported adverse effects were generally mild and required no further treatment. However, in one trial (<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>) 3% of participants taking a 5-day course of clindamycin developed gastric complications and were excluded from the trial.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-10-04 17:59:21 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-10-04 17:56:53 +0100" MODIFIED_BY="[Empty name]">
<P>This review included 18 double-blind placebo-controlled trials with a total of 2456 participants undergoing extraction of third molar (wisdom) teeth. None of the included studies were of patients undergoing tooth extraction in general dental practice, for the removal of severely decayed teeth. Thirteen of the included trials were at high risk of bias and the remaining five were at unclear risk of bias. There is evidence that antibiotics, administered to prevent infection in patients undergoing wisdom tooth extraction, reduce the risk of infection by approximately 70% (risk ratio (RR) 0.29 (95% confidence interval (CI) 0.16 to 0.50) P &lt; 0.0001), and reduce the risk of dry socket by about one third (RR 0.62 (95% CI 0.41 to 0.95) P = 0.03). There is also evidence that patients who have antibiotics have overall less pain 7 days after the extraction compared to those receiving placebo, mean difference (MD) -8.17 (95% CI -11.90 to -4.45) which may be a direct result of the lower risk of infection (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>There is no evidence of a difference between antibiotics and placebo in the outcomes of fever (RR 0.34, 95% CI 0.06 to 1.99), swelling (RR 0.92, 95% CI 0.65 to 1.30) or trismus (RR 0.84, 95% CI 0.42 to 1.71) 7 days after tooth extraction. However, antibiotics are associated with an increase in generally mild and transient adverse effects compared to placebo (RR 1.98 (95% CI 1.10 to 3.59) P = 0.02).</P>
<P>While antibiotic prophylaxis is shown to reduce the risk of infection and dry socket, these outcomes still occur in some healthy people who take antibiotic prophylaxis associated with the extraction of impacted third molars. It is interesting to note that the rate of infection in the placebo groups in the included trials varied between nil (<LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>; <LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>) and 56% (<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>) with a mean of 11.8% across the placebo groups of the included studies (Additional <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). Based on the evidence presented in this review the use of prophylactic antibiotics will reduce infection to a mean of 3%, which means that approximately 12 (range 10 to 17) people would need to receive antibiotic prophylaxis to prevent one infection.</P>
<P>The incidence of dry socket in the placebo group varied between nil (<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) and 34% (<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>) with a mean of 6.9%. This means that approximately 38 (range 24 to 250) healthy people would need to be treated with prophylactic antibiotics to prevent one case of dry socket (Additional <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
<P>However using prophylactic antibiotics is likely to result in at least one adverse effect for every 21 people treated (range 8 to 200), though adverse effects reported in the trials were generally mild and transient.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-10-04 17:58:04 +0100" MODIFIED_BY="[Empty name]">
<P>We conducted a comprehensive search including both electronic and handsearching through reference lists. We identified 18 randomised double-blind placebo-controlled trials including a combined total of approximately 2500 participants. Trials were conducted in different countries but included healthy patients in their 20s, undergoing extraction of impacted teeth (mainly of the lower jaw), thus making the results of our review quite sound regarding effectiveness of antibiotic prophylaxis of infectious complications in healthy young people undergoing wisdom tooth extractions, actually a very large proportion of surgical tooth extractions.</P>
<P>However, we identified no trials of patients attending general dental practices for the extraction of teeth due to caries or periodontitis. Identified trials did not include patients with depressed immune systems, patients with other illnesses, young children or elderly patients who required tooth extractions. Indeed, it is unlikely to be feasible or ethical to conduct placebo-controlled trials in this group of patients. The results of this review may or may not be generalisable to this group who would be expected to be at higher risk of infection. However, on the basis of the results of this review, it is likely that in subjects at higher risk of infectious complications, antibiotic prophylaxis may be more effective and the number of people needed to receive antibiotics to prevent one infection likely to decrease.</P>
<P>Another limit to generalisability of our results regards the clinical skill of the operators, as those in the included studies were mainly oral surgery specialists working in referral centres. Whether results would be similar for general dental practitioners is unclear.</P>
<P>Adverse effect frequency and severity can be important determinants in deciding about a preventive treatment. As for many medical areas, quality and quantity of information about adverse effects of interventions in these trials were inadequate (<LINK REF="REF-Ioannidis-2009" TYPE="REFERENCE">Ioannidis 2009</LINK>). However, on the basis of the drop-out rates, and the adverse effects in the five trials which reported adverse effects per patient, it seems likely that adverse effects were generally mild and well tolerated.</P>
<P>This review cannot provide any information on the extent to which the use of prophylactic antibiotics in association with tooth extraction in healthy people may have on the subsequent development of strains of bacteria resistant to antibiotics in common use in these situations (<LINK REF="REF-EU-Commission-2011" TYPE="REFERENCE">EU Commission 2011</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-10-04 17:58:31 +0100" MODIFIED_BY="[Empty name]">
<P>Although this review was restricted to double-blind placebo-controlled trials none of the included trials were at low risk of bias (unclear (5 trials) or high (13 trials)). The most common sources of bias were missing outcome data and selective reporting. In trials such as many of those included in this review, where the outcome events are uncommon even in the placebo group, losses to follow-up can potentially cause misleading results.</P>
<P>The quality of the body of evidence included in this review was evaluated using the GRADE system in <LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>. For most outcomes the quality of the evidence was moderate, because of high or unclear risk of bias in the studies. For the outcomes of fever and presence of pain on day 6-7, there was also heterogeneity between studies, so the quality of the body of evidence for these outcomes was graded as low.</P>
<P>We found no evidence concerning the use of prophylactic antibiotics in patients undergoing extraction for severe caries or periodontitis.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-10-04 17:59:12 +0100" MODIFIED_BY="[Empty name]">
<P>Data from some of the studies included in the present review, namely older ones, could not be entered in the meta-analysis because of the poor reporting that prevented data extraction. This may have introduced a reporting bias into this review. The funnel plot for the primary outcome of infection (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>) shows no evidence of publication bias (note the points on the plot are not independent because two of the trials (<LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>; <LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>) are included in two subgroups).</P>
<P>There were some post hoc changes from the protocol for this review, and we acknowledge that such changes can potentially introduce a bias into the review process (<I>see</I> <LINK TAG="PRO_REV_DIFF" TYPE="SECTION">Differences between protocol and review</LINK>). The inclusion criteria for the review were amended so that only randomised, double-blind placebo-controlled trials were included. The protocol planned to only include trials where the important clinical outcome of infection was reported. In this review we made it more explicit that trials which only reported other or intermediate outcomes (endocarditis incidence, bacteraemia or serum marker of infection) would be excluded. We think that these changes have resulted in higher quality clinically relevant trials being included in our review.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-10-04 17:59:21 +0100" MODIFIED_BY="[Empty name]">
<P>A systematic review on the same subject was published in 2007 (<LINK REF="REF-Ren-2007" TYPE="REFERENCE">Ren 2007</LINK>). This review included a different group of studies, because of different inclusion criteria (they considered mandibular third molar extractions only and did not limit the review to double-blind studies). <LINK REF="REF-Ren-2007" TYPE="REFERENCE">Ren 2007</LINK> concluded that antibiotic administration was effective in preventing wound infection, although they reported a higher number needed to treat: "on average 25 patients needed to be treated with systemic antibiotics to prevent 1 case of extraction wound infection" in this group of healthy patients.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-10-04 18:00:12 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-10-04 18:00:12 +0100" MODIFIED_BY="[Empty name]">
<P>There is moderate quality evidence that the use of prophylactic antibiotics reduces the risk of infectious complications following third molar extraction. There is no clear evidence that timing of antibiotic administration (pre-operative, post-operative or both) is important. The numbers of healthy people undergoing third molar extraction who need to be treated with antibiotics to prevent one infection range between 10 and 17, and to prevent a case of dry socket between 24 and 250 people would need to receive prophylactic antibiotics. The size of the benefit is not enough to recommend a routine use of this practice, due to the increased risk of mild adverse effects for the patients and also the potential for contributing to the development of bacterial resistance.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-09-20 16:36:10 +0100" MODIFIED_BY="[Empty name]">
<P>Future trials should investigate prophylactic antibiotics effectiveness in patients at high risk of infective complications, such as immunocompromised subjects and patients who have experienced infective complications following previous extractions. Trials on patients undergoing extractions for severe caries or periodontal disease are also needed. Future studies should also measure the outcomes of symptoms and clinical assessment using standardised measures and timepoints, and report these according to CONSORT guidelines.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-10-04 18:00:57 +0100" MODIFIED_BY="[Empty name]">
<P>Our thanks to Luisa Fernandez-Mauleffinch who translated two papers from Spanish to English, and to Annette Blumle who translated a paper from German to English. Our thanks to Jo Leese for her contributions to the plain language summary of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-10-04 18:02:11 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Conceiving, designing and co-ordinating the review: Giovanni Lodi (GL).</LI>
<LI>Screening search results and retrieved papers against inclusion criteria: GL, Susan Furness (SF), Lara Figini (LF).</LI>
<LI>Appraising quality of papers: GL, SF.</LI>
<LI>Extracting data from papers: GL SF, Andrea Sardella (AS).</LI>
<LI>Writing to authors of papers for additional information: GL, SF.</LI>
<LI>Data management for the review and entering data into RevMan: GL, SF, LF.</LI>
<LI>Analysis and interpretation of data: GL, SF, AS.</LI>
<LI>Preparing the summary of findings table: SF.</LI>
<LI>Providing a clinical perspective: GL, Antonio Carrassi (AC), Massimo Del Fabbro (MD).</LI>
<LI>Writing the text of the review: GL, SF.</LI>
<LI>Preparing the plain language summary: GL.</LI>
<LI>Providing comments on a draft of the review: AS, MD.</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-10-04 18:02:30 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised studies are no longer eligible for inclusion in this review because less biased evidence is available from randomised controlled trials.</P>
<P>It was decided to include only double-blind placebo-controlled studies because we believed that these studies were likely to provide the best evidence to inform practice.</P>
<P>We clarified excluded outcomes by specifically excluding trials where the outcome was endocarditis incidence, bacteraemia or serum marker of infection only.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-10-05 15:43:58 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-10-05 15:37:22 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Arteagoitia-2005" MODIFIED="2012-03-13 15:19:51 +0000" MODIFIED_BY="[Empty name]" NAME="Arteagoitia 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-03-13 15:19:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arteagoitia I, Diez A, Barbier L, Santamaria G, Santamaria J</AU>
<TI>Efficacy of amoxicillin/clavulanic acid in preventing infectious and inflammatory complications following impacted mandibular third molar extraction</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology</SO>
<YR>2005</YR>
<VL>100</VL>
<NO>1</NO>
<PG>e11-8</PG>
<IDENTIFIERS MODIFIED="2011-06-14 14:38:39 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barclay-1987" MODIFIED="2012-03-13 15:20:24 +0000" MODIFIED_BY="[Empty name]" NAME="Barclay 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-03-13 15:20:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barclay JK</AU>
<TI>Metronidazole and dry socket: prophylactic use in mandibular third molar removal complicated by non-acute pericoronitis</TI>
<SO>New Zealand Dental Journal</SO>
<YR>1987</YR>
<VL>83</VL>
<PG>71-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergdahl-2004" MODIFIED="2012-10-05 15:30:39 +0100" MODIFIED_BY="[Empty name]" NAME="Bergdahl 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-10-05 15:30:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergdahl M, Hedstrom L</AU>
<TI>Metronidazole for the prevention of dry socket after removal of partially impacted mandibular third molar: a randomised controlled trial</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>2004</YR>
<VL>42</VL>
<NO>6</NO>
<PG>555-8</PG>
<IDENTIFIERS MODIFIED="2011-06-14 14:40:13 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-10-28 14:46:46 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Bezerra-2011" MODIFIED="2012-10-05 15:33:04 +0100" MODIFIED_BY="[Empty name]" NAME="Bezerra 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-10-05 15:33:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bezerra T</AU>
<TI>Poster Board Number: 16: Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: A split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg)</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2010</YR>
<VL>68</VL>
<NO>9 (suppl)</NO>
<PG>e69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-05 15:31:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS</AU>
<TI>Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg)</TI>
<SO>Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<NO>11</NO>
<PG>e333-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bystedt-1980" MODIFIED="2012-03-13 15:21:13 +0000" MODIFIED_BY="[Empty name]" NAME="Bystedt 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-03-13 15:21:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Bystedt H, Nord CE, Nordenram A</AU>
<TI>Effect of azidocillin, erythromycin, clindamycin and doxycycline on postoperative complications after surgical removal of impacted mandibular third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1980</YR>
<VL>9</VL>
<NO>3</NO>
<PG>157-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bystedt-1981" MODIFIED="2012-10-05 15:33:21 +0100" MODIFIED_BY="[Empty name]" NAME="Bystedt 1981" YEAR="1981">
<REFERENCE MODIFIED="2012-10-05 15:33:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bystedt H, von Konow L, Nord CE</AU>
<TI>A comparison of the effect of phenoxymethylpenicillin and azidocillin on postoperative complications after surgical removal of impacted mandibular third molars</TI>
<SO>Swedish Dental Journal</SO>
<YR>1981</YR>
<VL>5</VL>
<NO>5-6</NO>
<PG>225-34</PG>
<IDENTIFIERS MODIFIED="2012-10-05 15:33:21 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Halpern-2007" MODIFIED="2012-03-13 15:21:31 +0000" MODIFIED_BY="[Empty name]" NAME="Halpern 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-03-13 15:21:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Halpern LR, Dodson TB</AU>
<TI>Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory complications after third molar surgery?</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>65</VL>
<NO>2</NO>
<PG>177-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Happonen-1990" MODIFIED="2012-10-05 15:33:30 +0100" MODIFIED_BY="[Empty name]" NAME="Happonen 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-10-05 15:33:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Happonen RP, Backstrom AC, Ylipaavalniemi P</AU>
<TI>Prophylactic use of phenoxymethylpenicillin and tinidazole in mandibular third molar surgery, a comparative placebo controlled clinical trial</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>1990</YR>
<VL>28</VL>
<NO>1</NO>
<PG>12-5</PG>
<IDENTIFIERS MODIFIED="2011-06-14 14:47:09 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaczmarzyk-2007" MODIFIED="2012-03-13 15:22:04 +0000" MODIFIED_BY="[Empty name]" NAME="Kaczmarzyk 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-03-13 15:22:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaczmarzyk T, Wichlinski J, Stypulkowska J, Zaleska M, Panas M, Woron J</AU>
<TI>Single-dose and multi-dose clindamycin therapy fails to demonstrate efficacy in preventing infectious and inflammatory complications in third molar surgery</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>36</VL>
<NO>5</NO>
<PG>417-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaziro-1984" MODIFIED="2012-10-05 15:36:41 +0100" MODIFIED_BY="[Empty name]" NAME="Kaziro 1984" YEAR="1984">
<REFERENCE MODIFIED="2012-10-05 15:36:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kaziro GS, Harris M</AU>
<TI>A comparative placebo controlled trial between metronidazole and Arnica Montana in preventing post-surgical complications</TI>
<SO>Journal of Dental Research</SO>
<YR>1981</YR>
<VL>60</VL>
<NO>Special Issue</NO>
<PG>1176</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-05 15:34:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kaziro GS</AU>
<TI>Metronidazole (Flagyl) and Arnica Montana in the prevention of post-surgical complications, a comparative placebo controlled clinical trial</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>1984</YR>
<VL>22</VL>
<NO>1</NO>
<PG>42-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lacasa-2007" MODIFIED="2012-10-05 15:34:35 +0100" MODIFIED_BY="[Empty name]" NAME="Lacasa 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-10-05 15:34:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacasa JM, Jiménez JA, Ferrás V, Bossom M, Sóla-Morales O, García-Rey C et al</AU>
<TI>Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg)</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>36</VL>
<NO>4</NO>
<PG>321-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Leon-Arcila-2001" MODIFIED="2012-10-05 15:34:46 +0100" MODIFIED_BY="[Empty name]" NAME="Leon Arcila 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-10-05 15:34:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Leon Arcila ME, Acosta P, Bravo BE, Mena A, Noguera DP, Zúñiga JR</AU>
<TI>Antibiotic prophylaxis in third molar surgery</TI>
<TO>Profilaxis antibiotica en cirugia de terceros molares incluidos</TO>
<SO>Revista Estomatologia</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>2</NO>
<PG>4-13</PG>
<IDENTIFIERS MODIFIED="2012-10-05 15:34:46 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" MODIFIED="2012-06-14 08:45:20 +0100" MODIFIED_BY="[Empty name]" NAME="López-Cedrún 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-23 12:04:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>López-Cedrún JL, Pijoan JI, Fernández S, Santamaria J, Hernandez G</AU>
<TI>Efficacy of amoxicillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>69</VL>
<PG>e5-e14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacGregor-1980" MODIFIED="2012-10-05 15:36:19 +0100" MODIFIED_BY="[Empty name]" NAME="MacGregor 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-10-05 15:36:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>MacGregor AJ, Addy AG</AU>
<TI>The effect of penicillin upon pain, swelling and trismus following the removal of impacted third molars</TI>
<SO>Journal of Dental Research</SO>
<YR>1980</YR>
<VL>59</VL>
<NO>Special Issue D Part 1</NO>
<PG>1799 (Abs No 35)</PG>
<MD>Incl - link to full paper mcGregor 1980</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-05 15:35:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Macgregor AJ, Addy A</AU>
<TI>Value of penicillin in the prevention of pain, swelling and trismus following the removal of ectopic mandibular third molars</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1980</YR>
<VL>9</VL>
<NO>3</NO>
<PG>166-72</PG>
<MD>Incl pdf on file</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1986" MODIFIED="2012-10-05 15:37:10 +0100" MODIFIED_BY="[Empty name]" NAME="Mitchell 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-10-05 15:37:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell DA</AU>
<TI>A controlled clinical trial of prophylactic tinidazole for chemoprophylaxis in third molar surgery</TI>
<SO>British Dental Journal</SO>
<YR>1986</YR>
<VL>160</VL>
<NO>8</NO>
<PG>284-6</PG>
<MD>Incl - get copy - copy order 19/3/12</MD>
<IDENTIFIERS MODIFIED="2012-10-05 15:37:02 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pasupathy-2011" MODIFIED="2012-10-05 15:37:22 +0100" MODIFIED_BY="[Empty name]" NAME="Pasupathy 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-10-05 15:37:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pasupathy S, Alexander M</AU>
<TI>Antibiotic prophylaxis in third molar surgery</TI>
<SO>Journal of Craniofacial Surgery</SO>
<YR>2011</YR>
<VL>22</VL>
<PG>551-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ritzau-1992" MODIFIED="2012-03-13 15:25:52 +0000" MODIFIED_BY="[Empty name]" NAME="Ritzau 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-03-13 15:25:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ritzau M, Hillerup S, Branebjerg PE, Ersbol BK</AU>
<TI>Does metronidazole prevent alveolitis sicca dolorosa? A double-blind, placebo-controlled clinical study</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1992</YR>
<VL>21</VL>
<NO>5</NO>
<PG>299-302</PG>
<IDENTIFIERS MODIFIED="2012-03-13 15:25:52 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sekhar-2001" MODIFIED="2012-03-13 15:25:59 +0000" MODIFIED_BY="[Empty name]" NAME="Sekhar 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-03-13 15:25:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sekhar CH, Narayanan V, Baig MF</AU>
<TI>Role of antimicrobials in third molar surgery: prospective, double blind,randomized, placebo-controlled clinical study</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>2</NO>
<PG>134-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-10-05 15:43:00 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abu_x002d_Mowais-1990" MODIFIED="2012-01-31 16:39:17 +0000" MODIFIED_BY="[Empty name]" NAME="Abu-Mowais 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-01-31 16:39:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Abu-Mowais M, Abdul-Amir R, El-Mostehy MR, Mansour M, Mohalhal I</AU>
<TI>The clinical safety and efficacy of antibiotic prophylaxis after surgical removal of third molars</TI>
<SO>Journal of the Kuwait Medical Association</SO>
<YR>1990</YR>
<VL>24</VL>
<NO>1</NO>
<PG>57-9</PG>
<MD>Exclude - single blinded</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ataoglu-2008" MODIFIED="2012-10-05 15:37:37 +0100" MODIFIED_BY="[Empty name]" NAME="Ataoglu 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-10-05 15:37:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Atao&#287;lu H, Oz GY, Candirli C, Kizilo&#287;lu D</AU>
<TI>Routine antibiotic prophylaxis is not necessary during operations to remove third molars</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>2</NO>
<PG>133-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bargnesi-1985" MODIFIED="2012-10-05 15:38:09 +0100" MODIFIED_BY="[Empty name]" NAME="Bargnesi 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-10-05 15:38:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bargnesi R, Bondi C, Cavalli A, Vallania G</AU>
<TI>A clinical double blind study of the usefulness of systemic prophylactic antibiotic therapy in minor oral surgery</TI>
<SO>Giornale di Stomatologia e di Ortognatodonzia</SO>
<YR>1985</YR>
<VL>4</VL>
<NO>2</NO>
<PG>29-32</PG>
<MD>? Incl</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Curran-1974" MODIFIED="2012-06-28 12:13:58 +0100" MODIFIED_BY="[Empty name]" NAME="Curran 1974" YEAR="1974">
<REFERENCE MODIFIED="2012-06-28 12:13:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Curran JB, Kennett S, Young AR</AU>
<TI>An assessment of the use of prophylactic antibiotics in third molar surgery</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1974</YR>
<VL>3</VL>
<NO>1</NO>
<PG>1-6</PG>
<MD>described as double blind RCT but pts not blinded only outcome assessment - ? put into excluded studies</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Delilbasi-2004" MODIFIED="2012-10-05 15:38:26 +0100" MODIFIED_BY="[Empty name]" NAME="Delilbasi 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-10-05 15:38:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delilbasi C, Saracoglu U, Keskin A</AU>
<TI>Effects of 0.2% chlorhexidine gluconate and amoxicillin plus clavulanic acid on the prevention of alveolar osteitis following mandibular third molar extractions</TI>
<SO>Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, &amp; Endodontology</SO>
<YR>2002</YR>
<VL>94</VL>
<NO>3</NO>
<PG>301-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Moura-2011" MODIFIED="2012-03-13 15:57:58 +0000" MODIFIED_BY="[Empty name]" NAME="de Moura 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-03-13 15:57:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Moura WL, de Moura WL, Freire SASR, Mendes SM, Olate S</AU>
<TI>Efficacy of amoxicillin treatment in preventing postoperative complications in patients undergoing third molar surgery: a double blind study</TI>
<TO>Eficacia del tratamiento con amoxicilina en la prevención de complicaciones postoperatorias en pacientes sometidos a cirugía del tercer molar: un estudio doble ciego</TO>
<SO>International Journal of Odontostomatology</SO>
<YR>2011</YR>
<VL>5</VL>
<NO>2</NO>
<PG>147-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foy-2004" MODIFIED="2012-10-05 15:38:41 +0100" MODIFIED_BY="[Empty name]" NAME="Foy 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-10-05 15:38:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Foy SP, Shugars DA, Phillips C, Marciani RD, Conrad SM, White RP Jr</AU>
<TI>The impact of intravenous antibiotics on health-related quality of life outcomes and clinical recovery after third molar surgery</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2004</YR>
<VL>62</VL>
<NO>1</NO>
<PG>15-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fridrich-1990" MODIFIED="2012-03-13 15:37:06 +0000" MODIFIED_BY="[Empty name]" NAME="Fridrich 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-03-13 15:37:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fridrich KL, Olson RA</AU>
<TI>Alveolar osteitis following surgical removal of mandibular third molars</TI>
<SO>Anesthesia Progress</SO>
<YR>1990</YR>
<VL>37</VL>
<NO>1</NO>
<PG>32-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graziani-2005" MODIFIED="2012-10-05 15:38:56 +0100" MODIFIED_BY="[Empty name]" NAME="Graziani 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-10-05 15:38:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graziani F, Corsi L, Fornai M, Antonioli L, Tonelli M, Ceia S et al</AU>
<TI>Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction</TI>
<SO>Pharmacological Research</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>6</NO>
<PG>485-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grossi-2007" MODIFIED="2012-10-05 15:39:13 +0100" MODIFIED_BY="[Empty name]" NAME="Grossi 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-10-05 15:39:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grossi GB, Maiorana C, Garramone RA, Borgonovo A, Creminelli L, Santoro F</AU>
<TI>Assessing postoperative discomfort after third molar surgery: a prospective study</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>65</VL>
<NO>5</NO>
<PG>901-17</PG>
<IDENTIFIERS MODIFIED="2012-03-13 15:42:35 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Head-1984" MODIFIED="2012-10-05 15:39:27 +0100" MODIFIED_BY="[Empty name]" NAME="Head 1984" YEAR="1984">
<REFERENCE MODIFIED="2012-10-05 15:39:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Head TW, Bentley KC, Millar EP, deVries JA</AU>
<TI>A comparative study of the effectiveness of metronidazole and penicillin V in eliminating anaerobes from postextraction bacteremias</TI>
<SO>Oral Surgery, Oral Medicine, and Oral Pathology</SO>
<YR>1984</YR>
<VL>58</VL>
<NO>2</NO>
<PG>152-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krekmanov-1980" MODIFIED="2012-03-13 15:50:59 +0000" MODIFIED_BY="[Empty name]" NAME="Krekmanov 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-03-13 15:50:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krekmanov L, Hallander HO</AU>
<TI>Relationship between bacterial contamination and alveolitis after third molar surgery</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1980</YR>
<VL>9</VL>
<NO>4</NO>
<PG>274-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krekmanov-1981" MODIFIED="2012-03-13 15:51:27 +0000" MODIFIED_BY="[Empty name]" NAME="Krekmanov 1981" YEAR="1981">
<REFERENCE MODIFIED="2012-03-13 15:51:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krekmanov L</AU>
<TI>Alveolitis after operative removal of third molars in the mandible</TI>
<SO>International Journal of Oral Surgery</SO>
<YR>1981</YR>
<VL>10</VL>
<NO>3</NO>
<PG>173-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krekmanov-1986" MODIFIED="2012-10-05 15:39:41 +0100" MODIFIED_BY="[Empty name]" NAME="Krekmanov 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-10-05 15:39:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krekmanov L, Nordenram A</AU>
<TI>Postoperative complications after surgical removal of mandibular third molars. Effects of penicillin V and chlorhexidine</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1986</YR>
<VL>15</VL>
<NO>1</NO>
<PG>25-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laird-1972" MODIFIED="2012-03-13 15:52:20 +0000" MODIFIED_BY="[Empty name]" NAME="Laird 1972" YEAR="1972">
<REFERENCE MODIFIED="2012-03-13 15:52:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Laird WR, Stenhouse D, Macfarlane TW</AU>
<TI>Control of post-operative infection. A comparative evaluation of clindamycin and phenoxymethylpenicillin</TI>
<SO>British Dental Journal</SO>
<YR>1972</YR>
<VL>133</VL>
<NO>3</NO>
<PG>106-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Limeres-2009" MODIFIED="2012-10-05 15:39:52 +0100" MODIFIED_BY="[Empty name]" NAME="Limeres 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-10-05 15:39:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Limeres J, Sanromán JF, Tomás I, Diz P</AU>
<TI>Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2009</YR>
<VL>67</VL>
<NO>2</NO>
<PG>286-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lombardia-Garcia-1987" MODIFIED="2012-10-05 15:40:23 +0100" MODIFIED_BY="[Empty name]" NAME="Lombardia Garcia 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-10-05 15:40:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lombardía García E, García Pola MJ, González García M, Gener González M</AU>
<TI>Antimicrobial prophylaxis in surgery of the third molar. Analytic study of postoperative complications</TI>
<SO>Archivos de Odonto Estomatologia</SO>
<YR>1987</YR>
<VL>3</VL>
<NO>3</NO>
<PG>130-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lopes-2011" MODIFIED="2012-03-13 16:23:37 +0000" MODIFIED_BY="[Empty name]" NAME="Lopes 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-03-13 16:23:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lopes DR, Peres MP, Levin AS</AU>
<TI>Randomized study of surgical prophylaxis in immunocompromised hosts</TI>
<SO>Journal of Dental Research</SO>
<YR>2011</YR>
<VL>90</VL>
<NO>2</NO>
<PG>225-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luaces_x002d_Rey-2010" MODIFIED="2012-10-05 15:40:44 +0100" MODIFIED_BY="[Empty name]" NAME="Luaces-Rey 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-10-05 15:40:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luaces-Rey R, Arenaz-Búa J, Lopez-Cedrun-Cembranos JL, Martínez-Roca C, Pértega-Díaz S, Sironvalle-Soliva S</AU>
<TI>Efficacy and safety comparison of two amoxicillin administration schedules after third molar removal. A randomized, double-blind and controlled clinical trial</TI>
<SO>Medicina Oral, Patologia Oral y Cirugia Bucal</SO>
<YR>2010</YR>
<VL>15</VL>
<NO>4</NO>
<PG>633-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lyall-1991" MODIFIED="2012-03-13 16:28:51 +0000" MODIFIED_BY="[Empty name]" NAME="Lyall 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-03-13 16:28:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lyall JB</AU>
<TI>Third molar surgery: the effect of primary closure, wound dressing and metronidazole on postoperative recovery</TI>
<SO>Journal of the Royal Army Medical Corps</SO>
<YR>1991</YR>
<VL>137</VL>
<NO>2</NO>
<PG>100-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacGregor-1973" MODIFIED="2012-03-13 16:29:04 +0000" MODIFIED_BY="[Empty name]" NAME="MacGregor 1973" YEAR="1973">
<REFERENCE MODIFIED="2012-03-13 16:29:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>MacGregor AJ, Hutchinson D</AU>
<TI>The effect of Nivemycin on pain and swelling following lower third molar removal</TI>
<SO>British Journal of Oral Surgery</SO>
<YR>1973</YR>
<VL>10</VL>
<NO>3</NO>
<PG>321-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mitchell-1987" MODIFIED="2012-10-05 15:40:57 +0100" MODIFIED_BY="[Empty name]" NAME="Mitchell 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-10-05 15:40:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mitchell DA, Morris TA</AU>
<TI>Tinidazole or pivampicillin in third molar surgery</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>1987</YR>
<VL>16</VL>
<NO>2</NO>
<PG>171-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monaco-1999" MODIFIED="2011-06-14 16:30:57 +0100" MODIFIED_BY="[Empty name]" NAME="Monaco 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-06-14 16:30:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monaco G, Staffolani C, Gatto MR, Checchi L</AU>
<TI>Antibiotic therapy in impacted third molar surgery</TI>
<SO>European Journal of Oral Science</SO>
<YR>1999</YR>
<VL>6</VL>
<NO>107</NO>
<PG>437-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Monaco-2009" MODIFIED="2012-10-05 15:41:07 +0100" MODIFIED_BY="[Empty name]" NAME="Monaco 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-10-05 15:41:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Monaco G, Tavernese L, Agostini R, Marchetti C</AU>
<TI>Evaluation of antibiotic prophylaxis in reducing postoperative infection after mandibular third molar extraction in young patients</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2009</YR>
<VL>67</VL>
<NO>7</NO>
<PG>1467-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Olusanya-2011" MODIFIED="2012-03-13 16:33:16 +0000" MODIFIED_BY="[Empty name]" NAME="Olusanya 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-03-13 16:33:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Olusanya AA, Arotiba JT, Fasola OA, Akadiri AO</AU>
<TI>Prophylaxis versus pre-emptive antibiotics in third molar surgery: a randomised control study</TI>
<SO>Nigerian Postgraduate Medical Journal</SO>
<YR>2011</YR>
<VL>18</VL>
<NO>2</NO>
<PG>105-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osborn-1979" MODIFIED="2012-10-05 15:41:30 +0100" MODIFIED_BY="[Empty name]" NAME="Osborn 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-10-05 15:41:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osborn JF, Jaques WA, Thalmann R, Spiessl B</AU>
<TI>Efficiency of systemic prophylactic antibiotics in the surgical removal of lower wisdom teeth</TI>
<SO>SSO: Schweizerische Monatsschrift fur Zahnheilkunde</SO>
<YR>1979</YR>
<VL>89</VL>
<NO>5</NO>
<PG>458-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poeschl-2004" MODIFIED="2012-10-05 15:41:58 +0100" MODIFIED_BY="[Empty name]" NAME="Poeschl 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-10-05 15:41:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poeschel PW, Eckel D</AU>
<TI>Antibiotic prophylaxis after out-patient removal of wisdom teeth: a necessity?</TI>
<SO>Stomatologie</SO>
<YR>2003</YR>
<VL>100</VL>
<NO>5</NO>
<PG>115</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-10-05 15:41:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Poeschl PW, Eckel D, Poeschl E</AU>
<TI>Postoperative prophylactic antibiotic treatment in third molar surgery--a necessity?</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2004</YR>
<VL>62</VL>
<NO>1</NO>
<PG>3-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reekie-2006" MODIFIED="2012-03-13 16:35:13 +0000" MODIFIED_BY="[Empty name]" NAME="Reekie 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-03-13 16:35:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reekie D, Downes P, Devlin CV, Nixon GM, Devlin H</AU>
<TI>The prevention of 'dry socket' with topical metronidazole in general dental practice</TI>
<SO>British Dental Journal</SO>
<YR>2006</YR>
<VL>200</VL>
<NO>4</NO>
<PG>210-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rood-1979" MODIFIED="2012-03-13 16:35:43 +0000" MODIFIED_BY="[Empty name]" NAME="Rood 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-03-13 16:35:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rood JP, Murgatroyd J</AU>
<TI>Metronidazole in the prevention of 'dry socket'</TI>
<SO>British Journal of Oral Surgery</SO>
<YR>1979</YR>
<VL>17</VL>
<NO>1</NO>
<PG>62-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Samsudin-1994" MODIFIED="2012-10-05 15:42:10 +0100" MODIFIED_BY="[Empty name]" NAME="Samsudin 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-10-05 15:42:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Samsudin AR, Mason DA</AU>
<TI>Symptoms from impacted wisdom teeth</TI>
<SO>British Journal of Oral &amp; Maxillofacial Surgery</SO>
<YR>1994</YR>
<VL>32</VL>
<NO>6</NO>
<PG>380-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siddiqi-2010" MODIFIED="2012-03-13 16:37:33 +0000" MODIFIED_BY="[Empty name]" NAME="Siddiqi 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-03-13 16:37:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siddiqi A, Morkel JA, Zafar S</AU>
<TI>Antibiotic prophylaxis in third molar surgery: A randomized double-blind placebo-controlled clinical trial using split-mouth technique</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2010</YR>
<VL>39</VL>
<NO>2</NO>
<PG>107-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stavropoulos-2006" MODIFIED="2012-10-05 15:42:24 +0100" MODIFIED_BY="[Empty name]" NAME="Stavropoulos 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-10-05 15:42:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stavropoulos MF, Shugars DA, Phillips C, Conrad SM, Fleuchaus PT, White RP Jr</AU>
<TI>Impact of topical minocycline with third molar surgery on clinical recovery and health-related quality of life outcomes</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2006</YR>
<VL>64</VL>
<NO>7</NO>
<PG>1059-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sulejmanagi_x0107_-2005" MODIFIED="2012-10-05 15:42:35 +0100" MODIFIED_BY="[Empty name]" NAME="Sulejmanagi&#263; 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-10-05 15:42:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sulejmanagi&#263; N, Sulejmanagi&#263; H, Ljutovi&#263; Z, Salihagi&#263; D, Sijerci&#263; M</AU>
<TI>Combined application of amoxicillin and clavulanic acid after oral surgical interventions</TI>
<SO>Bosnian Journal of Basic Medical Science</SO>
<YR>2005</YR>
<VL>5</VL>
<NO>1</NO>
<PG>61-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Swanson-1989" MODIFIED="2012-10-05 15:42:43 +0100" MODIFIED_BY="[Empty name]" NAME="Swanson 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-10-05 15:42:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Swanson AE</AU>
<TI>A double-blind study on the effectiveness of tetracycline in reducing the incidence of fibrinolytic alveolitis</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1989</YR>
<VL>47</VL>
<NO>2</NO>
<PG>165-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uluibau-2005" MODIFIED="2012-03-13 17:07:03 +0000" MODIFIED_BY="[Empty name]" NAME="Uluibau 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-03-13 16:45:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uluibau IC, Jaunay T, Goss AN</AU>
<TI>Severe odontogenic infections</TI>
<SO>Australian Dental Journal</SO>
<YR>2005</YR>
<VL>50</VL>
<NO>2</NO>
<PG>S74-S81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-03-13 17:07:03 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Walkow-1995" MODIFIED="2012-10-05 15:43:00 +0100" MODIFIED_BY="[Empty name]" NAME="Walkow 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-10-05 15:43:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Walkow T, Papageorge M, Norris L, Cottrell D</AU>
<TI>Prophylactic antibiotic efficacy in third molar surgery (AADR Abstract 1995)</TI>
<SO>Journal of Dental Research</SO>
<YR>1995</YR>
<VL>74</VL>
<NO>Special Issue</NO>
<PG>138 (Abs No 1013)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoshii-2002" MODIFIED="2012-03-13 17:00:01 +0000" MODIFIED_BY="[Empty name]" NAME="Yoshii 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-03-13 17:00:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Yoshii T, Hamamoto Y, Muraoka S, Furudoi S, Komori T</AU>
<TI>Differences in postoperative morbidity rates, including infection and dry socket, and differences in the healing process after mandibular third molar surgery in patients receiving 1-day or 3-day prophylaxis with lenampicillin</TI>
<SO>Journal of Infection &amp; Chemotherapy</SO>
<YR>2002</YR>
<VL>8</VL>
<NO>1</NO>
<PG>87-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-06-13 09:14:37 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2012-10-05 15:43:58 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Arteagoitia-2011" MODIFIED="2012-10-05 15:43:58 +0100" MODIFIED_BY="[Empty name]" NAME="Arteagoitia 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-10-05 15:43:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arteagoitia M, Santamaria G, Ramos E, Barbier L, Alvarez J, Martin J et al</AU>
<TI>Efficacy of amoxicillin/clavulanic acid 2000/125 mg in preventing infection after extraction of impacted mandibular third molar totally covered by bone: preliminary results</TI>
<SO>International Journal of Oral and Maxillofacial Surgery</SO>
<YR>2011</YR>
<VL>40</VL>
<NO>10</NO>
<PG>1048-9</PG>
<MD>Add to ongoing trials EUDRACT # 2008-005663-34 in RM5 /Interim results/ Jan 2012 search/ pdf and paper copy on file/</MD>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Aida-2009" MODIFIED="2012-03-15 13:22:15 +0000" MODIFIED_BY="[Empty name]" NAME="Aida 2009" TYPE="JOURNAL_ARTICLE">
<AU>Aida J, Morita M, Akhter R, Aoyama H, Masui M, Ando Y</AU>
<TI>Relationships between patient characteristics and reasons for tooth extraction in Japan</TI>
<SO>Community Dental Health</SO>
<YR>2009</YR>
<VL>26</VL>
<NO>2</NO>
<PG>104-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Akhter-2008" MODIFIED="2012-03-15 13:23:59 +0000" MODIFIED_BY="[Empty name]" NAME="Akhter 2008" TYPE="JOURNAL_ARTICLE">
<AU>Akhter R, Hassan NM, Aida J, Zaman KU, Morita M</AU>
<TI>Risk indicators for tooth loss due to caries and periodontal disease in recipients of free dental treatment in an adult population in Bangladesh</TI>
<SO>Oral Health &amp; Preventive Dentistry</SO>
<YR>2008</YR>
<VL>6</VL>
<NO>3</NO>
<PG>199-207</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Al_x002d_Shammari-2006" MODIFIED="2012-03-15 13:28:57 +0000" MODIFIED_BY="[Empty name]" NAME="Al-Shammari 2006" TYPE="JOURNAL_ARTICLE">
<AU>Al-Shammari KF, Al-Ansari JM, Al-Melh MA, Al-Khabbaz AK</AU>
<TI>Reasons for tooth extraction in Kuwait</TI>
<SO>Medical Principles &amp; Practice</SO>
<YR>2006</YR>
<VL>15</VL>
<NO>6</NO>
<PG>417-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Anand-2010" MODIFIED="2012-03-15 13:26:51 +0000" MODIFIED_BY="[Empty name]" NAME="Anand 2010" TYPE="JOURNAL_ARTICLE">
<AU>Anand PS, Kamath KP, Nair B</AU>
<TI>Trends in extraction of permanent teeth in private dental practices in Kerala state, India</TI>
<SO>Journal of Contemporary Dental Practice</SO>
<YR>2010</YR>
<VL>11</VL>
<NO>3</NO>
<PG>41-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Baqain-2007" MODIFIED="2012-03-15 13:28:42 +0000" MODIFIED_BY="[Empty name]" NAME="Baqain 2007" TYPE="JOURNAL_ARTICLE">
<AU>Baqain ZH, Khraisat A, Sawair F, Ghanam S, Shaini FJ, Rajab LD</AU>
<TI>Dental extraction for patients presenting at oral surgery student clinic</TI>
<SO>Compendium of Continuing Education in Dentistry</SO>
<YR>2007</YR>
<VL>28</VL>
<NO>3</NO>
<PG>146-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bortoluzzi-2010" MODIFIED="2012-03-15 13:29:47 +0000" MODIFIED_BY="[Empty name]" NAME="Bortoluzzi 2010" TYPE="JOURNAL_ARTICLE">
<AU>Bortoluzzi MC, Manfro R, De Déa BE, Dutra TC</AU>
<TI>Incidence of dry socket, alveolar infection, and postoperative pain following the extraction of erupted teeth</TI>
<SO>Journal of Contemporary Dental Practice</SO>
<YR>2010</YR>
<VL>11</VL>
<NO>1</NO>
<PG>E033-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bouloux-2007" MODIFIED="2012-10-05 15:44:45 +0100" MODIFIED_BY="[Empty name]" NAME="Bouloux 2007" TYPE="JOURNAL_ARTICLE">
<AU>Bouloux GF, Steed MB, Perciaccante VJ</AU>
<TI>Complications of third molar surgery</TI>
<SO>Oral and Maxillofacial Surgery Clinics of North America</SO>
<YR>2007</YR>
<VL>19</VL>
<NO>1</NO>
<PG>117-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Byahatti-2011" MODIFIED="2012-03-15 13:30:32 +0000" MODIFIED_BY="[Empty name]" NAME="Byahatti 2011" TYPE="JOURNAL_ARTICLE">
<AU>Byahatti SM, Ingafou MS</AU>
<TI>Reasons for extraction in a group of Libyan patients</TI>
<SO>International Dental Journal</SO>
<YR>2011</YR>
<VL>61</VL>
<NO>4</NO>
<PG>199-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chestnutt-2000" MODIFIED="2012-03-15 13:30:58 +0000" MODIFIED_BY="[Empty name]" NAME="Chestnutt 2000" TYPE="JOURNAL_ARTICLE">
<AU>Chestnutt IG, Binnie VI, Taylor MM</AU>
<TI>Reasons for tooth extraction in Scotland</TI>
<SO>Journal of Dentistry</SO>
<YR>2000</YR>
<VL>28</VL>
<NO>4</NO>
<PG>295-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chrysanthakopoulos-2011" MODIFIED="2012-03-15 13:32:07 +0000" MODIFIED_BY="[Empty name]" NAME="Chrysanthakopoulos 2011" TYPE="JOURNAL_ARTICLE">
<AU>Chrysanthakopoulos NA</AU>
<TI>Reasons for extraction of permanent teeth in Greece: a five-year follow-up study</TI>
<SO>International Dental Journal</SO>
<YR>2011</YR>
<VL>61</VL>
<NO>1</NO>
<PG>19-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Costelloe-2010" MODIFIED="2012-02-09 14:24:51 +0000" MODIFIED_BY="[Empty name]" NAME="Costelloe 2010" TYPE="JOURNAL_ARTICLE">
<AU>Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD</AU>
<TI>Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis</TI>
<SO>BMJ</SO>
<YR>2010</YR>
<VL>340</VL>
<PG>c2096</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Da_x0027_ameh-2006" MODIFIED="2012-03-15 13:33:34 +0000" MODIFIED_BY="[Empty name]" NAME="Da'ameh 2006" TYPE="JOURNAL_ARTICLE">
<AU>Da'ameh D</AU>
<TI>Reasons for permanent tooth extraction in the north of Afghanistan</TI>
<SO>Journal of Dentistry</SO>
<YR>2006</YR>
<VL>34</VL>
<NO>1</NO>
<PG>48-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Daly-2008" MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]" NAME="Daly 2008" TYPE="COCHRANE_PROTOCOL">
<AU>Daly B, Newton T, Nasser M, Jones K, Fedorowicz Z</AU>
<TI>Intrasocket interventions for the treatment of dry socket</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-05 16:03:03 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006968"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Danielson-2011" MODIFIED="2012-03-15 13:35:25 +0000" MODIFIED_BY="[Empty name]" NAME="Danielson 2011" TYPE="JOURNAL_ARTICLE">
<AU>Danielson OE, Chinedu AC, Oluyemisi EA, Bashiru BO, Ndubuisi OO</AU>
<TI>Frequency, causes and pattern of adult tooth extraction in a Nigerian rural health facility</TI>
<SO>Odonto-stomatologie Tropicale</SO>
<YR>2011</YR>
<VL>34</VL>
<NO>134</NO>
<PG>5-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dar_x002d_Odeh-2010" MODIFIED="2012-10-05 15:45:40 +0100" MODIFIED_BY="[Empty name]" NAME="Dar-Odeh 2010" TYPE="JOURNAL_ARTICLE">
<AU>Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA</AU>
<TI>Antibiotic prescribing practices by dentists: a review</TI>
<SO>Therapeutics and Clinical Risk Management</SO>
<YR>2010</YR>
<VL>6</VL>
<PG>301-6</PG>
<IDENTIFIERS MODIFIED="2012-10-05 15:45:12 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2012-10-05 15:46:17 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2012-07-30 15:23:49 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vaillancourt JM</AU>
<TI>Meta-analyses involving cross-over trials: methodological issues</TI>
<SO>International Journal of Epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<PG>140-9</PG>
<MD>crossover trials</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Epstein-2000" MODIFIED="2012-03-15 13:37:30 +0000" MODIFIED_BY="[Empty name]" NAME="Epstein 2000" TYPE="JOURNAL_ARTICLE">
<AU>Epstein JB, Chong S, Le ND</AU>
<TI>A survey of antibiotic use in dentistry</TI>
<SO>Journal of the American Dental Association</SO>
<YR>2000</YR>
<VL>131</VL>
<NO>11</NO>
<PG>1600-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EU-Commission-2011" MODIFIED="2012-10-05 15:47:40 +0100" MODIFIED_BY="[Empty name]" NAME="EU Commission 2011" TYPE="OTHER">
<AU>European Commission. Directorate-General for Health &amp; Consumers</AU>
<TI>Communication from the European Commission to the European Parliament and the Council. Action plan against the rising threats from Antimicrobial Resistance (COM (2011) 748)</TI>
<SO>http://ec.europa.eu/dgs/health_consumer/docs/communication_amr_2011_748_en.pdf</SO>
<YR>(accessed July 2012)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hersh-1999" MODIFIED="2012-03-15 13:47:37 +0000" MODIFIED_BY="[Empty name]" NAME="Hersh 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hersh EV</AU>
<TI>Adverse drug interactions in dental practice: interactions involving antibiotics</TI>
<SO>Journal of the American Dental Association</SO>
<YR>1999</YR>
<VL>130</VL>
<NO>2</NO>
<PG>236-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-10-05 15:48:20 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Howe-1985" MODIFIED="2012-10-05 15:49:06 +0100" MODIFIED_BY="[Empty name]" NAME="Howe 1985" TYPE="BOOK">
<AU>Howe LH</AU>
<SO>Minor Oral Surgery</SO>
<YR>1985</YR>
<EN>3rd</EN>
<PB>Wright</PB>
<CY>Bristol</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ioannidis-2009" MODIFIED="2012-10-05 15:49:31 +0100" MODIFIED_BY="[Empty name]" NAME="Ioannidis 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ioannidis JP</AU>
<TI>Adverse events in randomized trials: neglected, restricted, distorted, and silenced</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2009</YR>
<VL>169</VL>
<NO>19</NO>
<PG>1737-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jaafar-2000" MODIFIED="2012-03-15 13:48:25 +0000" MODIFIED_BY="[Empty name]" NAME="Jaafar 2000" TYPE="JOURNAL_ARTICLE">
<AU>Jaafar N, Nor GM</AU>
<TI>The prevalence of post-extraction complications in an outpatient dental clinic in Kuala Lumpur Malaysia-a retrospective survey</TI>
<SO>Singapore Dental Journal</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>1</NO>
<PG>24-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jovino_x002d_Silveira-2005" MODIFIED="2012-03-15 13:49:13 +0000" MODIFIED_BY="[Empty name]" NAME="Jovino-Silveira 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jovino-Silveira RC, Caldas Ade F Jr, de Souza EH, Gusmão ES</AU>
<TI>Primary reason for tooth extraction in a Brazilian adult population</TI>
<SO>Oral Health &amp; Preventive Dentistry</SO>
<YR>2005</YR>
<VL>3</VL>
<NO>3</NO>
<PG>151-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Karki-2011" MODIFIED="2012-03-15 13:51:00 +0000" MODIFIED_BY="[Empty name]" NAME="Karki 2011" TYPE="JOURNAL_ARTICLE">
<AU>Karki AJ, Holyfield G, Thomas D</AU>
<TI>Dental prescribing in Wales and associated public health issues</TI>
<SO>British Dental Journal</SO>
<YR>2011</YR>
<VL>210</VL>
<NO>1</NO>
<PG>E21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lesolang-2009" MODIFIED="2012-03-15 13:52:16 +0000" MODIFIED_BY="[Empty name]" NAME="Lesolang 2009" TYPE="JOURNAL_ARTICLE">
<AU>Lesolang RR, Motloba DP, Lalloo R</AU>
<TI>Patterns and reasons for tooth extraction at the Winterveldt Clinic: 1998-2002</TI>
<SO>South African Dental Journal</SO>
<YR>2009</YR>
<VL>64</VL>
<NO>5</NO>
<PG>214-5, 218</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-L_x00f6_kken-1975" MODIFIED="2012-03-15 13:53:19 +0000" MODIFIED_BY="[Empty name]" NAME="Lökken 1975" TYPE="JOURNAL_ARTICLE">
<AU>Lökken P, Olsen I, Bruaset I, Norman-Pedersen K</AU>
<TI>Bilateral surgical removal of impacted lower third molar teeth as a model for drug evaluation: a test with ibuprofen</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1975</YR>
<VL>8</VL>
<NO>3-4</NO>
<PG>209-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCaul-2001" NAME="McCaul 2001" TYPE="JOURNAL_ARTICLE">
<AU>McCaul LK, Jenkins WMM, Kay EJ</AU>
<TI>The reasons for extraction of permanent teeth in Scotland: a 15-year follow-up study</TI>
<SO>British Dental Journal</SO>
<YR>2001</YR>
<VL>190</VL>
<NO>12</NO>
<PG>658-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mettes-2012" MODIFIED="2012-10-05 15:49:49 +0100" MODIFIED_BY="[Empty name]" NAME="Mettes 2012" TYPE="COCHRANE_REVIEW">
<AU>Mettes TD, Ghaeminia H, Nienhuijs ME, Perry J, van der Sanden WJ, Plasschaert A</AU>
<TI>Surgical removal versus retention for the management of asymptomatic impacted wisdom teeth</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2012-07-30 11:40:49 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-30 11:40:49 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003879"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ren-2007" MODIFIED="2012-10-05 15:50:40 +0100" MODIFIED_BY="[Empty name]" NAME="Ren 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ren YF, Malmstrom HS</AU>
<TI>Effectiveness of antibiotic prophylaxis in third molar surgery: a meta-analysis of randomized controlled clinical trials</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>2007</YR>
<VL>65</VL>
<NO>10</NO>
<PG>1909-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richards-2005" MODIFIED="2012-03-15 13:54:34 +0000" MODIFIED_BY="[Empty name]" NAME="Richards 2005" TYPE="JOURNAL_ARTICLE">
<AU>Richards W, Ameen J, Coll AM, Higgs G</AU>
<TI>Reasons for tooth extraction in four general dental practices in South Wales</TI>
<SO>British Dental Journal</SO>
<YR>2005</YR>
<VL>198</VL>
<NO>5</NO>
<PG>275-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-R_x00fc_cker-2008" MODIFIED="2012-10-05 15:51:12 +0100" MODIFIED_BY="[Empty name]" NAME="Rücker 2008" TYPE="JOURNAL_ARTICLE">
<AU>Rucker G, Schwarzer G, Carpenter J</AU>
<TI>Arcsine test for publication bias in meta-analyses with binary outcomes</TI>
<SO>Statistics in Medicine</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>5</NO>
<PG>746-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sleeman-1995" MODIFIED="2012-03-15 13:55:11 +0000" MODIFIED_BY="[Empty name]" NAME="Sleeman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Sleeman D, Barry H, Ryan C, Allen F</AU>
<TI>Day case oral surgery: a review of 25 years experience at the Dublin Dental Hospital</TI>
<SO>British Dental Journal</SO>
<YR>1995</YR>
<VL>179</VL>
<NO>6</NO>
<PG>221-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thomas-1994" MODIFIED="2012-10-05 15:51:20 +0100" MODIFIED_BY="[Empty name]" NAME="Thomas 1994" TYPE="OTHER">
<AU>Thomas D, Walker R, Smith A, Shepherd J</AU>
<TI>The provision of oral surgery services in England and Wales 1984-1991</TI>
<SO>British Dental Journal</SO>
<YR>1994</YR>
<VL>176</VL>
<NO>6</NO>
<PG>215-9</PG>
<IDENTIFIERS MODIFIED="2012-10-05 15:51:20 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Trovik-2000" MODIFIED="2012-10-05 15:51:29 +0100" MODIFIED_BY="[Empty name]" NAME="Trovik 2000" TYPE="JOURNAL_ARTICLE">
<AU>Trovik TA, Klock KS, Haugejorden O</AU>
<TI>Trends in reasons for tooth extractions in Norway from 1968 to 1998</TI>
<SO>Acta Odontolologica Scandinavica</SO>
<YR>2000</YR>
<VL>58</VL>
<NO>2</NO>
<PG>89-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Worthington-1999" MODIFIED="2012-03-15 13:57:36 +0000" MODIFIED_BY="[Empty name]" NAME="Worthington 1999" TYPE="JOURNAL_ARTICLE">
<AU>Worthington H, Clarkson J, Davies R</AU>
<TI>Extraction of teeth over 5 years in regularly attending adults</TI>
<SO>Community Dentistry and Oral Epidemiology</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>3</NO>
<PG>187-94</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-10-05 20:59:58 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-10-05 20:59:58 +0100" MODIFIED_BY="[Empty name]" SORT_BY="YEAR" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-10-05 20:59:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MacGregor-1980">
<CHAR_METHODS MODIFIED="2012-10-05 14:32:11 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT where participants paired based on number of lower molars extracted.</P>
<P>Conducted in: Leeds, England.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:32:40 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: Caucasian patients requiring removal of 1 or 2 mandibular third molars under endotracheal anaesthesia. M3 had to be fully developed with an identifiable occlusal plane.</P>
<P>Exclusion criteria: patients who wear artificial dentures, who could not attend 4th day appointment or those whose operation had "undue haemorrhage". Patients who required antibiotics for other reasons (e.g. endocarditis) were also excluded.</P>
<P>Age group: not stated.</P>
<P>Number randomised: not stated.</P>
<P>Number evaluated: not stated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 20:59:22 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op penicillin versus placebo. </B>
</P>
<P>Group A: benzyl penicillin 300 mg + procaine penicillin 300 mg intramuscular 30 min pre-operatively.</P>
<P>Group B: placebo injection IM 30 min pre-operatively.</P>
<P>Procedures performed by 2 surgeons with attempts to standardise methods.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:34:18 +0100" MODIFIED_BY="[Empty name]">
<P>Pain, swelling and trismus on day 4 in graphs only.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-03-29 12:15:57 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 16:04:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bystedt-1980">
<CHAR_METHODS MODIFIED="2012-10-05 14:27:36 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: Sweden.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy outpatients requiring surgical removal of impacted third molar of mandible.</P>
<P>Exclusion criteria: history of significant gastric, hepatic or renal disease, those taking any other medication except analgesia during study period.</P>
<P>Age group: mean 29 years, range 17-79 years.</P>
<P>Number randomised: 140 in 3 separate subtrials.</P>
<P>Number evaluated: unclear, reported as percentage of combined groups.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 16:04:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison A: 1 hour pre-op + 7 days post-op azidocillin versus placebo.</B>
</P>
<P>
<B>Comparison B: 90 min pre-op + 7 days post-op erythromycin or clindamycin versus placebo.</B>
</P>
<P>
<B>Comparison C: 180 min pre-op + 7 days post-op doxycycline versus placebo.</B>
</P>
<P>Study  A (n = 40): either azidocillin 750 mg 1 hour pre-op + 750 mg bid for 7 days post-op or matching placebo.</P>
<P>Study  B (n = 60): either erythromycin stearate 500 mg or clindamycin 300 mg or placebo 90 min pre-op followed by 250 mg erythromycin or 150 mg clindamycin or placebo 4x daily for 7 days.</P>
<P>Study  C (n = 40): either 200 mg doxycycline or placebo 180 min pre-op plus either 100 mg doxycycline or placebo once daily for 7 days.</P>
<P>All participants had 0.5-1 g acetylsalicylic acid as needed for pain.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:31:18 +0100" MODIFIED_BY="[Empty name]">
<P>Capillary serum antibiotic levels, dental alveolar blood antibiotic levels, bone antibiotic levels, evaluated on day 2. Duration of operation, pain, trismus, swelling, wound healing, side effects evaluated on days 2, 5 and 7 post-op.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-13 15:31:02 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:36:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bystedt-1981">
<CHAR_METHODS MODIFIED="2012-10-05 14:34:38 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: 3-arm RCT.</P>
<P>Conducted in: Sweden.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: unclear.</P>
<P>Funding source: unspecified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:34:59 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy outpatients, referred for surgical removal of an impacted third molar of the mandible.</P>
<P>Exclusion criteria: not specified.</P>
<P>Age group: range 17-30 years.</P>
<P>Group A: randomised 20; analysed 20.</P>
<P>Group B: randomised 20; analysed 20.</P>
<P>Group C: randomised 20; analysed 20.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:35:55 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre- + post-op penicillin versus pre- + post-op azidocillin versus placebo.</B>
</P>
<P>Group A: phenoxmethylpenicillin 800 mg 1 hour before operation and then twice a day (at 9.00 AM and 9.00 PM) for 7 days.</P>
<P>Group B: azidocillin 750 mg 1 hour before operation and then twice a day (at 9.00 AM and 9.00 PM) for 7 days.</P>
<P>Group C: placebo 1 hour before operation and then twice a day (at 9.00 AM and 9.00 PM) for 7 days.</P>
<P>Aspirin 0.5-1.0 g was provided to all participants as a rescue analgesic to be taken when needed. No other medications except analgesics were allowed during the investigation period.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:36:12 +0100" MODIFIED_BY="[Empty name]">
<P>Pain was measured on the day of operation and on days 2, 5, and 7 on a 3-grade scale (I none or insignificant, II pain requiring no analgesic, II severe pain requiring analgesic).</P>
<P>Trismus was measured on the day of operation and on days 2, 5, and 7 measuring the ability to open the mouth, using a vernier gauge.</P>
<P>Extraoral swelling was measured according to the method described by <LINK REF="REF-L_x00f6_kken-1975" TYPE="REFERENCE">Lökken 1975</LINK>.</P>
<P>Dry socket diagnosis was made clinically on the basis of severe mandibular pain accompanied by necrotic debris or a denuded alveolus.</P>
<P>Wound healing (evidence of loose of periosteal flap and alveolitis).</P>
<P>Side effects: patients were questioned at each examination regarding side effects such as fever, indisposition or diarrhoea.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-03 12:50:08 +0100" MODIFIED_BY="[Empty name]">
<P>Only usable data that can be extracted by the paper are those on dry socket, subjects with no complications and adverse effects. Groups A and B have been considered together in the analysis.</P>
<P>All operations were carried out by the same surgeons under local anaesthesia.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:38:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaziro-1984">
<CHAR_METHODS MODIFIED="2012-10-05 14:36:30 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: UK.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:36:46 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients with impacted mandibular wisdom teeth.</P>
<P>Exclusion criteria: not described.</P>
<P>Age group: not stated.</P>
<P>Number randomised: 118.</P>
<P>Number evaluated: unclear.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:38:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: post-op metronidazole versus arnica versus placebo.</B>
</P>
<P>Group A (n = 41): metronidazole 400 mg 1 tablet twice daily post-operatively.</P>
<P>Group B (n = 39): arnica 200 tablets 1 tablet twice daily post-operatively.</P>
<P>Group C (n = 38): placebo 1 tablet twice daily post-operatively. </P>
<P>Tablets were taken for 3 days.</P>
<P>All participants had 2 Codis (aspirin plus codeine) tablets 3x daily for pain.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:38:20 +0100" MODIFIED_BY="[Empty name]">
<P>Pain, trismus, oedema, wound healing on 4<SUP>th</SUP> and 8<SUP>th</SUP> post-op day, wound breakdown.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:38:30 +0100" MODIFIED_BY="[Empty name]">
<P>Data presented in graphs only. Extractions were done by 1 of 6 surgeons blinded to allocated treatment.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:41:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1986">
<CHAR_METHODS MODIFIED="2012-10-05 14:39:27 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: parallel group RCT.</P>
<P>Conducted in: Newcastle, UK.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:40:20 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: inpatients, aged 18-30 years, attending hospital for removal of 1 or more third molars.</P>
<P>Exclusion criteria: those with a significant medical history or acute infection were excluded.</P>
<P>Age group: mean 24 years, range 17-33 years. </P>
<P>Number randomised: 50 participants (89 teeth).</P>
<P>Number evaluated: 50.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:41:39 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op tinidazole versus placebo. </B>
</P>
<P>Group A<B> </B>(n = 25 participants, 45 teeth): tinidazole 500 mg orally 12 hours pre-operatively.</P>
<P>Group B<B> </B>(n = 25 participants, 44 teeth): placebo oral 12 hours pre-operatively.</P>
<P>All patients had ibuprofen as required while in hospital and access to analgesics as required after discharge.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-03-29 13:30:13 +0100" MODIFIED_BY="[Empty name]">
<P>Infected socket, onset of painful socket increasing in severity, within first 7 days. Other signs of infection or dry socket, type of bone removal.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:40:48 +0100" MODIFIED_BY="[Empty name]">
<P>4 surgeons conducted the extractions, using a standardised technique.</P>
<P>1 clinician blinded to intervention assessed all patients both pre- and post-operatively.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:43:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barclay-1987">
<CHAR_METHODS MODIFIED="2012-10-05 14:42:31 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: New Zealand.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: unclear.</P>
<P>Funding source: metronidazole and placebo tablets were supplied by May and Baker New Zealand Ltd.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:43:00 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: "patients with a history of non-acute pericoronitis, and therefore likely to experience a high prevalence of dry socket". Patients had to meet 2 or more of the following criteria: a history of 2 or more episodes of previously diagnosed pericoronitis; the expression of pus from beneath a pericoronal flap in the absence of significant symptoms; radiographic enlargement of the follicular space distal to the third molar in the absence of significant symptoms; crater-like radiographic defect as described by Howe (<LINK REF="REF-Howe-1985" TYPE="REFERENCE">Howe 1985</LINK>).</P>
<P>Exclusion criteria: pregnancy.</P>
<P>Age group: mean 23 years, range 16-48 years.</P>
<P>Group A: randomised 50; analysed 45.</P>
<P>Group B: randomised 50; analysed 50.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:43:36 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre + post-op metronidazole versus placebo.</B>
</P>
<P>Group A: metronidazole 400 mg 1 hour before the intervention and then 3 times a day for 8 times.</P>
<P>Group B: placebo 1 hour before the intervention and then 3 times a day for 8 times.</P>
<P>All patients were given the same post-operative instructions, and were given 6 analgesic tablets (codeine phosphate and paracetamol).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:43:39 +0100" MODIFIED_BY="[Empty name]">
<P>Dry socket: continuous dull pain from an empty, or partially empty socket, or from the region of the socket. Pain: marked by patient on a 10 mm line (VAS). Outcomes were recorded at 2 and 7 days post-operatively.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:46:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Happonen-1990">
<CHAR_METHODS MODIFIED="2012-10-05 14:44:15 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: 3-arm RCT.</P>
<P>Conducted in: Finland.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: unclear.</P>
<P>Funding source: unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:44:33 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy consecutive students seeking treatment for impacted, not on any drugs, with the exception of oral contraceptives.</P>
<P>Exclusion criteria: hypersensitivity to penicillin or codeine.</P>
<P>Age group: mean 24 years.</P>
<P>Group A: randomised unclear; analysed 44.</P>
<P>Group B: randomised unclear; analysed 47.</P>
<P>Group C: randomised unclear; analysed 45.</P>
<P>8 of the patients enrolled (total 144) were not included in the analysis, but it is unclear in which group they were allocated.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:45:55 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre- + post-op penicillin versus pre- + post-op tinidazole versus placebo.</B>
</P>
<P>Group A: 1 tablet of phenoxmethylpenicillin 660 mg 1 hour before operation and then 3 times a day for 14 times.</P>
<P>Group B: 1 tablet of tinidazole 500 mg 1 hour before operation and then 3 times a day for 14 times.</P>
<P>Group C: 1 tablet of placebo 1 hour before operation and then 3 times a day for 14 times.</P>
<P>A 1 minute mouth rinse of 0.2% chlorhexidine was given before surgery.</P>
<P>3 tablets of a preparation containing aminophenazon (300 mg), phenobarbital (50 mg) codeine (30 mg) and caffeine (100 mg) was provided to all participants as a rescue analgesic to be taken when needed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:46:06 +0100" MODIFIED_BY="[Empty name]">
<P>Time of onset and resolution of post-operative swelling, as well as time of maximum swelling, as recorded by patients.</P>
<P>Post-operative pain every hour during the day of the surgery, and at intervals of 4 and 6 hours on the first and second post-operative day respectively. Number of analgesics was also reported.</P>
<P>Maximal opening of the mouth was measured before and after surgery (sixth day).</P>
<P>Patients were visited on the sixth post-operative day and signs of infection, fever, swelling and tender lymph nodes were recorded by the clinicians.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:46:15 +0100" MODIFIED_BY="[Empty name]">
<P>Group A and B were considered together in the present review.</P>
<P>All operations were carried out under local anaesthesia, by 1 surgeon, using a standardised procedure, 1 tooth being operated at a time.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:47:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ritzau-1992">
<CHAR_METHODS MODIFIED="2012-10-05 14:46:44 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: Denmark.</P>
<P>Number of centres: 2.</P>
<P>Recruitment period: between October 1987 and November 1988.</P>
<P>Funding source: unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:47:01 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy subjects scheduled for surgical removal of an impacted (partially or totally) mandibular third molar.</P>
<P>Exclusion criteria: any medical condition that might interfere with the study, acute pericoronitis, patients who had taken antibiotics within 48 hours before surgery were also excluded.</P>
<P>Age group: not stated.</P>
<P>A total of 312 subjects were randomised in 2 groups.</P>
<P>Group A: randomised unclear; analysed 135.</P>
<P>Group B: randomised unclear; analysed 135.</P>
<P>42 subjects did not complete the study: 4 did not comply with the protocol, 4 withdrew voluntarily, 1 had intercurrent disease, 11 were lost to follow-up for various reasons, 22 did not present for surgery after have been enrolled.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:47:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op metronidazole versus placebo.</B>
</P>
<P>Group A: 2 tablets with a total dose of 1000 mg metronidazole no later than 30 min before surgery.</P>
<P>Group B: 2 tablets of placebo no later than 30 min before surgery.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:47:23 +0100" MODIFIED_BY="[Empty name]">
<P>Follow- up examination was scheduled for a week after surgery when sutures were to be removed. Alveolitis sicca dolorosa (dry socket) was diagnosed when 2 criteria were simultaneously present: 1 severe pain irradiating from the empty socket towards the ipsilateral ear, and 2 disintegration (partial or total) of the socket coagulum.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:49:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leon-Arcila-2001">
<CHAR_METHODS MODIFIED="2012-10-05 14:48:08 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: University of Valley, Colombia.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: 1 September 1998 to 1 September 2000.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:48:39 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients aged 14-53 years, ASA1, with good oral hygiene, bacterial plaque index &lt;/= 30%, no oral cavity infections or inflammation or pericoronitis, who required extraction of third molars.</P>
<P>Exclusion criteria: allergy to penicillin.</P>
<P>Age group: not stated.</P>
<P>Number randomised: 102.</P>
<P>Number evaluated:102.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:49:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre- + post-op amoxicillin versus placebo.</B>
</P>
<P>Group A<B> </B>(n = 49): amoxicillin 1 gm orally 1 hour pre-operatively and 6 hours post-operatively.</P>
<P>Group B (n = 53): placebo 1 hour pre-op and 6 hours post-operatively.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:49:37 +0100" MODIFIED_BY="[Empty name]">
<P>Infection.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:49:40 +0100" MODIFIED_BY="[Empty name]">
<P>All patients had a single extraction - 38 upper teeth and 64 lower teeth.</P>
<P>Additional information supplied by author in response to email request.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:53:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sekhar-2001">
<CHAR_METHODS MODIFIED="2012-10-05 14:50:35 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: India.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
<P>Funding source: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients aged 19-36 requiring removal of lower wisdom teeth under local anaesthesia.</P>
<P>Exclusion criteria: pre-existing abscess or cellulitis, acute pericoronitis, pre-existing conditions associated with third molars, xerostomia. Those requiring antibiotic prophylaxis for other reasons, immunocompromised patients, pregnancy, diabetes, cancer or renal failure and those who had received antibiotics in 2 weeks prior to start of study.</P>
<P>Age group: mean 30 years.</P>
<P>Number randomised: 151 (53, 61 &amp; 37  in Groups A, B, C respectively).</P>
<P>Number evaluated: 125 (44, 47 &amp; 34 in Groups A, B, C respectively).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:52:40 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op versus post-op metronidazole versus placebo.</B>
</P>
<P>Group A: metronidazole 1 g 1 hour pre-op.</P>
<P>Group B: metronidazole 400 mg 8 hourly for 5 days.</P>
<P>Group C: placebo &#8211; frequency of administration not specified.</P>
<P>All participants had a prescription for ibuprofen 400 mg to be taken as required for pain relief.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:52:57 +0100" MODIFIED_BY="[Empty name]">
<P>Pain (4 point scale) measured on days 2 and 6 post-op, inter-incisal mouth opening (mm) whether there was purulent discharge from wound, dry socket on day 6.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:53:05 +0100" MODIFIED_BY="[Empty name]">
<P>Surgeons performing the extractions were either consultants, post-graduate trainees or house officers.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:54:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bergdahl-2004">
<CHAR_METHODS MODIFIED="2012-10-05 14:54:09 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: Sweden.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: unclear.</P>
<P>Funding source: unspecified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:54:28 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy subjects, not taking any other drugs apart from oral contraceptives, who needed removal of unilateral or bilateral mandibular third molar teeth. Only partially impacted teeth, which had partly broken through the mucosa, with a communication to the oral cavity, requiring surgical flap, were included in the study.</P>
<P>Exclusion criteria: subjects with teeth completely covered with mucosa.</P>
<P>Age group: mean 29 years, range 17-65 years.</P>
<P>Group A: randomised 60; analysed 59.</P>
<P>Group B: randomised 60; analysed 60.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:54:50 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op metronidazole versus placebo.</B>
</P>
<P>Group A: metronidazole 1600 mg as a single dose 45 min before the intervention.</P>
<P>Group B: placebo as a single dose 45 min before the intervention.</P>
<P>All patients were given the same post-operative instructions, and were given 20 analgesic tablets (paracetamol 500 mg with codeine 30 mg).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:54:55 +0100" MODIFIED_BY="[Empty name]">
<P>Dry socket assessed 4 days post-op.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-23 10:12:08 +0000" MODIFIED_BY="[Empty name]">
<P>Patients with acute pericoronitis were operated on after objective and subjective symptoms of pericoronitis had ceased.</P>
<P>Sample size calculation reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:57:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arteagoitia-2005">
<CHAR_METHODS MODIFIED="2012-10-05 14:56:25 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: Spain.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: between March 2001 and February 2003.</P>
<P>Funding source: financed by the Health Research Fund FIS/GRAN dossier number 00/0585. The trial patients' insurance was taken out by the Basque Health Department, Basque Health Service/Osakidetza, Osakidetza, pursuant to the conditions laid down in RD 561/1993. The antibiotic and placebo were supplied free of charge by Géminis (Novartis generics). Chlorhexidine was supplied free of charge by LACER.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:56:47 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients needing a third molar extraction under local anaesthesia.</P>
<P>Exclusion criteria: patients with any bacterial endocarditis risk factors, pregnant and breastfeeding women, patients with acute infections 10 days prior to the intervention, those who had to take antibiotics and those with a history of allergy or intolerance to the drugs used.</P>
<P>Age group: mean 24 years, range 18-60 years.</P>
<P>Group A: randomised 233; analysed 233 (ITT analysis).</P>
<P>Group B: randomised 261; analysed 261 (ITT analysis).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:57:08 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: post-op amoxicillin/clavulanate versus placebo.</B>
</P>
<P>Group A: amoxicillin/clavulanic acid 500/125 mg oral 3 times a day for 4 days after the procedure.</P>
<P>Group B: placebo oral 3 times a day for 4 days after the procedure.</P>
<P>All patients had irrigation of the alveolus with 0.12% chlorhexidine digluconate, and chlorhexidine mouthwashes were used for 3 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:57:18 +0100" MODIFIED_BY="[Empty name]">
<P>Fever (oral temperature &gt;37.88 after 24 hours for no other justifiable cause); intraoral abscess diagnosed via fluctuation pus drainage; dry socket defined as absence of clot with necrotic remains present in the alveolus accompanied by severe mandibular pain; severe pain persisting or increasing 48 hours after surgery accompanied by intraoral inflammation (moderate or severe) and/or intraoral erythema (moderate or severe); severe pain after 7th day accompanied by intraoral inflammation (moderate or severe) and/or intraoral erythema (moderate or severe) for no other justifiable reason which improves with antibiotic treatment. Lack of inflammatory complications. Diagnosis of post-operative infection and inflammatory complication was performed by the main researcher, according to previously published clinical criteria.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 14:57:24 +0100" MODIFIED_BY="[Empty name]">
<P>All extractions were performed by maxillofacial surgeons, under locoregional anaesthetic of the inferior alveolar and buccal nerves with Ultracain.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 14:59:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Halpern-2007">
<CHAR_METHODS MODIFIED="2012-10-05 14:58:21 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: US.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: between 1 June 2002 and 1 July 2005.</P>
<P>Funding source: supported in part by the Oral and Maxillofacial Surgery Foundation Research Grant and Massachusetts General Hospital (MGH) Center for Applied Clinical Investigation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 14:58:44 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients needing a third molar extraction under intravenous sedation or general anaesthesia in the office-based ambulatory setting.</P>
<P>Exclusion criteria: subjects with pre-existing conditions that could affect wound healing or predispose them to inflammatory complications, including previous radiation therapy to the maxillofacial region, human immunodeficiency virus infection, organ or marrow transplant candidates or recipients, diabetes, or organ failure (kidney, heart, liver); subjects requiring antibiotic prophylaxis for endocarditis, were currently on oral steroid therapy, were allergic to the antibiotics proposed for use in this study, deferred intravenous sedation or general anaesthesia; had local pathology, e.g. cysts or tumour, associated with M3s that was not incidental to the removal of the M3; acute inflammation in the area of the planned extraction characterized by frank purulence, erythema, induration, or trismus; supernumerary teeth to be removed; or deferred study participation.</P>
<P>Age group: mean 25 years.</P>
<P>Group A: randomised 60; analysed 59.</P>
<P>Group B: randomised 62; analysed 59.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 14:59:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op IV penicillin (or clindamycin) versus placebo.</B>
</P>
<P>Group A: solution of penicillin (15,000 units per kilogram) or, for penicillin-allergic subjects, clindamycin (600 mg) administered intravenously within 1 hour before the intervention.</P>
<P>Group B: placebo solution (10 cc saline 0.9%) administered intravenously within 1 hour before the intervention.</P>
<P>Post-operative analgesia consisted of the use of 1 or 2 acetaminophen (500 mg) and hydrocodone (5 mg) tablets administered orally every 3 to 4 hours.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 14:59:26 +0100" MODIFIED_BY="[Empty name]">
<P>Dry socket (a new onset or increasing pain more than 36 hours after the operation, with a loss of the blood clot in the extraction site as evidenced by exposed bone, gentle probing or irrigation of the wound duplicating the pain, and significant pain relief after application of an anodyne dressing; all elements needed to be present to make the diagnosis).</P>
<P>Surgical site infection (visual evidence of frank purulence in one or more of the extraction sites and a Gram&#8217;s stain demonstrating white blood cells present).</P>
<P>Any post-operative inflammatory complications (dry socket or surgical site infection).</P>
<P>Assessed on day 7 post-operatively (range 5-14).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 15:01:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kaczmarzyk-2007">
<CHAR_METHODS MODIFIED="2012-10-05 15:00:08 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: 3-arm RCT.</P>
<P>Conducted in: Poland.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: between January 2005 and April 2006.</P>
<P>Funding source: unclear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:00:21 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy volunteers, needing surgical extraction of a retained lower third molar, which was not the cause of inflammation (mainly due to orthodontic recommendations) that required bone removal.</P>
<P>Exclusion age under 18 or over 60, pregnancy, allergy to clindamycin, lactose intolerance (lactose was the main component of the placebo), episodes of diarrhoea after antibiotic therapy in the interview, any digestive diseases, inflammation in the area of the tooth to be extracted, and any antibiotic or analgesic intake within the previous 7 days.</P>
<P>Age group: mean 24 years.</P>
<P>Group A: randomised unclear; analysed 31.</P>
<P>Group B: randomised unclear; analysed 28.</P>
<P>Group C: randomised unclear; analysed 27.</P>
<P>Of the 100 patients enrolled 9 did not check in for the follow-up examination, 3 were disqualified due to complications and 2 resigned during the trial without stating any reason.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:01:01 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op versus pre- + post-op clindamycin versus placebo.</B>
</P>
<P>Group A: single-dose group: patients receiving 600 mg clindamycin hydrochloride orally 60 min pre-operatively, followed by a 300 mg placebo every 8 hours for 5 days.</P>
<P>Group B: 5-day group: patients receiving 600 mg clindamycin hydrochloride orally 60 min pre-operatively, followed by a dose of 300 mg clindamycin hydrochloride every 8 hours for 5 days.</P>
<P>Group C: placebo group: patients receiving 600 mg placebo orally 60 min prior to surgery, followed by a dose of 300 mg placebo every 8 hours for 5 days.</P>
<P>Only groups B and C were considered for the present review.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 15:01:37 +0100" MODIFIED_BY="[Empty name]">
<P>On the first, second and seventh post-operative day the following outcomes were evaluated: trismus (on a 4-grade scale), facial swelling (on a 4-grade scale), submandibular lymphadenopathy (on a 4-grade scale), body temperature, pain (on a 100-mm VAS), alveolar osteitis (clinical diagnosis of this complication was given in the case of the presence of a necrotic grey clot in a bare bony socket, foetor ex ore, accompanied by pain in this area).<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-02 10:38:44 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 15:04:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lacasa-2007">
<CHAR_METHODS MODIFIED="2012-10-05 15:02:39 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: 3-arm RCT.</P>
<P>Conducted in: Spain.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: between January and December 2002.</P>
<P>Funding source: the trial was supported by a grant from GlaxoSmithKline S.A., Tres Cantos, Madrid, Spain.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:02:54 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: adult patients (&gt;18 years of age) who were going to have third mandibular molar surgery.</P>
<P>Exclusion criteria: patients were excluded if they had a recent local infection prior to surgery (&lt;15 days), had known or suspected allergy to beta-lactams, known or suspected allergy to metamizol, history of renal failure, blood dyscrasia or chronic liver disease of any type, antecedents of recent and/or symptomatic peptic ulcer, or were on antiaggregants or corticosteroids prior (&lt;15 days) to entry. Female patients of child-bearing potential had to have a negative urine pregnancy test prior to enrolment.</P>
<P>Age group: mean 29 years.</P>
<P>Group A: randomised 75; analysed (day 7) 62.</P>
<P>Group B: randomised 75; analysed (day 7) 68.</P>
<P>Group C: randomised 75; analysed (day 7) 69.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:04:18 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op versus post-op amoxicillin/clavulanate versus placebo.</B>
</P>
<P>Group A: 2 amoxicillin/clavulanate 1000/62.5 mg matching placebo tablets (2000/125 mg) in a single dose before surgery, plus 2 amoxicillin/clavulanate 1000/62.5 mg matching placebo tablets (2000/125 mg, BID) for 5 days.</P>
<P>Group B: 2 active amoxicillin/clavulanate 1000/62.5 mg tablets (2000/125 mg) in a single dose before surgery followed by 2 matching placebo tablets (2000/125 mg, BID) for 5 days.</P>
<P>Group C: 2 matching placebo tablets (2000/125 mg) in a single dose before surgery followed by 2 active amoxicillin/clavulanate 1000/62.5 mg tablets (2000/125 mg, BID) for 5 days.</P>
<P>All patients were matched to receive the same analgesic drug throughout the study period with identical dosage. Metamizol (NolotilTM capsules) was used, 1 capsule every 8 hours, for a minimum of 48 hours, since it is much less anti-inflammatory than other analgesics. Patients were able to continue receiving analgesia afterwards (according to the investigator&#8217;s judgement), depending on the presence of pain.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-04-03 15:29:45 +0100" MODIFIED_BY="[Empty name]">
<P>The main study variables and subjective well being were evaluated on days 1, 3 and 7.</P>
<P>Infection was defined by any of the following: (1) presence of purulent discharge in the extraction socket and/or excessive swelling with fluctuation, with or without pain; (2) presence of a local abscess; (3) onset of facial or cervical cellulitis plus other signs suggesting infection such as pain, increased heat, erythema and/or fever; (4) presence of osteitis of dental alveolus defined as absence of the haematic clot of the orifice and presence of a putrid smell and intense neuralgic type pain.</P>
<P>Other inflammatory outcomes were recorded individually, and in a composite way using an inflammation score tabular display with a maximum permitted score of 10. They included swelling, trismus, pain, dysphagia, fever.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 15:04:27 +0100" MODIFIED_BY="[Empty name]">
<P>Only groups A and C were considered for the present review.</P>
<P>2 of the authors are employees of the funding company.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 15:07:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bezerra-2011">
<CHAR_METHODS MODIFIED="2012-10-05 15:06:00 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT cross-over.</P>
<P>Conducted in: Brazil.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: January to November 2008.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:06:33 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy patients with no periodontal disease requiring removal of 4 third molars, with similar degrees of impaction between sides of mouth.</P>
<P>Exclusion criteria: tobacco use, orthodontic bands on second molars, pregnancy or breastfeeding, chronic systemic disorders, allergies to antibiotics, history of adverse effects from antibiotics and use of antibiotics in 3 months prior to entering trial.</P>
<P>Age group: mean 21 years, range 18-31 years.</P>
<P>Number randomised: 36.</P>
<P>Number evaluated: 34.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:07:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op amoxicillin versus placebo.</B>
</P>
<P>Group A: amoxicillin 2 x 500 mg administered orally 1 hour pre-op.</P>
<P>Group B: placebo (2 tablets) identical in appearance administered 1 hour pre-op.</P>
<P>Standard post-operative treatment was Nimesulid (NSAID) 100 mg every 12 hours for 4 days and dipyrone (NSAID) 500 mg 6 hourly for 2 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 15:07:47 +0100" MODIFIED_BY="[Empty name]">
<P>Soft tissue edema/ulcer, pain (1-10 VAS), edema, limitation of mouth opening, infection (purulent secretion, alveolitis (pain + partially/totally disintegrated clot), fever  at 3, 7 and 14 days post-op.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-04-11 10:22:52 +0100" MODIFIED_BY="[Empty name]">
<P>Email from author 13/2/2012 stating duration of washout period at least 45 days. Additional outcome data provided.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 15:11:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<CHAR_METHODS MODIFIED="2012-10-05 15:08:53 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: Spain.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:09:25 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: at least 1 mandibular impacted or partially erupted third molar requiring extraction.</P>
<P>Exclusion criteria: aged &gt;60 or &lt;18 years, infectious or systemic diseases, immunosuppressive treatment, smoking, peptic ulcer, pregnancy, lactation, known or suspected allergy to ibuprofen or beta-lactam antibiotics, carious or non-impacted third molars, pericoronitis, or patients in whom excessive technical difficulty was expected.</P>
<P>Age group: mean 22 years, range 18-46 years. </P>
<P>Number randomised: 134.</P>
<P>Number evaluated:123.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:10:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op versus post-op amoxicillin versus placebo. </B>
</P>
<P>Group A: amoxicillin 4x 500 mg 2 hours prior to surgery plus 15 placebo tablets taken 3x daily for 5 days.</P>
<P>Group B:<B> </B>4 placebo tablets 2 hours pre-op plus 15<B> </B> placebo tablets taken 3x daily for 5 days.</P>
<P>Group C: 4 placebo tablets 2 hours pre-op plus 15 amoxicillin 500 mg to be taken 3x daily for 5 days.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 15:10:55 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoral swelling, maximal mouth opening, pain (100 point VAS) dysphagia, fever, purulent wound discharge, alveolar osteitis (dry socket), side effects of treatment at 7 days post-op.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 15:11:01 +0100" MODIFIED_BY="[Empty name]">
<P>All procedures were performed by the same surgeon.</P>
<P>Additional information supplied by author in response to email request.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-10-05 15:16:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pasupathy-2011">
<CHAR_METHODS MODIFIED="2012-10-05 15:13:59 +0100" MODIFIED_BY="[Empty name]">
<P>Study design: RCT.</P>
<P>Conducted in: India.</P>
<P>Number of centres: 1.</P>
<P>Recruitment period: unclear.</P>
<P>Funding source: not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:14:46 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: patients with mandibular mesioangularly impacted third molars requiring extraction.</P>
<P>Exclusion criteria: infections (space infections, acute pericoronitis), medically compromised, pregnant, allergic to either penicillin or metronidazole, those who have taken antibiotics in the 2 months prior to surgery.</P>
<P>Age group: mean 29 years, range 18-48 years.</P>
<P>Number randomised: 98.</P>
<P>Number evaluated: 89.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:15:47 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Comparison: pre-op amoxicillin versus pre-op metronidazole versus placebo.</B>
</P>
<P>Group A: amoxicillin 1 g orally 1 hour prior to surgery.</P>
<P>Group B: metronidazole 800 mg orally 1 hour prior to surgery.</P>
<P>Group C: placebo.</P>
<P>All patients received ibuprofen 600 mg 3x daily for pain.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 15:15:54 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical wound infection, purulent discharge, fever, restricted mouth opening on day 7 post-op.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-10-05 15:16:00 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size: reported that estimated sample size required was 107 in each group. Trial recruited ~30 per group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ITT = intention-to-treat; RCT = randomised controlled trial; VAS = visual analogue scale.</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-10-05 15:21:40 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abu_x002d_Mowais-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:24 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ataoglu-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:31 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bargnesi-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:39 +0100" MODIFIED_BY="[Empty name]">
<P>Study of antibiotics used in conjunction with a range of small dental surgical procedures including but not limited to tooth extractions.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-06-28 12:17:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Curran-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-06-28 12:17:22 +0100" MODIFIED_BY="[Empty name]">
<P>Described as double blind but control group received no treatment. Patients not blinded to treatment, and asked not to inform outcome assessors.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Moura-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:59 +0100" MODIFIED_BY="[Empty name]">
<P>Washout period 4 weeks (translated from Spanish).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Delilbasi-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:36 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foy-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:39 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fridrich-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:10 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised or quasi-randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Graziani-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:43 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grossi-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:46 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Head-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:21 +0100" MODIFIED_BY="[Empty name]">
<P>Bacteraemia outcomes only.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krekmanov-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:50 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krekmanov-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:54 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:17:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krekmanov-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:17:58 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laird-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:28 +0100" MODIFIED_BY="[Empty name]">
<P>This study compares 2 antibiotic regimens.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Limeres-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:33 +0100" MODIFIED_BY="[Empty name]">
<P>This study compares 2 antibiotic regimens.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lombardia-Garcia-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:02 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lopes-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:04 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luaces_x002d_Rey-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:39 +0100" MODIFIED_BY="[Empty name]">
<P>This study compares 2 antibiotic regimens.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lyall-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:08 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-MacGregor-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:46 +0100" MODIFIED_BY="[Empty name]">
<P>Topical antibiotic.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:19:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mitchell-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:19:50 +0100" MODIFIED_BY="[Empty name]">
<P>No blinding described.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Monaco-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:11 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Monaco-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:14 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Olusanya-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:04 +0100" MODIFIED_BY="[Empty name]">
<P>This study compares 2 antibiotic regimens.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osborn-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:15 +0100" MODIFIED_BY="[Empty name]">
<P>From translator: "it is clear that this study is double blinded but it is unclear how participants were allocated to treatment groups. Random not mentioned".</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poeschl-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:18 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reekie-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:23 +0100" MODIFIED_BY="[Empty name]">
<P>Topical antibiotic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rood-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:32 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Samsudin-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:40 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised or quasi and not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siddiqi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:53 +0100" MODIFIED_BY="[Empty name]">
<P>Washout period only 3 weeks (communication from author).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:20:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stavropoulos-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:20:59 +0100" MODIFIED_BY="[Empty name]">
<P>Authors considered only topical antibiotic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:21:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sulejmanagi_x0107_-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:21:25 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised or quasi-randomised and not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:21:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Swanson-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:21:30 +0100" MODIFIED_BY="[Empty name]">
<P>Topical antibiotic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:18:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Uluibau-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:18:25 +0100" MODIFIED_BY="[Empty name]">
<P>Not double blind.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:21:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Walkow-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract only, no mention of blinding and no subsequent trial report found.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-10-05 15:21:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yoshii-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-10-05 15:21:40 +0100" MODIFIED_BY="[Empty name]">
<P>No blinding described.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-06-13 09:14:37 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-10-05 15:22:29 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2012-10-05 15:22:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Arteagoitia-2011">
<CHAR_STUDY_NAME MODIFIED="2012-10-05 15:21:56 +0100" MODIFIED_BY="[Empty name]">
<P>Efficacy of amoxicillin/clavulanic acid 2000/125 mg in preventing infection after extraction of impacted mandibular third molar totally covered by bone (EUDRACT 2008-005663-34).</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2012-10-05 15:22:04 +0100" MODIFIED_BY="[Empty name]">
<P>Double-blind placebo-controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-10-05 15:22:07 +0100" MODIFIED_BY="[Empty name]">
<P>Patients with bony impactions of mandibular third molars undergoing extraction under locoregional anaesthesia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-10-05 15:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>Amoxicillin/clavulanic acid 2000/125 mg 1 hour pre-op plus post-op twice daily for 4 days versus placebo. All patients received 0.2% chlorhexidine rinses.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-10-05 15:22:10 +0100" MODIFIED_BY="[Empty name]">
<P>Infection.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2012-10-05 15:22:11 +0100" MODIFIED_BY="[Empty name]">
<P>26 June 2009.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2012-10-05 15:22:12 +0100" MODIFIED_BY="[Empty name]">
<P>Atreagoitia M Stomatology Department, University of the Basque Country, Leioa, Spain.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES/>
</ONGOING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-10-05 20:59:58 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-10-05 15:16:12 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:57:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>Quote: "The simple randomizations was performed using C4-SDP program and , which was used as the patient's number".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:43:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>Quote: "Assigned to one of two groups by a table of random numbers".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:55:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Quote: "a randomised trial". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:08:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Drugs/placebo placed into transparent, sterile boxes with code number. Patient chose one box for first procedure and a coin toss decided which side of mouth was done first.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:31:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>Quote: "assigned at random". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:29:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>Quote: "Patients were assigned at random". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:59:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>Quote: "randomized". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:46:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>Quote: "randomly assigned". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:01:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>Quote: "group assignment for one patient, determined in advance by a random number table".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:38:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>Quotes: "randomised allocation" "randomly divided". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:04:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>Quote: "randomised". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:49:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Quote: "Participants were randomised using a computer" (email from author).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:12:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>Pharmacist held the randomisation code and the drug code (a random alpha numeric code).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-29 12:12:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:41:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>Quote: "allocated in accordance with a pre-determined randomisation code during pre-operative assessment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:16:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Quote: "randomization table was prepared using a software program and a random allocating number was given to each patient".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:47:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>Quote: "random sequence ... generated by a computerized program".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:53:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>Quote: "randomly assigned using prepared randomizations in sealed envelopes". Method of sequence generation not described.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-10-05 15:16:24 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:57:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>Quote: "Each of enrolled patients was assigned the corresponding blinded random successive treatment number".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:43:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:55:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:08:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Unclear who performed the coin toss and how the result was communicated to the surgeon. However bias unlikely to result from this design.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:31:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:29:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:59:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>Quote: "Consecutively numbered, double-sealed envelopes were prepared containing the treatment assignment".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:46:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:01:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>Quote: "One hundred opaque and sequentially numbered envelopes were used for the concealment of allocation to trial groups".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:39:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>Code was kept by pharmacist at Royal London Homeopathic hospital.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:04:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:50:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Quote: "One of the researchers allocated the treatment. Surgeon, patient and statistician did not know such information" (email from author).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:13:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>Quote: "A set of opaque sealed envelopes contained the drug code for every patient. One envelope was opened for every patient and the patient was provided with the coded tablet pack that matched the number in the envelope".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:36:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Not mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:42:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>Quote: "drugs were individually packaged and allocated" -assumed allocation occurred at the pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:16:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Quote: "Sealed envelopes with the allotted number were used and were dispensed by 1 of our post graduate trainees throughout the study according to the allotted randomization number".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:47:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>Quote: "the code was unknown to the investigators until the termination of collection of clinical data".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:53:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>Allocation concealed in sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-07-30 15:48:02 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-10-05 15:02:01 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:57:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>Quote: "Double-blinded".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:43:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>Double blind. Quote: "None of the patients, nor the several operators, were aware of the active or placebo nature of the individual medication".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:55:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Quote: "double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:41:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Double blind &#8211; neither patient nor surgeon knew which treatment was given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:31:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:36:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:59:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>Quote: "Double blind. The surgeon and study subject were blinded to the true nature of the contents of the syringe".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:44:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 15:02:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>Quote: "The patients, the surgeon performing the qualification, operative procedure and follow-up examination, and the statistician were not aware of who received which study intervention".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:44:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:44:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:45:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:45:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:34:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Double blind (both participants and surgeons).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:46:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:46:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Triple blind &#8211; neither the patient nor the surgeon nor the outcome evaluator were aware of the allocated treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-30 15:46:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>Quote: "double-blind" and "metronidazole and placebo were manufactured in the shape of pills of identical size, shape, weight, and colour, packed and code numbered".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-10-05 14:53:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>Described as double blind, but dosing schedule different in each group. Outcome assessor was blinded to allocated treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-10-05 15:02:05 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:57:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>Quote: "Double-blinded".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:43:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>Double blind. Quote: "None of the patients, nor the several operators, were aware of the active or placebo nature of the individual medication".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:55:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Quote: "double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:41:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Double blind &#8211; neither patient nor surgeon knew which treatment was given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:31:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:36:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:59:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>Quote: "Double blind. The surgeon and study subject were blinded to the true nature of the contents of the syringe".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:44:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 15:02:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>Quote: "The patients, the surgeon performing the qualification, operative procedure and follow-up examination, and the statistician were not aware of who received which study intervention".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:44:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:45:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:45:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:45:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:34:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Double blind (both participants and surgeons).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:46:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>Quote: "Double blind".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:46:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Triple blind &#8211; neither the patient nor the surgeon nor the outcome evaluator were aware of the allocated treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-30 15:46:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>Quote: "double-blind" and "metronidazole and placebo were manufactured in the shape of pills of identical size, shape, weight, and colour, packed and code numbered".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-10-05 14:53:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>Described as double blind, but dosing schedule different in each group. Outcome assessor was blinded to allocated treatment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-10-05 20:59:58 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:57:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>2 participants lost to follow-up from each group but intention-to-treat analysis was performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:44:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>10% of antibiotic group not included in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:55:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Only "one patient had to be withdrawn because he had taken an oral antibiotic for other reasons two days after operation".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 15:08:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>2/36 patients were not included in analysis. Due to low number and cross-over design, attrition bias is unlikely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-11 10:28:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>Numbers of patients allocated to antibiotic or placebo not explicitly stated for each of the subtrials and numbers evaluated not stated for each subtrial for each outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-05-10 11:44:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>No missing data. All randomised participants included in result analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:59:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>1/60 and 3/62 participants lost to follow-up in the antibiotic and placebo groups, but low event rates mean that data from these participants could have changed the outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:46:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>8 out of 144 patients were lost at follow-up (5%), and it is unclear which groups these were from. No specific ITT approach is adopted.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 15:02:12 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>14 out of 100 patients were lost at follow-up (14%). No specific ITT approach is adopted and it is unclear which groups these were from. Due to low event rates for the dichotomous outcomes incomplete outcome data could have resulted in bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:39:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>Numbers of patients included in outcome assessments reported as percentage only.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 20:59:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>It is unclear whether authors used any ITT analysis. 3/225, 9/225 and 26/225 participants are lost to follow-up at days 1, 3 and 7 respectively. Given the low rate of infection this attrition could have introduced a bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:50:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Quote: "No drop outs or losses to follow up. Everybody was included" (email from author).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 15:13:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>11/134 (8%) were excluded from the analysis. 3, 0, 1 were excluded from pre-op, post-op and placebo groups due to technical difficulty of the procedure and 2,1, 4 due to inadequate follow-up. Due to the low event rate for infection it is probable that this attrition introduced a bias to the outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:34:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Numbers of patients allocated to treatment and assessed on day 4 not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:42:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>All randomised participants included in the outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 15:16:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>9/98 (9%) of randomised patients excluded from the analysis, due to either not returning for follow=up (n = 8) or use of antibiotic (n = 1). Allocated treatment group not described for these 9. Given low event rate this attrition is likely to have introduced bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-04-11 12:51:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>22/312 randomised participants did not have surgery. 20/290 (7%) patients who did undergo surgery were excluded from the outcome evaluation, but allocated treatment not stated. No specific ITT approach is reported, attrition rate is higher than event rate (4.8%) and bias in these results is considered to be likely.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-10-05 14:53:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>26/151 (17%) (9, 14 and 3 from groups A, B and C) of those randomised were excluded because they did not return for follow-up evaluation. Those excluded were more likely to have had bone removed and had longer mean operating times. Given low event rate this attrition could have resulted in biased outcome estimates.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-10-05 15:13:41 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:58:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>Planned outcomes of pain inflammation and erythema measured qualitatively and reported but VAS pain scores measured and not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:44:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>Planned outcomes of dry socket, pain (VAS), adverse effects and compliance were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-03 14:08:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Pain, bad odour or taste as assessed by patients were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:08:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Duration of surgery, inflammatory/infectious events, pain scores, edema, maximum mouth opening, swelling of soft tissues, alveolitis reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:31:52 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>All planned outcomes reported, but not for each randomised treatment group, and no estimates of variance given for pain.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:36:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>Data for swelling and trismus not reported, only comment that there was no difference.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:32:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>Surgical site infections and acute osteitis planned and reported. No report of pain swelling or trismus.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-03 14:22:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>Planned outcomes of duration of swelling, infection, fever reported. Pain (VAS) reported only in graph for first 13 hours, no data at day 7, yet this was the main reason given for time off work.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:02:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>Planned outcomes of post-operative inflammation (swelling, lymphadenopathy, trismus), pain, body temperature, and alveolar osteitis reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-14 10:14:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>All planned outcomes reported, but data only presented in graphs.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:05:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>According to the methods the planned outcomes were infection, inflammation, swelling, trismus, pain, dysphagia, fever and adverse effects. Data are reported for infection, and means without variance estimates for pain, but no other outcome data reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-15 11:34:31 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>Infection was the only planned outcome.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:13:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>All planned outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-03 08:42:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>Planned report of pain swelling and trismus presented only in graphs. No estimates per group given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:42:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>Infection per socket and per patient reported. Pain swelling and trismus not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-03 16:32:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Surgical wound infection, purulent discharge, reported for each group. Fever, pain and trismus is not reported per treatment group, although it seems likely that these data were collected.  </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:47:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>Methods section states that planned outcome was alveolitis sicca dolorosa (ASD) and this was reported, but other clinically important outcomes were not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:54:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>All planned outcomes reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-10-05 15:13:46 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:18:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Arteagoitia-2005">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:19:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barclay-1987">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:55:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bergdahl-2004">
<DESCRIPTION>
<P>Short duration of follow-up (4 days), unclear whether patients with acute pericoronitis prior to trial were treated with antibiotics.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:08:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bezerra-2011">
<DESCRIPTION>
<P>Indications of a significant period effect with regard to the outcome of pain. This is likely to bias this outcome towards no difference between active and placebo.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:31:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bystedt-1980">
<DESCRIPTION>
<P>No description of characteristics of patients by randomised group at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:31:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bystedt-1981">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:32:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Halpern-2007">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:32:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Happonen-1990">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-11 10:33:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kaczmarzyk-2007">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:39:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kaziro-1984">
<DESCRIPTION>
<P>No description of characteristics of patients by randomised group at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:05:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lacasa-2007">
<DESCRIPTION>
<P>Statistically significant difference in duration of operation between the placebo and pre-emptive groups. 2 of the authors are employed by the company that funded the trial.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-03-15 11:34:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Leon-Arcila-2001">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 15:13:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011">
<DESCRIPTION>
<P>Statistically significant difference in mean operating time between pre- and post-op antibiotic groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:34:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-MacGregor-1980">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-04-03 08:43:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mitchell-1986">
<DESCRIPTION>
<P>No other sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-14 10:49:43 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Pasupathy-2011">
<DESCRIPTION>
<P>Trial is very clearly underpowered and this is likely to bias results towards the null hypothesis of no difference between interventions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:47:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ritzau-1992">
<DESCRIPTION>
<P>13% loss of participants post-randomisation and no baseline characteristics reported for each group. Biases possible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-10-05 14:54:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sekhar-2001">
<DESCRIPTION>
<P>Percentage of patients in 2x daily metronidazole group who had bone removed appears to be significantly lower compared to other groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-10-05 15:26:37 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2012-10-05 15:26:37 +0100" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2012-06-13 16:57:44 +0100" MODIFIED_BY="Grade Profiler">Antibiotic compared to placebo for preventing infectious complications after tooth extraction</TITLE>
<TABLE COLS="7" ROWS="10">
<TR>
<TD COLSPAN="7">
<P>
<B>Antibiotic compared to placebo for preventing infectious complications after tooth extraction</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Patients undergoing tooth extraction<BR/>
<B>Settings:</B> Oral surgery referral centre<BR/>
<B>Intervention:</B> Antibiotic<BR/>
<B>Comparison: </B>Placebo</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Placebo</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Antibiotic</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Local sign of infection</B>
<BR/>Follow-up: mean 7 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>118 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>34 per 1000</B>
<BR/>(19 to 59)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.29 </B>
<BR/>(0.16 to 0.50)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1523<BR/>(10 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Dry socket </B>
<BR/>Follow-up: mean 7 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>69 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>43 per 1000</B>
<BR/>(28 to 65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.62 </B>
<BR/>(0.41 to 0.95)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>1429<BR/>(9 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pain (dichotomous on 6-7th day)</B>
<BR/>Follow-up: mean 6.5 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>126 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>76 per 1000</B>
<BR/>(40 to 140)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.60 </B>
<BR/>(0.32 to 1.11)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>675<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Pain score (VAS 7th day) </B>
<BR/>Scale from: 1 to 100.<BR/>Follow-up: mean 7 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>Mean pain score (VAS) in placebo groups was 15</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>The mean pain score (VAS 7th day) in the intervention groups was <B>8.17 lower</B>
<BR/>(11.9 to 4.45 lower)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>372<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Fever (6th-7th day)</B>
<BR/>Follow-up: mean 6.5 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>39 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>13 per 1000</B>
<BR/>(2 to 78)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.34 </B>
<BR/>(0.06 to 1.99)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>816<BR/>(4 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Swelling (7th day)</B>
<BR/>Follow-up: mean 7 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>307 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>282 per 1000</B>
<BR/>(200 to 399)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.92 </B>
<BR/>(0.65 to 1.30)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>334<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Adverse effects</B>
<BR/>Follow-up: mean 7 days</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>49 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>96 per 1000</B>
<BR/>(54 to 175)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 1.98 </B>
<BR/>(1.10 to 3.59)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>930<BR/>(5 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>
<B>moderate</B>
<SUP>9</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the mean control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% CI) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> confidence interval; <B>RR:</B> risk ratio.</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> 10 double-blind placebo-controlled trials - 7 trials at high risk of bias and 3 trials at unclear risk of bias.<BR/>
<SUP>2</SUP> 9 double-blind placebo-controlled trials - 7 trials at high risk of bias and 2 trials at unclear risk of bias<BR/>
<SUP>3</SUP> 3 double-blind placebo-controlled trials - 2 trials at high risk of bias and 1 trial at unclear risk of bias.<BR/>
<SUP>4</SUP> Substantial heterogeneity I<SUP>2</SUP> 57% P = 0.07.<BR/>
<SUP>5</SUP> 4 double-blind placebo-controlled trials - all at high risk of bias.<BR/>
<SUP>6</SUP> 4 double-blind placebo-controlled trials - 3 at high risk of bias and 1 at unclear risk of bias.<BR/>
<SUP>7</SUP> Substantial heterogeneity I<SUP>2</SUP> 60% (P = 0.11).<BR/>
<SUP>8</SUP> 3 double-blind placebo-controlled trials at high risk of bias.<BR/>
<SUP>9</SUP> 5 double-blind placebo-controlled trials - 4 at high risk of bias and 1 at unclear risk of bias.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2012-10-05 15:30:15 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-04-12 15:33:55 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-02-09 12:07:35 +0000" MODIFIED_BY="[Empty name]">Studies of reasons for tooth extraction</TITLE>
<TABLE COLS="4" ROWS="16">
<TR>
<TH>
<P>
<B>Author</B>
</P>
</TH>
<TH>
<P>
<B>Country</B>
</P>
</TH>
<TH>
<P>
<B>% for caries</B>
</P>
</TH>
<TH>
<P>
<B>% for periodontitis</B>
</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Da_x0027_ameh-2006" TYPE="REFERENCE">Da'ameh 2006</LINK>
</P>
</TD>
<TD>
<P>Afghanistan</P>
</TD>
<TD>
<P>59.2</P>
</TD>
<TD>
<P>35.3</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Akhter-2008" TYPE="REFERENCE">Akhter 2008</LINK>
</P>
</TD>
<TD>
<P>Bangladesh</P>
</TD>
<TD>
<P>67.5</P>
</TD>
<TD>
<P>18.5</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Jovino_x002d_Silveira-2005" TYPE="REFERENCE">Jovino-Silveira 2005</LINK>
</P>
</TD>
<TD>
<P>Brazil</P>
</TD>
<TD>
<P>63.3</P>
</TD>
<TD>
<P>13.1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Chrysanthakopoulos-2011" TYPE="REFERENCE">Chrysanthakopoulos 2011</LINK>
</P>
</TD>
<TD>
<P>Greece</P>
</TD>
<TD>
<P>45.6</P>
</TD>
<TD>
<P>32.1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Anand-2010" TYPE="REFERENCE">Anand 2010</LINK>
</P>
</TD>
<TD>
<P>India</P>
</TD>
<TD>
<P>44.6</P>
</TD>
<TD>
<P>33.2</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Aida-2009" TYPE="REFERENCE">Aida 2009</LINK>
</P>
</TD>
<TD>
<P>Japan</P>
</TD>
<TD>
<P>43.6</P>
</TD>
<TD>
<P>37.1</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Baqain-2007" TYPE="REFERENCE">Baqain 2007</LINK>
</P>
</TD>
<TD>
<P>Jordan</P>
</TD>
<TD>
<P>63.8</P>
</TD>
<TD>
<P>22.9</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Al_x002d_Shammari-2006" TYPE="REFERENCE">Al-Shammari 2006</LINK>
</P>
</TD>
<TD>
<P>Kuwait</P>
</TD>
<TD>
<P>43.7</P>
</TD>
<TD>
<P>37.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Byahatti-2011" TYPE="REFERENCE">Byahatti 2011</LINK>
</P>
</TD>
<TD>
<P>Libya</P>
</TD>
<TD>
<P>55.9</P>
</TD>
<TD>
<P>34.4</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Danielson-2011" TYPE="REFERENCE">Danielson 2011</LINK>
</P>
</TD>
<TD>
<P>Nigeria</P>
</TD>
<TD>
<P>32.6</P>
</TD>
<TD>
<P>45</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Trovik-2000" TYPE="REFERENCE">Trovik 2000</LINK>
</P>
</TD>
<TD>
<P>Norway</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>24</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Chestnutt-2000" TYPE="REFERENCE">Chestnutt 2000</LINK>
</P>
</TD>
<TD>
<P>Scotland</P>
</TD>
<TD>
<P>51</P>
</TD>
<TD>
<P>21</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-McCaul-2001" TYPE="REFERENCE">McCaul 2001</LINK>
</P>
</TD>
<TD>
<P>Scotland</P>
</TD>
<TD>
<P>54.7</P>
</TD>
<TD>
<P>16.7</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Lesolang-2009" TYPE="REFERENCE">Lesolang 2009</LINK>
</P>
</TD>
<TD>
<P>South Africa</P>
</TD>
<TD>
<P>47.9</P>
</TD>
<TD>
<P>22.6</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="REF-Richards-2005" TYPE="REFERENCE">Richards 2005</LINK>
</P>
</TD>
<TD>
<P>Wales</P>
</TD>
<TD>
<P>59</P>
</TD>
<TD>
<P>29.1</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2012-10-05 15:27:21 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-10-05 15:26:59 +0100" MODIFIED_BY="[Empty name]">Kaziro 1984 outcome data (from graphs)</TITLE>
<TABLE COLS="3" ROWS="4">
<TR>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TH VALIGN="TOP">
<P>Antibiotic group</P>
</TH>
<TH VALIGN="TOP">
<P>Placebo group</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Infection- wound breakdown</P>
</TD>
<TD VALIGN="TOP">
<P>5%</P>
</TD>
<TD VALIGN="TOP">
<P>27%</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Pain - Day 8</P>
</TD>
<TD VALIGN="TOP">
<P>60% pain free</P>
</TD>
<TD VALIGN="TOP">
<P>22% pain free</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>Swelling - Day 8</P>
</TD>
<TD VALIGN="TOP">
<P>80% minimal swelling</P>
</TD>
<TD VALIGN="TOP">
<P>66% minimal swelling</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2012-10-05 15:27:56 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-10-05 15:27:36 +0100" MODIFIED_BY="[Empty name]">Raw outcome data - Local signs of infection</TITLE>
<TABLE COLS="3" ROWS="19">
<TR>
<TH COLSPAN="3">
<P>Infection (%)</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Antibiotic</P>
</TD>
<TD>
<P>Placebo</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Mitchell-1986" TYPE="STUDY">Mitchell 1986</LINK>
</P>
</TD>
<TD>
<P>4/25 (16%)</P>
</TD>
<TD>
<P>14/25 (56%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>
</P>
</TD>
<TD>
<P>1/44 (2%)</P>
</TD>
<TD>
<P>0/17</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>
</P>
</TD>
<TD>
<P>4/75 (5%)</P>
</TD>
<TD>
<P>6/38 (16%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>
</P>
</TD>
<TD>
<P>0/59</P>
</TD>
<TD>
<P>5/59 (8%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>
</P>
</TD>
<TD>
<P>0/34</P>
</TD>
<TD>
<P>0/34</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>0/39</P>
</TD>
<TD>
<P>3/20 (15%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Pasupathy-2011" TYPE="STUDY">Pasupathy 2011</LINK>
</P>
</TD>
<TD>
<P>2/60 (3%)</P>
</TD>
<TD>
<P>3/29 (10%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Post-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Sekhar-2001" TYPE="STUDY">Sekhar 2001</LINK>
</P>
</TD>
<TD>
<P>0/47</P>
</TD>
<TD>
<P>0/17</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>
</P>
</TD>
<TD>
<P>5/259 (2%)</P>
</TD>
<TD>
<P>30/231 (13%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Lacasa-2007" TYPE="STUDY">Lacasa 2007</LINK>
</P>
</TD>
<TD>
<P>2/72 (3%)</P>
</TD>
<TD>
<P>6/37 (16%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>0/44</P>
</TD>
<TD>
<P>2/20 (10%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre- and post-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Happonen-1990" TYPE="STUDY">Happonen 1990</LINK>
</P>
</TD>
<TD>
<P>11/91 (12%)</P>
</TD>
<TD>
<P>5/45 (11%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Leon-Arcila-2001" TYPE="STUDY">Leon Arcila 2001</LINK>
</P>
</TD>
<TD>
<P>0/49</P>
</TD>
<TD>
<P>0/53</P>
</TD>
</TR>
<TR>
<TD>
<P>Mean incidence of infection per group</P>
</TD>
<TD>
<P>29/898 (3.4%)</P>
</TD>
<TD>
<P>74/625 (12.5%)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2012-10-05 15:28:32 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-10-05 15:28:04 +0100" MODIFIED_BY="[Empty name]">Raw outcome data - Dry socket</TITLE>
<TABLE COLS="3" ROWS="17">
<TR>
<TH COLSPAN="3">
<P>Dry socket</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Antibiotic</P>
</TD>
<TD>
<P>Placebo</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Ritzau-1992" TYPE="STUDY">Ritzau 1992</LINK>
</P>
</TD>
<TD>
<P>6/135 (4.4%)</P>
</TD>
<TD>
<P>7/135 (5.2%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bergdahl-2004" TYPE="STUDY">Bergdahl 2004</LINK>*</P>
</TD>
<TD>
<P>10/59 (16.9%)</P>
</TD>
<TD>
<P>13/60 (21.6%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>
</P>
</TD>
<TD>
<P>1/31 (3.2%)</P>
</TD>
<TD>
<P>2/13 (15.4%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Halpern-2007" TYPE="STUDY">Halpern 2007</LINK>
</P>
</TD>
<TD>
<P>0/59</P>
</TD>
<TD>
<P>0/59</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>
</P>
</TD>
<TD>
<P>0/34</P>
</TD>
<TD>
<P>0/34</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>0/39</P>
</TD>
<TD>
<P>0/20</P>
</TD>
</TR>
<TR>
<TD>
<P>Post-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Arteagoitia-2005" TYPE="STUDY">Arteagoitia 2005</LINK>
</P>
</TD>
<TD>
<P>0/259</P>
</TD>
<TD>
<P>2/231 (0.9%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>0/44</P>
</TD>
<TD>
<P>0/20</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre- and post-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bystedt-1981" TYPE="STUDY">Bystedt 1981</LINK>
</P>
</TD>
<TD>
<P>2/40 (5%)</P>
</TD>
<TD>
<P>2/20 (1%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>*</P>
</TD>
<TD>
<P>8/45 (17.8%)</P>
</TD>
<TD>
<P>17/50 (34%)</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>
</P>
</TD>
<TD>
<P>2/28 (7.1%)</P>
</TD>
<TD>
<P>2/14 (14.3%)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mean incidence dry socket per group</P>
</TD>
<TD>
<P>29/773 (3.8%)</P>
</TD>
<TD>
<P>45/656 (6.9%)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>* Participants in both these studies had some pericoronitis in the recent past and were therefore at higher risk of infection.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2012-10-05 15:30:15 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-10-05 15:28:40 +0100" MODIFIED_BY="[Empty name]">Raw outcome data - VAS pain scores</TITLE>
<TABLE COLS="3" ROWS="10">
<TR>
<TH COLSPAN="3">
<P>Mean (SD) VAS pain scores</P>
</TH>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Antibiotic</P>
</TD>
<TD>
<P>Placebo</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>
</P>
</TD>
<TD>
<P>9.51 (28.83)</P>
<P>n = 31</P>
</TD>
<TD>
<P>10.14 (19.54)</P>
<P>n = 13</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>10.92 (16.89)</P>
<P>n = 39</P>
</TD>
<TD>
<P>5.75 (12.26)</P>
<P>n = 20</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Bezerra-2011" TYPE="STUDY">Bezerra 2011</LINK>
</P>
</TD>
<TD>
<P>15.9 (23.6)</P>
<P>n = 34</P>
</TD>
<TD>
<P>31.2 (29.5)</P>
<P>n = 34</P>
</TD>
</TR>
<TR>
<TD>
<P>Pre- and post-operative prophylaxis</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Barclay-1987" TYPE="STUDY">Barclay 1987</LINK>*</P>
</TD>
<TD>
<P>6.33 (12.58)</P>
<P>n = 45</P>
</TD>
<TD>
<P>14.79 (23.09)</P>
<P>n = 50</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Kaczmarzyk-2007" TYPE="STUDY">Kaczmarzyk 2007</LINK>
</P>
</TD>
<TD>
<P>3.92 (9.79)</P>
<P>n = 28</P>
</TD>
<TD>
<P>10.14 (19.54)</P>
<P>n = 14</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TYPE="STUDY">López-Cedrún 2011</LINK>
</P>
</TD>
<TD>
<P>15.02 (23.44)</P>
<P>n = 44</P>
</TD>
<TD>
<P>5.75 (12.26)</P>
<P>n = 20</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>*Participants in this study had some pericoronitis in the recent past and were therefore at higher risk of infection.<BR/>SD = standard deviation; VAS = visual analogue scale.<BR/>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-10-05 21:10:14 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-10-05 21:10:14 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Antibiotic versus placebo</NAME>
<IV_OUTCOME CHI2="12.457743530233259" CI_END="0.5018404036202768" CI_START="0.1631988137899636" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_SIZE="0.2861813386346247" ESTIMABLE="YES" I2="27.755777134452824" I2_Q="79.70698026114485" ID="CMP-001.01" LOG_CI_END="-0.2994343761761491" LOG_CI_START="-0.787283002238686" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.5433586892074175" MODIFIED="2012-10-05 15:52:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.18871625744899934" P_Q="0.007242412784111307" P_Z="1.2656643027795724E-5" Q="9.855605650304419" RANDOM="YES" SCALE="361.46" SHOW_PARTICIPANTS="NO" SORT_BY="YEAR" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.2094310316343011" TOTALS="YES" TOTAL_1="842" TOTAL_2="565" WEIGHT="100.00000000000001" Z="4.365958638149017">
<NAME>Local sign of infection</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="2.2826280001555004" CI_END="0.5422408117267503" CI_START="0.15073443238753292" DF="5" EFFECT_SIZE="0.2858922191543289" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="-0.265807798373574" LOG_CI_START="-0.821787530115226" LOG_EFFECT_SIZE="-0.5437976642444" MODIFIED="2012-10-05 15:52:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8088150605871867" P_Z="1.2605641978339515E-4" STUDIES="7" TAU2="0.0" TOTAL_1="277" TOTAL_2="162" WEIGHT="50.30351926151343" Z="3.834038458406562">
<NAME>Pre-operative prophylaxis</NAME>
<IV_DATA CI_END="0.7485077673186906" CI_START="0.10905245194391691" EFFECT_SIZE="0.2857037054802931" ESTIMABLE="YES" ESTIMATE="-1.2528" LOG_CI_END="-0.12580368859261362" LOG_CI_START="-0.9623645652641741" LOG_EFFECT_SIZE="-0.5440841269283938" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="58" SE="0.4914" STUDY_ID="STD-Mitchell-1986" TOTAL_1="0" TOTAL_2="0" WEIGHT="18.212112877657546"/>
<IV_DATA CI_END="27.502421185934697" CI_START="0.05010301746203546" EFFECT_SIZE="1.1738629770663782" ESTIMABLE="YES" ESTIMATE="0.1603" LOG_CI_END="1.4393709287904375" LOG_CI_START="-1.300136117892255" LOG_EFFECT_SIZE="0.06961740544909129" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="123" SE="1.6092" STUDY_ID="STD-Sekhar-2001" TOTAL_1="44" TOTAL_2="17" WEIGHT="2.9339273529645435"/>
<IV_DATA CI_END="1.6080386532180824" CI_START="0.005139419166438268" EFFECT_SIZE="0.09090866116450398" ESTIMABLE="YES" ESTIMATE="-2.3979" LOG_CI_END="0.2062964838885283" LOG_CI_START="-2.2890859602001434" LOG_EFFECT_SIZE="-1.0413947381558075" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="124" SE="1.4658" STUDY_ID="STD-Halpern-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="3.482582809890183">
<FOOTNOTE>Adminstered intravenously</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="1.1252642382346838" CI_START="0.10138624108714481" EFFECT_SIZE="0.3377666522088941" ESTIMABLE="YES" ESTIMATE="-1.0854" LOG_CI_END="0.05125451687613203" LOG_CI_START="-0.9940209781917112" LOG_EFFECT_SIZE="-0.4713832306577895" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="127" SE="0.614" STUDY_ID="STD-Lacasa-2007" TOTAL_1="75" TOTAL_2="38" WEIGHT="14.003332318869171"/>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="43" SE="0.0" STUDY_ID="STD-Bezerra-2011" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0"/>
<IV_DATA CI_END="1.3845046516134016" CI_START="0.004062558126359099" EFFECT_SIZE="0.0749975374488656" ESTIMABLE="YES" ESTIMATE="-2.5903" LOG_CI_END="0.14129441921242655" LOG_CI_START="-2.391200412160413" LOG_EFFECT_SIZE="-1.1249529964739933" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="126" SE="1.4876" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="39" TOTAL_2="19" WEIGHT="3.390019881689733"/>
<IV_DATA CI_END="1.8237451252547414" CI_START="0.05693231642019819" EFFECT_SIZE="0.32222668191941667" ESTIMABLE="YES" ESTIMATE="-1.1325" LOG_CI_END="0.2609641440637858" LOG_CI_START="-1.2446411455746513" LOG_EFFECT_SIZE="-0.49183850075543273" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="125" SE="0.8844" STUDY_ID="STD-Pasupathy-2011" TOTAL_1="60" TOTAL_2="29" WEIGHT="8.281544020442254"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.31950987977333906" CI_END="0.3141945316041086" CI_START="0.06745267839273798" DF="2" EFFECT_SIZE="0.14557905994011944" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="-0.502801377904662" LOG_CI_START="-1.171000800801685" LOG_EFFECT_SIZE="-0.8369010893531735" MODIFIED="2012-10-05 15:52:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8523526611470075" P_Z="9.126228257708673E-7" STUDIES="4" TAU2="0.0" TOTAL_1="425" TOTAL_2="305" WEIGHT="32.11538534116326" Z="4.90960015093382">
<NAME>Post-operative prophylaxis</NAME>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-22 10:31:03 +0000" MODIFIED_BY="[Empty name]" ORDER="117" SE="0.0" STUDY_ID="STD-Sekhar-2001" TOTAL_1="47" TOTAL_2="17" WEIGHT="0.0"/>
<IV_DATA CI_END="0.37674109077400764" CI_START="0.0586479351586074" EFFECT_SIZE="0.14864416256044846" ESTIMABLE="YES" ESTIMATE="-1.9062" LOG_CI_END="-0.42395700914852946" LOG_CI_START="-1.2317472736594277" LOG_EFFECT_SIZE="-0.8278521414039786" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="118" SE="0.4745" STUDY_ID="STD-Arteagoitia-2005" TOTAL_1="259" TOTAL_2="231" WEIGHT="18.896194916313586"/>
<IV_DATA CI_END="0.807293093055199" CI_START="0.036343805151392315" EFFECT_SIZE="0.17128952937661712" ESTIMABLE="YES" ESTIMATE="-1.7644" LOG_CI_END="-0.09296876318714647" LOG_CI_START="-1.4395696045530486" LOG_EFFECT_SIZE="-0.7662691838700975" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="119" SE="0.791" STUDY_ID="STD-Lacasa-2007" TOTAL_1="75" TOTAL_2="37" WEIGHT="9.833330491805393"/>
<IV_DATA CI_END="1.2330643189082027" CI_START="0.0036040308209981833" EFFECT_SIZE="0.0666633468228103" ESTIMABLE="YES" ESTIMATE="-2.7081" LOG_CI_END="0.09098573078743834" LOG_CI_START="-2.4432115036718307" LOG_EFFECT_SIZE="-1.1761128864421964" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="116" SE="1.4886" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="44" TOTAL_2="20" WEIGHT="3.385859933044279"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="2.9422591909469302" CI_START="0.4022917454816206" DF="0" EFFECT_SIZE="1.0879552314251637" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.468680928160305" LOG_CI_START="-0.39545887851141676" LOG_EFFECT_SIZE="0.03661102482444412" MODIFIED="2012-10-05 15:52:50 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8680974164855715" STUDIES="2" TAU2="0.0" TOTAL_1="140" TOTAL_2="98" WEIGHT="17.58109539732332" Z="0.1660756501182033">
<NAME>Pre- and post-operative prophylaxis</NAME>
<IV_DATA CI_END="2.9422591909469302" CI_START="0.4022917454816206" EFFECT_SIZE="1.0879552314251637" ESTIMABLE="YES" ESTIMATE="0.0843" LOG_CI_END="0.468680928160305" LOG_CI_START="-0.39545887851141676" LOG_EFFECT_SIZE="0.03661102482444412" MODIFIED="2012-04-12 14:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="121" SE="0.5076" STUDY_ID="STD-Happonen-1990" TOTAL_1="91" TOTAL_2="45" WEIGHT="17.58109539732332"/>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-22 10:24:14 +0000" MODIFIED_BY="[Empty name]" ORDER="120" SE="0.0" STUDY_ID="STD-Leon-Arcila-2001" TOTAL_1="49" TOTAL_2="53" WEIGHT="0.0"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<IV_OUTCOME CHI2="2.648900348697383" CI_END="0.9476371389586172" CI_START="0.4051067570060125" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_SIZE="0.6195919691070741" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.023357927129596077" LOG_CI_START="-0.39243051291132186" LOG_DATA="YES" LOG_EFFECT_SIZE="-0.20789422002045893" MODIFIED="2012-10-05 15:53:20 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.915473839640544" P_Q="0.5059008316839353" P_Z="0.02724085501160455" Q="1.3628294146799842" RANDOM="YES" SCALE="100.0" SHOW_PARTICIPANTS="NO" SORT_BY="YEAR" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="680" TOTAL_2="615" WEIGHT="100.0" Z="2.2080490371350723">
<NAME>Dry socket</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<EFFECT_MEASURE>Risk Ratio</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="1.2827180554611974" CI_END="1.3308517901637933" CI_START="0.4209082760776454" DF="3" EFFECT_SIZE="0.7484427384327345" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.12412969311706173" LOG_CI_START="-0.3758125348851041" LOG_EFFECT_SIZE="-0.12584142088402114" MODIFIED="2012-10-05 15:53:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7332409874211796" P_Z="0.32379336336548514" STUDIES="6" TAU2="0.0" TOTAL_1="292" TOTAL_2="294" WEIGHT="54.4984226336846" Z="0.9866926171915993">
<NAME>Pre-operative prophylaxis</NAME>
<IV_DATA CI_END="2.4839857993493304" CI_START="0.2957429993600137" EFFECT_SIZE="0.8571005837515526" ESTIMABLE="YES" ESTIMATE="-0.1542" LOG_CI_END="0.39514910870186387" LOG_CI_START="-0.5290855269208268" LOG_EFFECT_SIZE="-0.06696820910948141" MODIFIED="2012-02-22 13:50:55 +0000" MODIFIED_BY="[Empty name]" ORDER="155" SE="0.5429" STUDY_ID="STD-Ritzau-1992" TOTAL_1="135" TOTAL_2="135" WEIGHT="15.94626936283736"/>
<IV_DATA CI_END="1.6428661428359654" CI_START="0.3724537669086959" EFFECT_SIZE="0.7822350563775669" ESTIMABLE="YES" ESTIMATE="-0.2456" LOG_CI_END="0.2156021795057058" LOG_CI_START="-0.42892762901658316" LOG_EFFECT_SIZE="-0.10666272475543861" MODIFIED="2012-02-22 13:50:32 +0000" MODIFIED_BY="[Empty name]" ORDER="158" SE="0.3786" STUDY_ID="STD-Bergdahl-2004" TOTAL_1="59" TOTAL_2="60" WEIGHT="32.78970881107226"/>
<IV_DATA CI_END="2.115276479173242" CI_START="0.020783715096664133" EFFECT_SIZE="0.20967428000069888" ESTIMABLE="YES" ESTIMATE="-1.5622" LOG_CI_END="0.3253671402840196" LOG_CI_START="-1.6822768195425397" LOG_EFFECT_SIZE="-0.67845483962926" MODIFIED="2012-02-23 15:31:26 +0000" MODIFIED_BY="[Empty name]" ORDER="48" SE="1.1793" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="3.379482346209934"/>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-04-11 16:34:16 +0100" MODIFIED_BY="[Empty name]" ORDER="157" SE="0.0" STUDY_ID="STD-Halpern-2007" TOTAL_1="59" TOTAL_2="59" WEIGHT="0.0">
<FOOTNOTE>Administered intravenoulsy</FOOTNOTE>
</IV_DATA>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-23 10:36:40 +0000" MODIFIED_BY="[Empty name]" ORDER="159" SE="0.0" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="39" TOTAL_2="40" WEIGHT="0.0"/>
<IV_DATA CI_END="15.682938785226465" CI_START="0.06376355947662138" EFFECT_SIZE="1.0" ESTIMABLE="YES" ESTIMATE="0.0" LOG_CI_END="1.1954274472909436" LOG_CI_START="-1.1954274472909436" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-23 10:21:18 +0000" MODIFIED_BY="[Empty name]" ORDER="156" SE="1.4044" STUDY_ID="STD-Bezerra-2011" TOTAL_1="0" TOTAL_2="0" WEIGHT="2.382962113565042"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0" CI_END="3.6983260504833897" CI_START="0.008611297297999374" DF="0" EFFECT_SIZE="0.1784583568389228" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.5680051966240319" LOG_CI_START="-2.0649314168481605" LOG_EFFECT_SIZE="-0.7484631101120642" MODIFIED="2012-10-05 15:53:15 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2651439753489908" STUDIES="2" TAU2="0.0" TOTAL_1="303" TOTAL_2="251" WEIGHT="1.9649104732554272" Z="1.1143152722100091">
<NAME>Post-operative prophylaxis</NAME>
<IV_DATA CI_END="3.6983260504833897" CI_START="0.008611297297999374" EFFECT_SIZE="0.1784583568389228" ESTIMABLE="YES" ESTIMATE="-1.7234" LOG_CI_END="0.5680051966240319" LOG_CI_START="-2.0649314168481605" LOG_EFFECT_SIZE="-0.7484631101120642" MODIFIED="2012-02-22 13:53:26 +0000" MODIFIED_BY="[Empty name]" ORDER="160" SE="1.5466" STUDY_ID="STD-Arteagoitia-2005" TOTAL_1="259" TOTAL_2="231" WEIGHT="1.9649104732554272"/>
<IV_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" ESTIMATE="0.0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-22 13:49:32 +0000" MODIFIED_BY="[Empty name]" ORDER="161" SE="0.0" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="44" TOTAL_2="20" WEIGHT="0.0"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.0033528785562017185" CI_END="0.9850675961459049" CI_START="0.27171606481554167" DF="2" EFFECT_SIZE="0.5173574110825808" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="-0.0065339668364966285" LOG_CI_START="-0.5658846837959843" LOG_EFFECT_SIZE="-0.2862093253162405" MODIFIED="2012-10-05 15:53:20 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9983249659455681" P_Z="0.04488250043893394" STUDIES="3" TAU2="0.0" TOTAL_1="85" TOTAL_2="70" WEIGHT="43.53666689305997" Z="2.0057540024569884">
<NAME>Pre- and post-operative prophylaxis</NAME>
<IV_DATA CI_END="3.293640079591494" CI_START="0.07591102408008721" EFFECT_SIZE="0.5000235908364827" ESTIMABLE="YES" ESTIMATE="-0.6931" LOG_CI_END="0.5176761388569046" LOG_CI_START="-1.1196951496711922" LOG_EFFECT_SIZE="-0.30100950540714383" MODIFIED="2012-02-22 13:53:59 +0000" MODIFIED_BY="[Empty name]" ORDER="163" SE="0.9618" STUDY_ID="STD-Bystedt-1981" TOTAL_1="40" TOTAL_2="20" WEIGHT="5.08076647066746"/>
<IV_DATA CI_END="1.0932276280391096" CI_START="0.25008999462854714" EFFECT_SIZE="0.5228817185789538" ESTIMABLE="YES" ESTIMATE="-0.6484" LOG_CI_END="0.038710598645681826" LOG_CI_START="-0.6019036827778188" LOG_EFFECT_SIZE="-0.28159654206606843" MODIFIED="2012-02-22 13:53:48 +0000" MODIFIED_BY="[Empty name]" ORDER="162" SE="0.3763" STUDY_ID="STD-Barclay-1987" TOTAL_1="45" TOTAL_2="50" WEIGHT="33.191764660246086"/>
<IV_DATA CI_END="3.1863305885580977" CI_START="0.07846756149246674" EFFECT_SIZE="0.5000235908364827" ESTIMABLE="YES" ESTIMATE="-0.6931" LOG_CI_END="0.5032908327765735" LOG_CI_START="-1.1053098435908613" LOG_EFFECT_SIZE="-0.30100950540714383" MODIFIED="2012-02-23 15:33:46 +0000" MODIFIED_BY="[Empty name]" ORDER="49" SE="0.9449" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="0" TOTAL_2="0" WEIGHT="5.2641357621464255"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="7.0452358865355045" CI_END="1.1134827992057483" CI_START="0.3199045801028586" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5968318417541666" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="36" I2="57.41803328780734" I2_Q="34.28197714662606" ID="CMP-001.03" LOG_CI_END="0.0466835125530597" LOG_CI_START="-0.49497954203793476" LOG_EFFECT_SIZE="-0.22414801474243753" METHOD="MH" MODIFIED="2012-10-05 21:10:14 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.07046993236870869" P_Q="0.2183508227781107" P_Z="0.10477702501525217" Q="3.043305189601152" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.22634477190112515" TOTALS="YES" TOTAL_1="390" TOTAL_2="285" WEIGHT="100.0" Z="1.6221229503387833">
<NAME>Pain (dichotomous on 6th-7th day)</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4890276392635108E-31" CI_END="1.7585065160571611" CI_START="0.5305526953591906" DF="0" EFFECT_SIZE="0.9659090909090909" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" I2="100.0" ID="CMP-001.03.01" LOG_CI_END="0.24514398191223113" LOG_CI_START="-0.27527147478398284" LOG_EFFECT_SIZE="-0.01506374643587588" MODIFIED="2012-10-05 15:53:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.9096621212857369" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="17" WEIGHT="31.65653397568809" Z="0.11346473324982286">
<NAME>Pre-operative prophylaxis</NAME>
<DICH_DATA CI_END="1.7585065160571611" CI_START="0.5305526953591906" EFFECT_SIZE="0.9659090909090909" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" LOG_CI_END="0.24514398191223113" LOG_CI_START="-0.27527147478398284" LOG_EFFECT_SIZE="-0.01506374643587588" MODIFIED="2012-02-22 14:34:25 +0000" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.3056946153614135" STUDY_ID="STD-Sekhar-2001" TOTAL_1="44" TOTAL_2="17" VAR="0.09344919786096255" WEIGHT="31.65653397568809"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.9643965430206967" CI_END="1.8204236476146405" CI_START="0.14110103937715385" DF="1" EFFECT_SIZE="0.5068171946423833" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" I2="74.7754799715862" ID="CMP-001.03.02" LOG_CI_END="0.2601724684306218" LOG_CI_START="-0.8504697871379272" LOG_EFFECT_SIZE="-0.2951486593536527" MODIFIED="2012-10-05 15:53:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.04647224715183962" P_Z="0.2975485293811164" STUDIES="2" TAU2="0.644488133781957" TOTAL_1="306" TOTAL_2="248" WEIGHT="47.85878483090637" Z="1.0417049045595876">
<NAME>Post-operative prophylaxis</NAME>
<DICH_DATA CI_END="1.7398120013899636" CI_START="0.4435081115630777" EFFECT_SIZE="0.878419452887538" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.2405023223228116" LOG_CI_START="-0.35309843270966457" LOG_EFFECT_SIZE="-0.05629805519342645" MODIFIED="2012-02-22 14:34:55 +0000" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.3486840218772033" STUDY_ID="STD-Sekhar-2001" TOTAL_1="47" TOTAL_2="17" VAR="0.12158054711246201" WEIGHT="29.096958789016313"/>
<DICH_DATA CI_END="0.7632068577308951" CI_START="0.08508364343297317" EFFECT_SIZE="0.2548262548262548" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="14" LOG_CI_END="-0.11735773596996552" LOG_CI_START="-1.0701539211088007" LOG_EFFECT_SIZE="-0.5937558285393831" MODIFIED="2012-04-03 11:56:07 +0100" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.5596771955677337" STUDY_ID="STD-Arteagoitia-2005" TOTAL_1="259" TOTAL_2="231" VAR="0.3132385632385632" WEIGHT="18.761826041890064"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9848738818690956" CI_START="0.12951000402822818" DF="0" EFFECT_SIZE="0.3571428571428572" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="-0.006619379568493195" LOG_CI_START="-0.8876966831159451" LOG_EFFECT_SIZE="-0.44715803134221915" MODIFIED="2012-10-05 15:53:40 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.046655556805994765" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="20" WEIGHT="20.48468119340553" Z="1.989413717275221">
<NAME>Pre- and post-operative prophylaxis</NAME>
<DICH_DATA CI_END="0.9848738818690956" CI_START="0.12951000402822818" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="-0.006619379568493195" LOG_CI_START="-0.8876966831159451" LOG_EFFECT_SIZE="-0.4471580313422192" MODIFIED="2012-04-04 16:43:47 +0100" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.5175491695067657" STUDY_ID="STD-Bystedt-1981" TOTAL_1="40" TOTAL_2="20" VAR="0.26785714285714285" WEIGHT="20.48468119340553"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<IV_OUTCOME CHI2="4.5439143663084245" CI_END="-4.4463637230373765" CI_START="-11.902558822565023" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_SIZE="-8.1744612728012" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_DATA="NO" LOG_EFFECT_SIZE="NaN" MODIFIED="2012-10-05 15:53:57 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.47402948729170524" P_Q="0.8616755164809216" P_Z="1.7270382147078436E-5" Q="0.030360185549562185" RANDOM="YES" SCALE="50.0" SHOW_PARTICIPANTS="NO" SORT_BY="YEAR" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="104" TOTAL_2="77" WEIGHT="100.0" Z="4.297540360423987">
<NAME>Pain score (VAS 7th day)</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<EFFECT_MEASURE>Mean Difference</EFFECT_MEASURE>
<IV_SUBGROUP CHI2="4.340145571083458" CI_END="1.362609740959451" CI_START="-16.17904881148234" DF="2" EFFECT_SIZE="-7.408219535261445" ESTIMABLE="YES" I2="53.91859634098109" ID="CMP-001.04.01" LOG_CI_END="0.13437148927813064" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" MODIFIED="2012-10-05 15:53:52 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11416938523971687" P_Z="0.09782922613554963" STUDIES="3" TAU2="32.17945051487818" TOTAL_1="31" TOTAL_2="14" WEIGHT="41.60272435953307" Z="1.6554698559740617">
<NAME>Pre-operative prophylaxis</NAME>
<IV_DATA CI_END="12.904923288038253" CI_START="-14.164923288038255" EFFECT_SIZE="-0.63" ESTIMABLE="YES" ESTIMATE="-0.63" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-23 16:35:32 +0000" MODIFIED_BY="[Empty name]" ORDER="168" SE="6.9057" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="31" TOTAL_2="14" WEIGHT="7.586875160016102"/>
<IV_DATA CI_END="-6.212038996484678" CI_START="-24.387961003515322" EFFECT_SIZE="-15.3" ESTIMABLE="YES" ESTIMATE="-15.3" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-06-13 10:24:38 +0100" MODIFIED_BY="[Empty name]" ORDER="167" SE="4.6368" STUDY_ID="STD-Bezerra-2011" TOTAL_1="0" TOTAL_2="0" WEIGHT="16.828353472819597"/>
<IV_DATA CI_END="4.892510757468223" CI_START="-13.092510757468222" EFFECT_SIZE="-4.1" ESTIMABLE="YES" ESTIMATE="-4.1" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-04-12 10:01:42 +0100" MODIFIED_BY="[Empty name]" ORDER="54" SE="4.5881" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="0" TOTAL_2="0" WEIGHT="17.187495726697374"/>
</IV_SUBGROUP>
<IV_SUBGROUP CHI2="0.19761025022344011" CI_END="-3.4219008299736116" CI_START="-13.179005633540136" DF="2" EFFECT_SIZE="-8.300453231756874" ESTIMABLE="YES" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="NaN" LOG_CI_START="NaN" LOG_EFFECT_SIZE="NaN" MODIFIED="2012-10-05 15:53:57 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.905919304008966" P_Z="8.538639048442503E-4" STUDIES="3" TAU2="0.0" TOTAL_1="73" TOTAL_2="63" WEIGHT="58.39727564046692" Z="3.3347165408443495">
<NAME>Pre- and post-operative prophylaxis</NAME>
<IV_DATA CI_END="-1.0795596198159725" CI_START="-15.84044038018403" EFFECT_SIZE="-8.46" ESTIMABLE="YES" ESTIMATE="-8.46" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-03-27 09:31:55 +0100" MODIFIED_BY="[Empty name]" ORDER="166" SE="3.7656" STUDY_ID="STD-Barclay-1987" TOTAL_1="45" TOTAL_2="50" WEIGHT="25.515846604576875"/>
<IV_DATA CI_END="4.638788463547264" CI_START="-17.078788463547262" EFFECT_SIZE="-6.22" ESTIMABLE="YES" ESTIMATE="-6.22" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-02-23 16:41:56 +0000" MODIFIED_BY="[Empty name]" ORDER="165" SE="5.5403" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="28" TOTAL_2="13" WEIGHT="11.787230859577194"/>
<IV_DATA CI_END="-1.152809158027365" CI_START="-17.387190841972632" EFFECT_SIZE="-9.27" ESTIMABLE="YES" ESTIMATE="-9.27" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-04-12 10:02:41 +0100" MODIFIED_BY="[Empty name]" ORDER="55" SE="4.1415" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="0" TOTAL_2="0" WEIGHT="21.094198176312855"/>
</IV_SUBGROUP>
</IV_OUTCOME>
<DICH_OUTCOME CHI2="2.5307545520254657" CI_END="1.9852863526742077" CI_START="0.0573948173065648" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.33755762102632575" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" I2="60.486093003382756" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.2978231571530733" LOG_CI_START="-1.2411273221800823" LOG_EFFECT_SIZE="-0.47165208251350443" METHOD="MH" MODIFIED="2012-10-05 21:09:44 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.1116471312042917" P_Q="1.0" P_Z="0.22960942983142374" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.052596904984144" TOTALS="YES" TOTAL_1="458" TOTAL_2="358" WEIGHT="99.99999999999999" Z="1.2013656155594359">
<NAME>Fever (6th-7th day)</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-04-12 10:17:06 +0100" MODIFIED_BY="[Empty name]" ORDER="6" O_E="0.0" SE="0.0" STUDY_ID="STD-Lacasa-2007" TOTAL_1="68" TOTAL_2="62" VAR="0.0" WEIGHT="0.0">
<FOOTNOTE>Preoperative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.8846377664822603" CI_START="0.014050085967419263" EFFECT_SIZE="0.11148648648648649" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="8" LOG_CI_END="-0.05323452390295844" LOG_CI_START="-1.852321018459144" LOG_EFFECT_SIZE="-0.9527777711810511" MODIFIED="2012-10-05 21:09:29 +0100" MODIFIED_BY="[Empty name]" ORDER="8" O_E="0.0" SE="1.0567923125240795" STUDY_ID="STD-Arteagoitia-2005" TOTAL_1="259" TOTAL_2="231" VAR="1.1168099918099919" WEIGHT="37.668946820793316">
<FOOTNOTE>Post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-05 21:09:38 +0100" MODIFIED_BY="[Empty name]" ORDER="9" O_E="0.0" SE="0.0" STUDY_ID="STD-Bystedt-1981" TOTAL_1="40" TOTAL_2="20" VAR="0.0" WEIGHT="0.0">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="1.7858626706853602" CI_START="0.24342863098926812" EFFECT_SIZE="0.6593406593406593" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.25184805944802346" LOG_CI_START="-0.6136283433229234" LOG_EFFECT_SIZE="-0.18089014193744998" MODIFIED="2012-10-05 21:09:44 +0100" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="0.5083851231649422" STUDY_ID="STD-Happonen-1990" TOTAL_1="91" TOTAL_2="45" VAR="0.2584554334554334" WEIGHT="62.33105317920667">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.949372077117282" CI_END="1.301680954277532" CI_START="0.6467436955282038" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9175259946007688" ESTIMABLE="YES" EVENTS_1="70" EVENTS_2="31" I2="0.0" I2_Q="44.76713521401112" ID="CMP-001.06" LOG_CI_END="0.11450455045640001" LOG_CI_START="-0.189267796102965" LOG_EFFECT_SIZE="-0.03738162282328248" METHOD="MH" MODIFIED="2012-10-05 15:54:21 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.4220902744457462" P_Q="0.1635697375437125" P_Z="0.6295370464755518" Q="3.6210325279150597" RANDOM="YES" SCALE="100.0" SORT_BY="YEAR" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="233" TOTAL_2="101" WEIGHT="100.00000000000001" Z="0.4823785657064472">
<NAME>Swelling (7th day)</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1068511860985502" CI_END="1.8258152355292205" CI_START="0.693269001736492" DF="2" EFFECT_SIZE="1.1250693781676846" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="15" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="0.26145682673056236" LOG_CI_START="-0.15909821805560362" LOG_EFFECT_SIZE="0.05117930433747933" MODIFIED="2012-10-05 15:54:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5749769300756201" P_Z="0.6333376902451024" STUDIES="3" TAU2="0.0" TOTAL_1="114" TOTAL_2="51" WEIGHT="52.17359686170572" Z="0.4770343121494464">
<NAME>Pre-operative prophylaxis</NAME>
<DICH_DATA CI_END="2.213332954350513" CI_START="0.6069993820389434" EFFECT_SIZE="1.1590909090909092" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="7" LOG_CI_END="0.3450467502853302" LOG_CI_START="-0.21681175106183223" LOG_EFFECT_SIZE="0.06411749961174897" MODIFIED="2012-02-23 13:55:13 +0000" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.3300384649357602" STUDY_ID="STD-Sekhar-2001" TOTAL_1="44" TOTAL_2="17" VAR="0.10892538833715303" WEIGHT="29.230925031348725"/>
<DICH_DATA CI_END="8.209590453038906" CI_START="0.5030790347479552" EFFECT_SIZE="2.032258064516129" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="0.9143214922690501" LOG_CI_START="-0.29836378103043226" LOG_EFFECT_SIZE="0.30797885561930904" MODIFIED="2012-02-22 14:42:40 +0000" MODIFIED_BY="[Empty name]" ORDER="27" O_E="0.0" SE="0.7123373324250322" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="31" TOTAL_2="14" VAR="0.5074244751664108" WEIGHT="6.274805446563594"/>
<DICH_DATA CI_END="2.0130027680581333" CI_START="0.3628974398932744" EFFECT_SIZE="0.8547008547008547" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.3038443720826666" LOG_CI_START="-0.44021609557499" LOG_EFFECT_SIZE="-0.06818586174616166" MODIFIED="2012-04-03 16:11:39 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.43706480186082364" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="39" TOTAL_2="20" VAR="0.191025641025641" WEIGHT="16.6678663837934"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0240963909343137" CI_START="0.24152755644671647" DF="0" EFFECT_SIZE="0.4973404255319148" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="0.010340835624896978" LOG_CI_START="-0.6170333124072214" LOG_EFFECT_SIZE="-0.30334623839116215" MODIFIED="2012-10-05 15:54:16 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.05804566559654922" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="17" WEIGHT="23.44462195738243" Z="1.89535288936369">
<NAME>Post-operative prophylaxis</NAME>
<DICH_DATA CI_END="1.024096390934314" CI_START="0.24152755644671653" EFFECT_SIZE="0.4973404255319149" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.010340835624897071" LOG_CI_START="-0.6170333124072213" LOG_EFFECT_SIZE="-0.3033462383911621" MODIFIED="2012-02-23 12:53:55 +0000" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="0.3685226801061847" STUDY_ID="STD-Sekhar-2001" TOTAL_1="47" TOTAL_2="17" VAR="0.13580896575264534" WEIGHT="23.44462195738243"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.1678016804566694" CI_END="2.1699593381983693" CI_START="0.5263234702004784" DF="1" EFFECT_SIZE="1.0686910353673316" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="8" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="0.3364515958939097" LOG_CI_START="-0.27874726317427256" LOG_EFFECT_SIZE="0.02885216635981855" MODIFIED="2012-10-05 15:54:21 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6820732155192523" P_Z="0.8541386495347988" STUDIES="2" TAU2="0.0" TOTAL_1="72" TOTAL_2="33" WEIGHT="24.381781180911858" Z="0.18384041552630756">
<NAME>Pre- and post-operative prophylaxis</NAME>
<DICH_DATA CI_END="5.990770087190526" CI_START="0.32384000590448014" EFFECT_SIZE="1.3928571428571428" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="0.7774826526265093" LOG_CI_START="-0.48966950125794934" LOG_EFFECT_SIZE="0.14390657568427997" MODIFIED="2012-02-22 14:43:10 +0000" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="0.7443314476960543" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="28" TOTAL_2="13" VAR="0.5540293040293041" WEIGHT="5.746970128362484"/>
<DICH_DATA CI_END="2.214205642922804" CI_START="0.4380471801291367" EFFECT_SIZE="0.9848484848484849" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="6" LOG_CI_END="0.3452179532361108" LOG_CI_START="-0.35847911103413693" LOG_EFFECT_SIZE="-0.006630578899013093" MODIFIED="2012-04-03 16:12:05 +0100" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.41335513890899056" STUDY_ID="STD-L_x00f3_pez_x002d_Cedr_x00fa_n-2011" TOTAL_1="44" TOTAL_2="20" VAR="0.17086247086247086" WEIGHT="18.634811052549374"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.43644961202463495" CI_END="1.705618438424298" CI_START="0.41809778480583937" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8444615389875337" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.23188188227063644" LOG_CI_START="-0.378722133452094" LOG_EFFECT_SIZE="-0.07342012559072877" METHOD="MH" MODIFIED="2012-10-05 21:09:02 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.8039448142069441" P_Q="1.0" P_Z="0.6373985334124703" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="119" TOTAL_2="56" WEIGHT="100.0" Z="0.4713391926448776">
<NAME>Trismus (7th day)</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4854411471731512" CI_START="0.31858733009856105" EFFECT_SIZE="1.053763440860215" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.5422577539284337" LOG_CI_START="-0.4967714996513141" LOG_EFFECT_SIZE="0.02274312713855972" MODIFIED="2012-04-12 10:23:54 +0100" MODIFIED_BY="[Empty name]" ORDER="26" O_E="0.0" SE="0.6103309268304988" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="31" TOTAL_2="14" VAR="0.37250384024577576" WEIGHT="34.53534206868187">
<FOOTNOTE>Preoperative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="2.083194602722558" CI_START="0.17522000135468113" EFFECT_SIZE="0.6041666666666666" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.31872984169087876" LOG_CI_START="-0.7564163206441411" LOG_EFFECT_SIZE="-0.21884323947663115" MODIFIED="2012-10-05 21:08:50 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.6315461778149273" STUDY_ID="STD-Pasupathy-2011" TOTAL_1="60" TOTAL_2="29" VAR="0.3988505747126437" WEIGHT="32.25405292208466">
<FOOTNOTE>Pre-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="3.1447786384809926" CI_START="0.2741830179740949" EFFECT_SIZE="0.9285714285714286" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.49759008079252803" LOG_CI_START="-0.5619594475353306" LOG_EFFECT_SIZE="-0.03218468337140124" MODIFIED="2012-10-05 21:09:02 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.6223846377945373" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="28" TOTAL_2="13" VAR="0.3873626373626374" WEIGHT="33.21060500923346">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.504457653550084" CI_END="3.5873777373717806" CI_START="1.0981402440545605" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.9848032305579673" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="19" I2="11.199076389418538" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.5547771086578415" LOG_CI_START="0.04065780762737334" LOG_EFFECT_SIZE="0.29771745814260736" METHOD="MH" MODIFIED="2012-10-05 21:08:26 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.34201936706760994" P_Q="1.0" P_Z="0.023209922477673856" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="USER" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.06726823487184168" TOTALS="YES" TOTAL_1="540" TOTAL_2="390" WEIGHT="99.99999999999999" Z="2.269961444196941">
<NAME>Adverse effects</NAME>
<GROUP_LABEL_1>Antibiotic</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours antibiotic</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-05 21:07:37 +0100" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.0" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="31" TOTAL_2="14" VAR="0.0" WEIGHT="0.0">
<FOOTNOTE>Pre-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="7.053684234322808" CI_START="0.029463853614526882" EFFECT_SIZE="0.45588235294117646" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8484160141122141" LOG_CI_START="-1.5307104518561414" LOG_EFFECT_SIZE="-0.34114721887196364" MODIFIED="2012-10-05 21:07:41 +0100" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="1.3975106629757534" STUDY_ID="STD-Lacasa-2007" TOTAL_1="68" TOTAL_2="31" VAR="1.9530360531309299" WEIGHT="4.51425653350401">
<FOOTNOTE>Pre-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="27.178806803132645" CI_START="1.4341352980149882" EFFECT_SIZE="6.243243243243243" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="2" LOG_CI_END="1.4342303865322348" LOG_CI_START="0.15659012511806406" LOG_EFFECT_SIZE="0.7954102558251493" MODIFIED="2012-10-05 21:07:47 +0100" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.7504922139759768" STUDY_ID="STD-Arteagoitia-2005" TOTAL_1="259" TOTAL_2="231" VAR="0.5632385632385633" WEIGHT="14.464827118621635">
<FOOTNOTE>Post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="9.65189217773383" CI_START="0.5228206746143881" EFFECT_SIZE="2.246376811594203" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="2" LOG_CI_END="0.984612461716154" LOG_CI_START="-0.2816472468500817" LOG_EFFECT_SIZE="0.3514826074330362" MODIFIED="2012-10-05 21:07:52 +0100" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.7438072208984547" STUDY_ID="STD-Lacasa-2007" TOTAL_1="69" TOTAL_2="31" VAR="0.5532491818606826" WEIGHT="14.697688712441018">
<FOOTNOTE>Post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-10-05 21:08:04 +0100" MODIFIED_BY="[Empty name]" ORDER="64" O_E="0.0" SE="0.0" STUDY_ID="STD-Bystedt-1981" TOTAL_1="40" TOTAL_2="20" VAR="0.0" WEIGHT="0.0">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="2.755614112622722" CI_START="0.9143248024129615" EFFECT_SIZE="1.5873015873015872" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="14" LOG_CI_END="0.44021840028481285" LOG_CI_START="-0.038899499191976265" LOG_EFFECT_SIZE="0.20065945054641826" MODIFIED="2012-10-05 21:08:16 +0100" MODIFIED_BY="[Empty name]" ORDER="66" O_E="0.0" SE="0.28143622582451816" STUDY_ID="STD-Barclay-1987" TOTAL_1="45" TOTAL_2="50" VAR="0.0792063492063492" WEIGHT="62.264534759929155">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="61.0316758478415" CI_START="0.18711166370606253" EFFECT_SIZE="3.3793103448275863" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.7855552952634524" LOG_CI_START="-0.7278991396763749" LOG_EFFECT_SIZE="0.5288280777935388" MODIFIED="2012-10-05 21:08:26 +0100" MODIFIED_BY="[Empty name]" ORDER="67" O_E="0.0" SE="1.4764155768837663" STUDY_ID="STD-Kaczmarzyk-2007" TOTAL_1="28" TOTAL_2="13" VAR="2.1798029556650245" WEIGHT="4.058692875504183">
<FOOTNOTE>Pre- and post-operative antibiotics</FOOTNOTE>
</DICH_DATA>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-10-05 20:59:59 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-10-05 15:54:57 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjEAAALiCAYAAAAoxYd1AAAp9ElEQVR42u3d4bKrOJIu0H7/l+4b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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-10-05 20:59:59 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAVgAAANxCAIAAAAuMjbAAAAw/ElEQVR42u3dv24kxfrG8ZGQEIGD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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-10-05 20:59:59 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2012-10-05 15:52:51 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_STUDY_NAMES:NO;SHOW_EFFECT_ESTIMATE:YES;DISTINGUISH_SUBGROUPS:YES;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Antibiotic versus placebo, outcome: 1.1 Local sign of infection.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2013-04-24 14:08:57 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2013-04-24 14:08:57 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch" NO="1">
<TITLE MODIFIED="2013-04-24 13:53:23 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">Comment from Dr John Curran</TITLE>
<DATE_SUBMITTED>
<DATE DAY="11" MONTH="2" YEAR="2013"/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY MODIFIED="2013-04-24 14:08:46 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<P>Very good review. Unfortunately the difficulty of designing a randomised trial still exists partly due to ethical requirements and logistics -e.g. with third molar surgery assessment of difficulty and surgical ability are hard to measure. Post-operative assessment also needs to be done sooner than the 7 days used in the review. Little has changed in but I believe that in patient age groups most prevalent in the North America context the incidence of infection is even lower than reported -i.e. antibiotic usage should be highly selective.</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2013-04-24 14:08:57 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<P>Thank you for your interest in our work and for your comment.<BR/>I absolutely agree that real incidence of infectious complications in a population similar to study groups is likely to be lower, and for that reason we did not really recommend for regular antibiotic prophylaxis. Unfortunately because of the lack of studies on patients at higher risk, no evidence is available on cases for which antibiotic prophylaxis is (anecdotally) recommended.</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS MODIFIED="2013-04-24 13:55:41 +0100" MODIFIED_BY="Luisa Fdez Mauleffinch">
<P>Summary: John Curran.<BR/>Reply: Giovanni Lodi. </P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2012-10-04 18:06:29 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2012-10-04 18:04:42 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-10-04 18:04:42 +0100" MODIFIED_BY="[Empty name]">Cochrane Oral Health Group's Trials Register search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-25 15:47:02 +0000" MODIFIED_BY="[Empty name]">
<P>((extract* or remov* or exodontia or "impacted teeth" or "impacted tooth" or "oral surg*" or (tooth and surg*) or (teeth and surg*) or ("third molar*" and surg*)) AND (antibiotic* or erthromycin* or metronidaz* or tetracycline* or clindamycin* or teicoplanin* or vancomycin* or floxacillin* or gentamicin* or cephalexin* or "anti biotic*" or anti-biotic* or penicillin* or antibacterial* or anti-bacterial* or "anti bacterial*" or erthromycin* or cephalsporin* or suphonamide* or clindamicin* or augmentin* or flagyl* or amoxyl* or amoxil* or co-amox* or antifungal* or anti-fungal* or "anti fungal*" or vancomicin* or flucloxacillin* or floxacillin* or gentamycin* or cephalexin*))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-10-04 18:04:58 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-10-04 18:04:58 +0100" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-04 16:13:29 +0100" MODIFIED_BY="[Empty name]">
<P>#1        MeSH descriptor Tooth extraction explode all trees <BR/>#2        exodontia in All Text<BR/>#3        ((tooth in All Text near/4 extract* in All Text) or (teeth in All Text near/4 extract* in All Text) or ("third molar*" in All Text near/4 extract* in All Text) or (3rd in All Text and (molar* in All Text near/4 extract* in All Text) ) or "dental extract*" in All Text or (tooth in All Text near/4 remov* in All Text) or (teeth in All Text near/4 remov* in All Text) or ("third molar*" in All Text near/4 remov* in All Text) or ("3rd molar*" in All Text near/4 remov* in All Text) or (tooth in All Text near/4 surg* in All Text) or (teeth in All Text near/4 surg* in All Text) or ("third molar*" in All Text near/4 surg* in All Text) or ("3rd molar*" in All Text near/4 surg* in All Text))<BR/>#4        (#1 or #2 or #3)<BR/>#5        MeSH descriptor Molar explode all trees<BR/>#6        MeSH descriptor Tooth, impacted this term only<BR/>#7        ("wisdom tooth" in All Text or "wisdom teeth" in All Text or (third in All Text near/3 molar in All Text))<BR/>#8        "impacted tooth" in All Text<BR/>#9        "impacted teeth" in All Text<BR/>#10      (#5 or #6 or #7 or #8 or #9)<BR/>#11      (extract* in All Text or remov* in All Text or surg* in All Text)<BR/>#12      (#10 and #11)<BR/>#13      (#4 or #12)<BR/>#14      MeSH descriptor Anti-Bacterial Agents explode all trees<BR/>#15      MeSH descriptor Antibiotic prophylaxis this term only<BR/>#16      MeSH descriptor Erythromycin explode all trees<BR/>#17      MeSH descriptor Metronidazole this term only<BR/>#18      MeSH descriptor Tetracyclines this term only<BR/>#19      MeSH descriptor Clindamycin this term only<BR/>#20      MeSH descriptor Teicoplanin this term only<BR/>#21      MeSH descriptor Vancomycin this term only<BR/>#22      MeSH descriptor Floxacillin this term only<BR/>#23      MeSH descriptor Gentamicins this term only<BR/>#24      MeSH descriptor Cephalexin this term only<BR/>#25      (antibiot* in All Text or "anti biot*" in All Text or anti-biot* in All Text)<BR/>#26      (penicillin* in All Text or erythromycin* in All Text or metronidazol* in All Text or cephalosporin* in All Text)<BR/>#27      (sulphonamide* in All Text or tetracycline* in All Text or clindamycin* in All Text or clindamicin* in All Text or augmentin* in All Text or flagyl* in All Text or amoxyl* in All Text or amoxil* in All Text or co-amox* in All Text or antifungal* in All Text or anti-fungal* in All Text or "anti fungal*" in All Text or teicoplanin* in All Text or vancomycin* in All Text or vancomicin* in All Text or flucloxacillin* in All Text or floxacillin* in All Text or gentamicin* in All Text or gentamycin* in All Text or cephalexin* in All Text)<BR/>#28      (antibacterial in All Text or anti-bacterial in All Text or "anti bacterial" in All Text)   <BR/>#29      (#14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28)<BR/>#30      (#13 and #29)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-10-04 18:06:06 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-10-04 18:05:16 +0100" MODIFIED_BY="[Empty name]">MEDLINE via OVID search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-10-04 18:06:06 +0100" MODIFIED_BY="[Empty name]">
<P>1.         exp TOOTH EXTRACTION/<BR/>2.         exodontia.mp.                                    <BR/>3.         ((tooth adj4 extract$) or (teeth adj4 extract$) or ("third molar$" adj4 extract$) or ("3rd molar$" adj4 extract$) or "dental extract$" or (tooth adj4 remov$) or (teeth adj4 remov$) or ("third molar$" adj4 remov$) or ("third molar$" adj4 remov$) or (tooth adj4 surg$) or (teeth adj4 surg$) or ("third molar$" adj4 surg$) or ("3rd molar$" adj4 surg$)).mp.           <BR/>4.         1 or 2 or 3                               <BR/>5.         MOLAR/                                 <BR/>6.         TOOTH IMPACTED/                                    <BR/>7.         ("wisdom tooth" or "wisdom teeth" or (third adj3 molar$) or (3rd adj3 molar$)).mp.                        <BR/>8.         "impacted tooth".mp.                         <BR/>9.         "impacted teeth".mp.                         <BR/>10.       (5 or 6 or 7 or 8 or 9) and (extract$ or remov$ or surg$).mp.                       <BR/>11.       10 or 4                                    <BR/>12.       exp ANTIBIOTICS/                            <BR/>13.       ANTIBIOTIC PROPHYLAXIS/                                  <BR/>14.       ERYTHROMYCIN/                           <BR/>15.       METRONIDAZOLE/                          <BR/>16.       TETRACYCLINES/                           <BR/>17.       CLINDAMYCIN/                                <BR/>18.       TEICOPLANIN/                                 <BR/>19.       VANCOMYCIN/                                <BR/>20.       FLOXACILLIN/                                  <BR/>21.       GENTAMICINS/                                <BR/>22.       CEPHALEXIN/                                  <BR/>23.       (Antibiot$ or "anti biot$" or anti-biot$).mp.<BR/>24.       (penicillin$ or erythromycin$ or Metronidazol$ or Cephalosporin$).mp.<BR/>25.       (antibacterial or anti-bacterial or "anti bacterial").mp.<BR/>26.       (sulphonamide$ or tetracycline$ or clindamycin$ or clindamicin$ or augmentin$ or flagyl$ or amoxyl$ or amoxil$ or co-amox$ or antifungal$ or anti-fungal$ or "anti fungal$" or teicoplanin$ or vancomycin$ or vancomicin$ or flucloxacillin or floxacillin or gentamicin$ or gentamycin$ or cephalexin$).mp.                 <BR/>27.       or/12-26                                  <BR/>28.       27 and 11</P>
<P>The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the<I> Cochrane Handbook for Systematic Reviews of Interventions</I> version 5.1.0 (updated March 2011).</P>
<P>1. randomized controlled trial.pt.<BR/>2. controlled clinical trial.pt.<BR/>3. randomized.ab.<BR/>4. placebo.ab.<BR/>5. drug therapy.fs.<BR/>6. randomly.ab.<BR/>7. trial.ab.<BR/>8. groups.ab.<BR/>9. or/1-8<BR/>10. exp animals/ not humans.sh.<BR/>11. 9 not 10</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2012-10-04 18:06:13 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2012-10-04 18:06:13 +0100" MODIFIED_BY="[Empty name]">EMBASE via OVID search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-25 15:50:22 +0000" MODIFIED_BY="[Empty name]">
<P>1.         exp TOOTH EXTRACTION/<BR/>2.         exodontia.ti,ab.                                   <BR/>3.         ((tooth adj4 extract$) or (teeth adj4 extract$) or ("third molar$" adj4 extract$) or ("3rd molar$" adj4 extract$) or "dental extract$" or (tooth adj4 remov$) or (teeth adj4 remov$) or ("third molar$" adj4 remov$) or ("third molar$" adj4 remov$) or (tooth adj4 surg$) or (teeth adj4 surg$) or ("third molar$" adj4 surg$) or ("3rd molar$" adj4 surg$)).ti,ab.<BR/>4.         1 or 2 or 3                               <BR/>5.         exp TOOTH/                          <BR/>6.         ("wisdom tooth" or "wisdom teeth" or (third adj3 molar$) or (3rd adj3 molar$)).ti,ab.                                   <BR/>7.         "impacted tooth".ti,ab.                                    <BR/>8.         "impacted teeth".ti,ab.                                    <BR/>9.         or/5-8                          <BR/>10.       (extract$ or remov$ or surg$).ti,ab.                           <BR/>11.       9 and 10                                 <BR/>12.       4 or 11                                    <BR/>13.       exp ANTIBIOTIC AGENT/                            <BR/>14.       ANTIBIOTIC PROPHYLAXIS/                                  <BR/>15.       METRONIDAZOLE/                          <BR/>16.       (Antibiot$ or "anti biot$" or anti-biot$).ti,ab.                            <BR/>17.       (penicillin$ or erythromycin$ or Metronidazol$ or Cephalosporin$).ti,ab.<BR/>18.       (antibacterial or anti-bacterial or "anti bacterial").ti,ab.                                  <BR/>19.       (sulphonamide$ or tetracycline$ or clindamycin$ or clindamicin$ or  anti-fungal$ or "anti fungal$" or teicoplanin$ or vancomycin$ or vancomicin$ or flucloxacillin or floxacillin or gentamicin$ or gentamycin$ or cephalexin$).ti,ab.<BR/>20.       or/13-19                                  <BR/>21.       12 and 20</P>
<P>The above subject search was linked to the Cochrane Oral Health Group filter for EMBASE via OVID:</P>
<P>1. random$.ti,ab.<BR/>2. factorial$.ti,ab.<BR/>3. (crossover$ or cross over$ or cross-over$).ti,ab.<BR/>4. placebo$.ti,ab.<BR/>5. (doubl$ adj blind$).ti,ab.<BR/>6. (singl$ adj blind$).ti,ab.<BR/>7. assign$.ti,ab.<BR/>8. allocat$.ti,ab.<BR/>9. volunteer$.ti,ab.<BR/>10. CROSSOVER PROCEDURE.sh.<BR/>11. DOUBLE-BLIND PROCEDURE.sh.<BR/>12. RANDOMIZED CONTROLLED TRIAL.sh.<BR/>13. SINGLE BLIND PROCEDURE.sh.<BR/>14. or/1-13<BR/>15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/<BR/>16. HUMAN/<BR/>17. 16 and 15<BR/>18. 15 not 17<BR/>19. 14 not 18</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2012-10-04 18:06:29 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2012-10-04 18:06:29 +0100" MODIFIED_BY="[Empty name]">LILACS via BIREME search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-01-25 15:50:41 +0000" MODIFIED_BY="[Empty name]">
<P>(Mh Tooth extraction or Mh Extracción Dental or Mh Extração Dentária or ((Tw tooth or Tw teeth or Tw molar$ or Tw dental) and (Tw extrac$ or Tw remov$ or Tw surg$))) [Words] and (Mh Anti-Bacterial Agents or Mh Agentes Antibacterianos or Mh Antibiotic Prophylaxis or Profilaxis Antibiótica or Mh Antibioticoprofilaxia or antibiot$ or "anti biot$" or anti-biot$ or antibacte$ or anti-bacte$ or "anti bacte$" or penicillin$ or erythromycin$ or metronidazol$ or cephalosporin$ or sulphonamide$ or tetracycline$ or clindamycin$ or clindamicin$ or augmentin$ or flagyl$ or amoxyl$ or amoxil$ or co-amox$ or teicoplanin$ or vancomycin$ or vancomicin$ or flucloxacillin$ or floxacillin$ or gentamicin$ or gentamycin$ or cephalexin$) [Words]</P>
<P>The above subject search was linked to the Brazilian Cochrane Center filter for LILACs via BIREME:</P>
<P>Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct animal AND NOT (Ct human and Ct animal)))and not (Ct ANIMAL AND NOT (Ct HUMAN and Ct ANIMAL)))</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;15 studies included in quantitative synthesis (meta-analysis), and 3 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 studies (21 references) included in this review&lt;/p&gt;" WIDTH="160">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 further studies identified from searches of reference lists of included studies&lt;/p&gt;"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;16 studies (19 references) met the inclusion criteria&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;56 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1053 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1053 records after duplicates removed&lt;/p&gt;" WIDTH="120"/>
<OUT TEXT="&lt;p&gt;997 records discarded as not relevant based on title and abstract&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;37 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>